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JiBstract 
ABSTRACT 
The thesis entitled, "Derivatization of Selected Fatty Acids" consists of six 
chapters. The work is based on the synthesis of fatty acid derivatives of olefinic and 
hydroxylolefinic fatty acids. Preparation of such derivatives is a valuable addition to 
the fatty acid chemistry. The synthesized compounds were further screened for their 
antimicrobial activity. 
1. SYNTHESIS OF FATTY HYDRAZONES* 
Eight different hydrazones V-Vm and IX-XH were synthesized from four 
fatty acid hydrazides namely undecanoic hydrazide (I), octadecanoic hydrazide (II), 
12-hydroxyoctadecanoic hydrazide (HI) and 9-hydrOxyoctadecanoic hydrazide (TV) 
by condensing them with carbonyl group of methyl acetoacetate and acetylacetone. 
The structural elucidation of these compounds is based on their spectral data (IR, H 
NMR,^^CNMRandMS). 
CH3 
CH3COCH2COOCH3^ RCONHN=CCH2COOCH3 
RCONHNH2 
(I-IV) 
Abs. ethanol. Reflux (V-Vni) 
CH3 
CH3COCH2COCH3 RCONHN=CCH2COCIl3 
Abs. ethanol. Reflux „- . „ „ 
Compound R 
I, V, IX CH3(CH2)9 
n,vi,x CH3(CH2)i6 ,xSV 
III, Vn, XI CH3(CH2)5CHOH(CH2)]o 
IV, Vm, Xn CH3(CH2)8CHOH(CH2)7 
Scheme 1: Sjmthesis of hydrazones from hydrazides. 
\^' 
* The work has been published. "Synthesis, characterization and antimicrobial 
activity of long-chain hydrazones" Abdul Rauf, Mudasir R. Banday and Rayees H. 
Manoo, Acta Chim. Slov., 2008, 55, 448-452. 
(i) 
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2. SYNTHESIS OF 2,5-DISUBSTITUTED-l^,4-OXADIAZOLES* 
Fatty acid hydrazides namely undec-10-enoic (XIII), (9Z)-octadec-9-enoic 
(XIV). (9Z,12/?)-12-hydroxyoctadec-9-enoic (XV) and (9^,122)-9-hydroxyoctadec-
12-enoic acids (XVI) were used as cheap starting materials in the synthesis of 5-
(alkenyl)-2-amino-l,3,4-oxadiazoIe (XVH-XX) and 2-(alkenyl)-5-phenyl-1.3,4-
oxadiazole (XXI-XXIV) using cyanogen bromide and benzoic acid or benzoyl 
chloride as reagents, respectively. The structure of these compounds was confirmed 
by IR, ' H N M R , '^C N M R and mass spectra. 
O 
II 
R-C-NH-NH2 
(xm-xvi) 
CNBr 
Dry,MeOH 
PhCOOH or PhCOCl 
POCl3,CIC2H4Cl 
O O 
I^ R-C-NH-NH-C-Ph J 
N- -N 
W 
•NH2 
O' 
(xvn-xx) 
• N 
W 
o ' 
(xxi-xxrv) 
Ph 
Compound 
XIII, x v n , XXI 
XIV, xvm, xxn 
XV, XDC, x x m 
XVI, XX, XXIV 
R 
CH2=CH-(CH2)8 
CH3-(CH2)7-CH=CH-(CH2)7 
CH3-(CH2)5-CH(OH)-CH2-CH=CH-(CH2)7 
CH3-(CH2)4-CH=CH-(CH2)2-CH(OH)-(CH2)7 
Scheme 2: Synthesis of 2,5-disubstituted-l,3,4-oxadiazoles. 
*This work entitled "Synthesis, characterization and antibacterial activity of 5-
(alkenyl)-2-amino- and 2-(alkenyl)-5-phenyI-l,3,4-oxadiazoles" has been awarded 
"Young Scientist Award" 2007, from Indian Council of Chemists at Dr. H. S. Gaur 
University, Sagar (M.P.) INDIA. 
(ii) 
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3. SYNTHESIS OF 2,5-DISUBSTITUTED-l,3,4-THIADUZ::,LES* 
Lenzoylisothiocynate a versatile reagent for synthesis of different 
thiosemicarbazides was prepared according to known literature method. Fatty acM 
hydrazides Xni-XVI were dissolved in minimum amount cf ethyl acetate and adaed 
portion wise to benzoylisothiocynate solution while stirring at refluxing temperature 
for 3 hrs. Removing the excess solvent the compound was precipitated which was 
filtered and recryslallized from benzene-chK''form to gi\e thiosemicarbazides 
XXV-XXVni. These thiosemicarbazides on stirring with concentrated sulphuric 
acid at 0°C for 1 hr afforded 1,3,4-thiadiazoles XXIX-XXXII in quantitative yields. 
(xxv-xxvni) (xxi^ 'XII) 
R 
Compound R 
XXV, XXDC CH5=CH-(CH2)8 
XXVI, XXX CH3-(CIT.)7-CH=CH-(CH2)7 
XXVn, XXXI CH3- •:CH2)5-CH(OH)-CH2-CH=CH-(CH2)7 
xxvm, xxxn ^' :'^:'I?;4-CH-CH-(CH2)2-CH(OH)-(CH2)7 
Scheme 3; Synthesis of thioscmiccj-oazide^ an'^  2,5-disubstitutca-l,3,4-thi&Jia2oles 
4. SYNTHESIS OF 1,2,4-TRIAZlyLES \ND 4-CXO-l,3-THlA OL^DLVES ^ 
The compounds 5-alkenyl-1-phenyl-3-thione-2/^-l,2,4-triazoIes (XXXVH-
XL) and N-[4-oxo-2-(phenyIimino}-thiazolidin-3-yl]-aIkenamides (XU-ZIAV) 
nave been syathesized from different fatt>* thiosemicarbazides XXXni-XXXVI by 
refluxing with NaOH and chloroacetyl chloride respectivelly. The structural 
elucidation of these compounds is based on IR, 'H NMR, '^C NMR, mass spectral 
data and elemental analysis. 
*'rhe work has been published. "Synthesis and evaluation of in vitro antibacterial 
activity of novel 2,5-disubstituted-l,3,4-thiadiazoles from fatty acids" Mudasir R 
Banday ana Abdul Rauf, Chin. Chem. Utt. 2008, 79, 1427-1430. 
^ The work has been accepted for publication entitled, 'Substituted 1,2,4-triazoles 
and thiazolidinones from fatty acids: Spectral characterization and antimicrobial 
activity" Mudasir R Banday and Abdul Rauf, Ind. J. Chem. Sec B. 
(iii) 
JLSstract 
0 S A X 
R^C—NH-NH—C-NH—/ \ 
(xxxra-xxxvi) \ ^ = / 
a 
u 
N-NH 
N 
0 
R — C - N H — N — ^ \ _ / 
N-
(xxxvn-XL) 
Compound 
XXXIII, xxxvn, XLi 
XXXIV, XXXVm, XLH 
XXXV, XXXIX, xLm 
XXXVI, XL, XLIV 
o 
(XLI-XLIV) 
R 
CH2=CH-(CH2)8 
CH3-(CH2)rCH=CH-(CH2)7 
CH3-(:H2)5-CH(OH)-CH2-CH=CH-(CH2)7 
CH3-(CH2)4-CH=CH-(CH2)2-CH(OHHCH2)7 
Scheme 4; Synthesis of 1,2,4-triazoIes and 4-oxo-l,3-thiazoHdines. 
5. SYNTHESIS OF FATTY ACID ANALOGS OF CHOLESTEROL 
Synthesis and spectral studies of new cholesterol analogs containing CI 1 and 
C18 fatty acids has been reported. Fatty acids incorporated at the 3p-hydroxy group 
of cholesterol (LI) are undec-10-enioc (XLV), 10,11-dibromoundecanoic (XLVI), 
10,11-epoxyundecanoic acid (XLVII), (9Z)-octadec-9-enoic (XLVm), (9Z,12/?)-
12-hydroxyoctadec-9-enoic (ricinolic XLIX) acid and (9i?,12Z)-9-hydroxyoctadec-
12-enoic (isoricinolic L) acid and that of 5a,6p-dibromocholestrol (LII) are undec-
10-enioc (XLV) and 10,11-dibromoundecanoic (XLVI). DCC and DMAP were 
used as reagents for the esterification. 
(iv) 
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o 
II 
R—C-OH 
(XLV-L) 
O 
R—C—O 
(LHI, LV, LVn-LX) 
Compound R 
XLV, Lm, LIV CH2=CH—(CH2)8 
XLVI, LV, LVI CH2-CH—(CH2)8 
Br Br 
(LIV, LVI) 
XLvn, Lvn 
XLvm, Lvm 
XLIX, LIX 
L,LX 
CH2-CH—(CH-^ V V 
CH3—(CH^V-CH-^CH—(CH2>7 
CH3—(CH,.)5—CH-CH2—CH=CH—(CH2>7 
OH 
CH3—(CH2)4~CH=CH—(CH2)2—CH—(CH2>7 
OH 
Scheme 5: Synthesis of different fatty acid analogs of cholesterol. 
6. \NTIMICROBLVL ACTIVITY OF SYNTHESIZED COMPOUNDS 
The in vitro antibacterial activity of hydrazones V-Xn was earned out 
against Gram-negative bacteria Escherichia coH and Gram-positive bacteria 
Staphylococcus aureus and Staphylococcus albus. Antibacterial activity of 2,5-
disubstituted oxadiazoles XVII-XXIV, triazoles XXXVH-XL and oxathiazolidins 
XLI-XLIV was carried cut against E. coli, , Enterobacter aerogenes and S. aureus 
(V) 
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while as the same activity of 2,5-disubstituted thiadiazoles XXV-XXXn was carried 
out against Gram-negative bacteria E. coii. Salmonella typhii and Gram-positive 
bacteria S. aureus and S. albus. 
The in vitro antibacterial activities of LUI to LX were tested using the 
bacterial cultures of Streptococcus mutants, Pseudomonas aeruginosa, S. aureus. 
Streptococcus pyogenes. Salmonella typhimurium, E. coli and fiingal cultures of 
Candida albicans, Candida krusei, Candida parapsilosis, Cryptococcus 
neoformans, by the disk diffusion method and then the minimum inhibitory 
concentration (MiC) of all the compounds were determined. 
Most of the compounds exhibited moderate to good activity. The new 
synthesized compounds may be more efficient against microbes for which a 
thorough study of these compounds has to be performed. 
.^t<5 
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Introduction 
INTRODUCTION 
Abundant fatty acids from natural sources are recognized as a versatile group 
of chemicals in oleochemical industry Since the past two decades the utilization of 
fatty acids as agrichemicals finds their way into industries not only in a simple acid 
or ester form but also through derivatization. The reactions of fatty acids are readily 
accepted to lead towards general perfection of the development and progress of 
organic chemistry. 
The recent trends in technology of fats and fatty acids have given importance 
to such industrial processes as polymerization, oxidation and metathesis 
Consequently fatty acids have increasingly been found usable as specific and 
characteristic base materials for the emerging organic chemical industry. 
In recent years the attention of chemists has been diverted to synthesize 
oleochemicals (oils/fats derived chemicals) due to ever-increasing cost of 
petrochemicals Oleochemicals by virtue of their economic and ecological 
advantages are now competing with petrochemicals. These fat-derived chemicals are 
essential to a variety of industrial uses such as in coatings, surfactants, plasticizers, 
lubricant additives, cosmetics, pharmaceuticals and organic pesticides. 
The widespread occurrence of heterocyclic compounds in nature such as 
alkaloid, vitamin and variety of plant and animal cell constituents is widely known. 
The current research in organic chemistry development and closely allied branches 
of biology is characterized by extensive investigation of physiologically active 
compounds encountered in the plant and animal world. The search for these active 
constituents which control the biological process of various systems has acted as 
powerful stimulus to the further development of chemistry of the heteroatom and 
heterocyclic compounds. A survey of literature reveals that long-chain fatty acids 
possessing a heteroatom or heterocyclic ring in the chain are a rarity in nature. 
However some long-chain furanoid, epoxy and cyclopropene esters have been 
reported as minor constituents of oils and fats. 
A variety of new industrially and biologically useful compounds can be thus 
prepared by taking advantage of the inherently present functional groups in fatty 
•vrTJ^ii^ 
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acids. The functionalities of the alkyl chain or derivatization of the chain functional 
groups could provide a host of new fatty chemicals One of the more exciting 
properties of fatty acid derivatives is their insecticida! and antimicrobial activities 
Keeping in view the aforementioned importance of heteroatom and 
heterocyclic compounds, the hydrazones, oxadiazoles, thiadiazoles, triazoles, 
oxothiazoiidines and fatty-alkenoates have been synthesized from olefmic and 
hydroxyolefmic fatty acids. Further, these synthesized compounds were screened for 
their antimicrobial activity. 
CHAPTEE-1 
Syntfiesis of Tatty 
!Hydrazones 
^atty Ifydrazones 
I.ITHEORITICAL 
Hydrazones are the class of organic compounds with general formula 
R2C=NNR2, which are usually prepared from aldehyde or ketone by replacing =0 
by =NNH2 (or substituted analogues) Hydrazones have been found to possess 
diverse pharmacological properties which include antimicrobial^''^, antitubercular'^ ''*, 
anticonvulsant^ antiinflamatory'' and antiprotozoal^ activities. Hydrazones are also 
known as very effective charge transporting compounds. Together with polymer 
binders hydrazones are used in electrophotographic photoreceptors.*''" Pyridoxyl 
isonicotinyl hydrazones and its analogues are proposed chemotherapeutics^' 
functioning as iron chelators for treatment of iron loaded diseases. 
Development of resistance to existing drugs is a constantly growing 
phenomenon that has concerned researchers throughout the world and has now 
reached alarming levels for certain infectious diseases In view of drug resistance 
problem, it is important that new drugs inhibit targets different from those of 
currently used drugs. Antibacterial resistance to dmgs can be countered by designing 
new derivatives. There are two basic approaches to develop new drugs: 
(a) Synthesis of analogues, modification or derivatization of existing 
compounds. 
(b) Searching for novel structures that the drug resistant organism has never 
been presented before. 
To pursue this goal, our research efforts are directed to synthesize derivatives 
of the compounds which are known to have their own biological activities and fatty 
acids are one such class of compounds Being the most important and widely 
distributed constituent of seed oils, fatty acids are extensively studied as they can be 
of high value for the chemical and pharmaceutical industry '^•''' Fatty acid 
derivatives have been found to be associated with diverse biological activities such 
as herbicidal,'^ antifeedant,^^ neuroprotective,'^ bactericidal,^^ ftingicidal,^ 
antioxidant, ^ ° antimicrobial,'^'^^ antiparasitic,^^ antifogging,^ "* and anti-
inflammatory,^^ Thus use of fatty acid substrates as starting materials has become 
significant because of their own biological activities 
^atty JCydrazcmes 
On thQ basis of these observations, we had the impetus to synthesize a 
number of hydrazones of fatty acids and subsequently evaluate their m-vitro 
antimicrobial activities (Chapter 6). 
A number of methods for synthesis of hydrazones have been reported''The 
convenient synthesis of hydrazones involves reaction of an aldehyde or ketone with 
a hydrazide in water by shaking, in alcohol at reflux temperature or by refluxing 
hydrazide with same aldehyde or ketone. 
YaXeetal.^ have synthesized different hydrazones from isonicotinohydrazide 
(1) by different methods Isobutyraldehyde isonicotinylhydrazone (3) was prepared 
by shaking compound 1 with freshly distilled isobutyraldehyde (2) in water. 
/ = \ V \ CH3 / = x 0 CH3 
N > - C - N H N H 2 +-H—C—CH ^ ^ ' " > N^ > — C - N H N = C H — C H 
Isonicotino-hydrazide (1) on refluxing with excess of acetone (4) gave 
acetone isonicotinylhydrazone (5). 
O 0 ^ 0 
. / = \ I  ... I  „. . / -^ CH N >—C -NHNH2+CH3— t—CH3 M^}^^ n y-C - N H N - C / 
\ _ / '^ // ^ C H 
Reaction of 2-fliroic acid hydrazide (6) with 4-acetamidobenzaldehyde (7) in 
aq ethanol gave 4-acetamidobenzaldehyde-2-fUroylhydrazone (8) 9-Hendecenal 
isonicotinylhydrazone (9) was changed to hendecanal isonicotinylhydrazon (10) at 
50 Lb of hydrogen in presence of platinum oxide in 95% ethanol. 
Tatty IfydrazoTies 
0 
-C-NHNH2 + H - C 
F / = o 
II 
NH-C—CH3 
O 
II 
NH-C—CH3 
N 
/ • 
O 
N \ C-NHN=CH—(CH2)7—CH=CH-CH3 
0 
\J .C-NHN=CH—(CH2)9 CH3 
10 
Ottana et al.^^ synthesized tri flu oroacet aldehyde (12a) and 1,1,1 
trifluoroacetone isonicotinylhydrazones (12b) by reacting trifluoroacetaldehyde 
ethyihemiacetal or 1,1,1 trifluoroacetone (11) in ethanol having catalytic amount of 
6M HCl with compound 1 and refluxed for 48 hrs. 
C-NHNH2 + 0 = C 
R 
CF3 
Ethanol 
Reflux, 48 hrs N 
r^ 
n 
Compound 
12a 
12b 
R 
H 
CH3 
O 
-C-NHN=C 
12a,b 
R 
CF. 
Hydrazones (14a-f) of dihydrazide of l,3,4-thiadiazole-2,5-dithiogIycolic 
acid (13) were prepared by reacting it with different aldehydes at 70°C for 1 hr.^ ^ 
Tatty ^ Cyirazones 
H2NNHCCH2S 
o 
R^R^C=NNHCCH2S 
O 
N ~ N 
SCH2CNHNH2 
O 
R'R^CO 
N - N 
S 
14a-f 
S C H 2 C N H N = C R ' R ^ 
o 
Compound 
14a 
14b 
14c 
14d 
14e 
14f 
R' 
H 
H 
H 
H 
CH3 
CH3 
R^ 
CH3 
C4H3O 
2-HO,3-CH30C6H3 
4-CH3OC6H4 
3,4-(OCH20)-C6H3 
2,4-(OH)2-C6H3 
Richardson et al}^ reported a series of pyridoxyl hydrazones (17a-f) via 
Schiff base condensation of an aromatic aldehyde, pyridoxal (16), with an acid 
hydrazide (1,15a-e) in one step. 
Ph 
O 
I- NHNH, 
+ 
1, ISa-e 
H 
0=i OH 
HO ^ N 
16 
-CH, 
0 H 
II I 
Ph—C-NHN=-C OH 
-CH3 
HO ' ^ N 
17a-f 
Tatty 9Cydrazones 
Compound Ph Compound Ph 
1,17a 
15a, 17b 
\ // 
N 
\ / 
15c, 17d 
15d,17e 
\ / 
OCH^ 
15b,17c v// 15e, 17f 
Rutavichyus and Valyulene^* further reported a series of hydrazones (19a-f) 
of S,S'-(l,3,4-thiadia2oIe-2,5-diyl)bis(2-mercaptopropionic acid) dihydrazide (18) 
by stining at 70°C with different aldehydes or ketones for 1.5 hr. 
CH3 N - N CH3 
NR /L J . X /L .NH-
NH2' 
0 18 O 
•NH2 
2 1 ^NH^ R V C = N 
Compound 
19a 
19b 
19c 
19d 
19e 
19f 
CH3 
II 
0 
R^ 
H 
H 
H 
H 
C3H7 
CH3 
' 
R'R^CO 
N - N CH3 
19a-f ^ 
R^ 
2,3-(OCH3)2-C6H3 
2,4-(OH)2-C6H3 
2-HO,3-CH30C6H3 
4-(CH3)2NC6H4 
C3H7 
3,4-(OCH20)-C6H3 
Tatty Ifydrazones 
A series of different glass foaming hydrazones (22a,b) were synthesized by 
reacting N,N-diphenyl hydrazine hydrochloride (21a) or N-methyl-N-phenyJ 
hydrazine hydrochloride (21b) with different substituted carbaldehydes (20a,b) 
under reflux conditions.^^ 
+ NH2-N' 
20a,b 21a,b 22a, b 
Compound 
20a 
20b 
21a 
21b 
22a 
22b 
R' 
CHO 
CHO 
-
-
-
-
R^ 
H 
CHO 
-
-
-
-
R' 
-
-
C6H5 
CH3 
CfiHj 
CH3 
R^ 
-
-
-
-
H 
=N-N(R^)-
Rutavicius and Kuodis^^ have further reported hydrazones of [5-(4-pyridyl)-
l,3,4-oxadiazol-2-yUhio]acetic acid 4-ethoxy-4-oxo-2-butylidenehydrazide (24a) 
and [5-(4-pyridyl)-l,3,4-oxadiazol-2-ylthioJacetic acid ethoxymethylidenehydrazide 
(24b) by refluxing 23 with excess of ethylacetoacetate or ethyl orthoformate at 105-
llO^Cforlhrs. 
Tatty Kydrazones 
N 
N - N 
0 ' S 
23 
NK 
NH2 
N // 
o 
is' 
.NH^ 
O 
24a 
N 
O 
\ 
0 
N - N 
) 
X 
,NH 
N H ^ 0 
O 
24b 
Roiias et al' rqwrted a series of hydrazones of 4-fIuorobenzoic acid hydrazide (25) 
by condensing with different aldehydes (26a-d) in water. 
-CONHNH2 + 0 = - C H — A T ^20 ^ F 
25 26a-d 
-CONHNH=CH~Ar 
27a-d 
Compound Ar Compound Ar 
26a, 27a 26c, 27c 
O' •NO2 \ // 
NO2 
26b,27b 26d,27d 
^ > - N 0 . 
O2N 
Refluxing 2-hydroxy acetophenone (28) with compound 1 in the presence of 
glacial acetic acid in ethanolic medium for 9 hrs to give acid hydrazone (29)."'^  
Tatty 9€ydrazones 
CH 
N. 
\ 
CONHNH2 +0=C CH3COOH C2H5OH N \\ 
CH3 
•CONHNH==C— l\ / 
HO HO 
28 29 
Cacic et al synthesized hydrazones of (7-hydroxy-2-oxo-2H-chromen-4-
yl)-acetic acid hydrazide (30) by reacting with appropriate aromatic aldehyde or 
with a diketone. 
O 
o o 
NH. 
o ^ \ 
hfH' 
.0 , 
O 
o 
,NH^  
NH' 
30 
H O ^ ^ ^ ^ O ^ ^ O 
31 
O 
0 i 
AT-" ^ H 
NH Ar 
32a-f 
Compound Ar 
32a 
32b 
/ \ 
HO 
/ \ 
CI. 
32c / \ 
Compound Ar 
CI 
32d 
32e 
/ \ 
HO OH 
/ \ 
HO 
32f / \ OH 
A series of hydrazones of 4-substituted benzoic acid hydrazide (33) were 
synthesized by reacting with substituted aldehydes in ethanol.^ 
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R 
-CONHNH2 + 0 -=CH—AT ^^^^^ KR-
33 34 
Reflux 2-2.5hrs 
-CONHNH=€H—AT 
35a-j 
Compound R Ar 
35a H O2N 
Compound R 
35f 
Ar 
F O2N. .0. 
35b 
35c 
H 
Br 
r\ 
r\ 
35g 
35h 
-NO-
35d CI O2N- 35i NO2 *^2N. 
35e CI O2N .0. 35j NO2 
Siriram et al}^ further reported hydrazones (37a-d) of diclofenac acid in 
moderate yields by carrying out a reaction between diclofenac acid hydra^ide (36) 
and appropriate aldehydes in ethanol by stirring at room temperature for 1 hr. 
NHNH2 
36 
O 
\ / 
R" "R ' 
•*- Cf 
NHN: 
NH 0 
r^ 
37a-d 
R 
R' 
U 
Tatty Kydrazones 
Compound R R' 
37a, 37b 
37c, 37d 
H 
CH3 F 
COOH F 
COOH 
COOH 
COOH 
Ming et al?^ synthesized trifluoromethyl benzoyl-hydrazone (39) in 
quantative yields using diketone-ethyl acetoacetate and trifluoromethyl benzoyl 
hydrazide (38). 
O 0 0 
NH2 
NH OC2H5 
CF. CFi 
38 
O CH3 
/N-^C-CHjCOOCjHs 
NH 
39 
Metwally et ai^^ obtained hydrazones (41a-h) of 2-aryl-quinoline-4-
carboxylic acid hydrazide by condensing the acid hydrazides (40) with the 
appropriate aldehydes in glacial acetic acid under reflux conditions. [X= H, CI ] 
X, 
CONHNH, 
• N ' 
R' 
~R 
40 41a-h 
12 
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Compound 
41a 
41b 
41c 
41d 
R 
H 
H 
CI 
CI 
R 
H 
4-Cl 
4-Br 
4-OCH3 
Compound 
41e 
41f 
41g 
41h 
R 
CH3 
CH3 
OCH3 
OCH3 
R 
2-NO2 
4-NO2 
4-Cl 
4-OCH3 
Isatin (44a-d) and benzoisatin (44e-h) hydrazones were prepared by carrying 
out reaction between isatin and benzoisatin with different secondary amine acetic 
acid hydrazides in ethanol and 3 ml of 12M HCl and boiling the contents for 10 
mm. 
34 
\ HCl Conc.EtOH, b.p 
^ ^ 2 10 min, 45-80% * 
o y 
mm NRn 
Compound 
44a, 44e 
44b,44f 
44c 44g 
R 
H/-(CH=CH)2-
H/-(CH=CH)2-
H / -(CH-CH)2-
NR2 
N 
^ ^ C H 3 
-CH3 
A 
N 
/ 
O N 
44d,44h H/-(CH=CH)2- N 
Recently Kuodis et al^^ reported a series of 2-(5-thioxo-4,5dihydro-l,3,4-
thiadiazoie-2-yhhio) aceto hydrazide by reacting with equimolar amount of an 
aldehyde or ketone in 1,4-dioxane and water by stirring for 3 hrs at 85°C. 
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NH-N 0 
/ w II 
Compound 
45a 
45b 
45c 
45d 
45e 
45f 
^Sg, ^Sh 
45i, 45j 
NH 
0 
R'--^R^ 
NH2 
R' 
H 
H 
H 
CH3 
CH3 
CH3 
H/CH3 
H/CH3 
NH-N 0 
/ W II 
45a-j 
R^ 
4-CH3O-C6H4 
2-HO,5-Br-C6H3 
2-HO,3-CH30-C6H3 
CeHs 
4-HO-C6H4 
2-CH3O-C6H4 
2-HO~C6H4 
2,4-HO-C6H3 
R^  
/ 
R' 
14 
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1.2 RESULTS AND DISCUSSION 
The required fatty acid hydrazides were prepared by stirring and refluxing 
the fatty esters with hydrazine hydrate in ethanol in the presence of air. Absence of 
peaks for olefinic protons (5 5.4-^.6) suggest that hydrogenation of double bond of 
the fatty acid chain has taken place. This indicates that hydrazine hydrate can 
hydrogenate double bonds in the presence of air. Such findings are already reported 
in the literature.^^'^^ The synthetic pathway followed for the synthesis of hydrazones 
is presented in the Scheme 1.1 to 1.8. Carbonyl group of methyl acetoacetate and 
acetylacetone has been employed to build the newly synthesized hydrazones from 
different fatty acid hydrazides. 
Reaction of undecanoic hydrazide (I) with methyl acetoacetate 
Fatty acid hydrazide I and methyl acetoacetate were refluxed in absolute 
efhanof with a catalytic amount of hydrochiotic acid for 3 firs to afford an oily 
product which was chromatographed over a column of silica gel using petroleum 
ether-diethyl ether (98:2 v/v) as an eluent to afford an oily compound V. 
O 0 0 
II II II 
CH3—(CH2)9—C-NHNH2 + CH3—C—CH2—C—OCH3 
(I) 
0 O 
II II 
CH3—(CH2)9— C -NHN=C-CH2—C—OCH3 
CH3 
(V) 
Scheme 1.1: Synthesis of methyl 3-(2 '-undecanoyJhydrazono)butanoate (V) 
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Structural elucidation of the compound 
undecanoylhydrazono) butanoate 
as methyl 3.(2'-
It was an oily compound which exhibited intensive IR bands at 3210 (NH), 
1743 (0=C0CH3), 1660 (0=C-NH), 1449 cm'' (C=N). The ' H N M R spectrum of 
compound V gave diagnostic signals at 5 10.35 (IH, s, NH, exchangeable with 
D2O), 3.66 (3H, s, OCH3), 2.01 (2H, s, C//2CO2CH3). 1.56 (3H, s, N=C-CH3). In 
'^C NMR characteristic peaks at 6 174.7 and 174.5 (COOCH3, CONH), 159,2 
(C=N) and 25.0 (COCH3) also supported the structure assigned. The MS spectrum 
of compound V showed molecular ion peak at m/z 298, an intense peak at 154 in 
addition to other fragment ions (detailed in experimental section). The struaure was 
further supported by its elemental analysis which was also in good agreement with 
the calculated values. Based on the above facts compound V was characterized as 
methyl 3-(2'-undecanoylhydrazono)butanoate 
Reaction of octadecanoic hydrazide (II) with methyl acetoacetate 
Refluxing octadecanoic hydrazide (H) with methyl acetoacetate in absolute 
ethanol for 4 hrs in presence of catalytic amount of hydrochloric acid gave a solid 
product after removing the excess solvent which was crystallized in ethanol to give a 
white powder. 
o 00 
II II II 
CH3—(CH2)i6—C-NHNH2 + CH3—C—CH2—C—OCH3 
(II) 
& 
o o 
CH3—(CH2)i6—C —NHN=C—CH2—C—OCH3 
CH3 
(VI) 
Scheme 1.2: Synthesis of methyl 3-(2'-octadecanoylhydrazono)butanoate (VI) 
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Structural elucidation of the compound VI as methyl 3-(2'-
octadecanoylhydrazono)butanoate 
It was a white powder showing IR bands at 3207 (NH), 1736 (O-COCH3), 
1658 (0=C-NH), 1455 cm"' (C=N). In 'H N M R diagnostic peaks at 5 10.35 (IH, s, 
NH, exchangeable with D2O), 3.66 (3H, s, OCH3), 1.94 (2H, s, C//2CO2CH3) and 
1.59 (3H, s, N=C-CH3) were observed. In "C NMR characteristic peaks at 6 174.8 
and 174.5 (COOCH3, CONH), 159.1 (C=N) and 25.1 (COCH3) were found which 
also supported the structure. The MS spectrum of compound VI showed molecular 
ion peak at m/z 396, an intense peak at 298 and other fragment ions were also 
observed (detailed in experimental section). Elemental analysis was also in good 
agreement with the calculated values. Thus keeping in view the above observations 
the compound VI was assigned as methyl 3-(2'-octadecanoylhydrazono)butanoate 
Reaction of 12-hydroxyoctadecanoic hydrazide (HI) with methyl acetoacetate 
A 4 hrs refluxing of 12-hydroxyoctadecanoic hydrazide (HI) with methyl 
acetoacetate in absolute ethanol with a catalytic amount of hydrochloric acid, a solid 
product was obtained after concentrating and cooling the reaction mixture which 
was crystallized in ethanol to give an off-white powder. 
O 0 0 
II II II 
CH3—(CH2)5—CH—(CH2)io—C-NHNH2 + CH5—C—CH2—C-OCH3 
an) OH 
c 
> 
*o 
o o 
II II 
CH3—(CH2)5—CH—(CH2)io-C-NHN=C-CH2—C-OCH3 
OH CH3 
(VH) 
Scheme 1.3: Synthesis of methyl 3-[2'-(12-hydroxyoctadecanoylhydrazono)]-
butanoate (VII) 
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Structural elucidation of the compound Vn as methyl 3-[2'-(12-
hydroxyoctadecanoy]hydrazono)]butanoate 
An off-white powder giving characteristic IR bands at 332l(OH), 3212 
(NH), 1737 (0=C0CH3), 1660 (0=C-NH) and 1458 cm' (C=N). The ' H N M R was 
more informative in assigning the structure. In addition to the normal fatty acid 
chain peaks, diagnostic peaks at 6 10.34 (IH, s, NH, exchangeable with D2O), 3.98 
(IH, m, CH-OH), 3.66 (3H, s, OCH3), 3.58 (IH, br. s, OH, exchangeable with D2O) 
1.91 (2H, s, C//2CO2CH3) and 1.59 (3H, s, N=C-CH3) were observed. '^ C NMR 
spectrum also supported the structure. Peaks at 6 174.44 and 174.40 (COOCH3, 
CONH), 159.2 (C=N), 72.1 (CH-OH) and 25.0 (COCH3) were observed. Molecular 
ion peak at m/z 412 and an intense peak at 297 were observed. Other fragment ions 
were also observed (detailed in experimental section). Elemental analysis was also 
in good agreement with the calculated values. Based on above findings the 
compound V n was named as methyl 3-[2'-(12-
hydroxyoctadecanoylhydrazono)]butanoate. 
Reaction of 9-hydroxyoctadecanoic hydrazide (IV) with methyl acetoacetate 
Refluxing of 9-hydroxyoctadecanoic hydrazide (IV) with methyl 
acetoacetate in absolute ethanol for 4 hrs with a catalytic amount of hydrochloric 
acid and concentrating and cooling the reaction mixture a solid product was obtained 
which was crystallized in ethanol to give a white powder. 
O 0 0 
11 II II 
CH3—(CH2)8—CH—(CH2>7—C-NHNH2 + CH/~C-CH2—C-OCH3 
OH (IV) 
O O 
!l 
CH3—(CH2)8—CH—(CH2)r-C-NHN=C-CH2—C-OCH3 
OH ( v m ) CH3 
Scheme 1.4: Synthesis of methyl 3-[2'-(9-hydroxyoctadecanoylhydrazono)]-
butanoate (Vm) 
Tatty Kydrazones 
Structural elucidation of the compound Vni as methyl 3-[2'-(9-
hydroxyoctadecanoylhydrazono)]butanoate 
Compound Vin was obtained as a white powder giving characteristic IR 
bands at 3327(OH), 3214 (NH), 1737 (O^COCHj), 1658 (0=C-NH) and 1459 cm-' 
(C=N). In ^H NMR spectrum diagnostic peaks at 6 10.35 (IH, s, NH, exchangeable 
with D2O), 4.11 (IH, m, C/f-OH), 3.66 (3H, s, OCH3X 3.58 (IH, br. s, OH, 
exchangeable with D2O) 1.91 (2H, s, C//2CO2CH3) and 1.55 (3H, s, N=C-CH3) 
were observed. '^C NMR spectrum also supported the structure assigned by showing 
peaks at 5 174.5 and 174.4 (COOCH3, CONH). 159.2 (C=N), 72.0 (CH-OH) and 
25.0 (COCHs)- Molecular ion peak at m/z 412 and an intense peak at 299 were 
observed. Other fragment ions were also observed (detailed in experimental section). 
Elemental analysis was also in good agreement with that of calculated values. Based 
on above facts the compound v n i was characterized as methyl 3-[2'-(9-
hydroxyoctadecanoylhydrazono)]butanoate. 
Reaction of undecanoic hydrazide (I) with acetylacetone 
Undecanoic hydrazide I and acetylacetone in equimolar ratio were refluxed 
for 4 hrs in absolute ethanol containing few drops of hydrochloric acid as a catalyst. 
After completion of reaction (monitored by TLC) the reaction mixture was 
concentrated and cooled to give an oily compound which was chromatographed over 
a column of silica gel using petroleum ether-diethyl ether (96:4 v/v) as eluent to give 
an oily compound IX. 
0 0 0 
II II II 
CH3—(CH2)9—C-NHNH2 + CH3—C—CH2—C—CH3 
f 
0 ' O 
II I! 
CH3—(CH2)9— C ~NHN=C—CH2—C—CH3 
CH3 
(IX) 
Scheme 1.5: Synthesis of A'"'-(4-oxopentane-2-yIidene)undecanohydrazide (IX) 
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Structural elucidation of the compound DC as 7V'-(4-oxopentane-2-ylidene)-
undecanohydrazide 
It was obtained as an oily compound showing intensive IR bands at 3205 
(NH), 1721 (C=0) and 1664 cm"^  (0=C-NH) confirming the presence of these 
functional groups. The ' H N M R data gave characteristic peaks at 6 10.33 (IH, s, 
NH), 2.04 (3H, s, CH3), 1.94 (2H. s, CHz-COCB.^) and 1.56 (3H, s, N=C-CH3) 
supporting the structure. In '^ C NMR signals at 5 174.4 and 174.3 (COOCH3 and 
CONH), 161.3 (C=N) and 29.2 (COCH3) were observed. The MS spectrum of 
compound IX showed molecular ion peak at m/z 282, an intense peak at 137 besides 
other fragment ions (detailed in experimental section). The observed elemental 
analysis data found was in good agreement with that of calculated values. Thus 
keeping in view the above observations the compoimd IX was assigned as 7V'-(4-
oxopentane-2-ylidene)undecanohydrazide. 
Reaction of octadecanoic hydrazide (II) with acetylacetone 
Refluxing of octadecanoic hydrazide (H) with acetylacetone in absolute 
ethanol for 4 hrs with a catalytic amount of hydrochloric acid and removing excess 
solvent from the reaction mixture gave a solid product which was crystallized in 
ethanol to give a white crystal. 
O 0 0 
II II II 
CH3—(CH2)i6—C-NHNH2 + CH3^C—CH2—C—CH3 
(11) 
& 
ii II 
CH3—(CH2)i6—C ~NHN=C—CH2—C—CH3 
CH3 
(X) 
Scheme 1.6: Synthesis of7 '^-(4-oxopentane-2-ylidene)octadecanohydrazide (X) 
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Structural elucidation of the compound X as 7V'-(4-oxopentane-2-ylidene)-
octadecanohydrazide 
Compound X was obtained as white crystals giving characteristic IR bands at 
3207 (NH), 1723 (C=0), 1662 (0=C-NH) and 1443 cm' (C=N). In 'H NMR 
spectrum diagnostic peaks at 5 10.33 (IH, s, NH, exchangeable with D2O). 2.04 (3H, 
s, CH3). 1.94 (2H, s. Ci/2C02CH3) and 1.59 (3H, s, N^C-CHa) were observed. ^^ C 
NMR spectrum also supported the structure assigned by showing peaks at 5 174.38 
and 174.36 (COOCH3 and CONH), 161.3 {C=N) and 29.3 (COCH3). Molecular ion 
peak at OT/Z 380 and an intense peak at 137 were observed besides other fragment 
ions (detailed in experimental section). Elemental analysis was also in good 
agreement with that of calculated values. Based on above facts the compound X was 
characterized as A '^-(4-oxopentane-2-ylidene)octadecanohydrazide. 
Reaction of 12-hydroxyoctadecanoic hydrazide (III) with acetylacetone 
Refluxing 12-hydroxyoctadecanoic hydrazide (IH) with acetylacetone in 
absolute ethanol for 4 hrs in presence of catalytic amount of hydrochloric acid gave 
a solid product after removing the excess solvent which was crystallized in ethanol 
to give a ofF-white powder. 
CH3-(CH2)5-CH-(CH2)io-
OH 
(in) 
o 0 0 
II II ii 
-C -NHNH2 + CH3—C—CH2—C-CH3 
CH3-(CH2)5~CH-(CH2)io-
OH 
o o 
II 11 
-C -NHN=C—CH2—C—CH3 
CH3 
(XI) 
Scheme 1.7: Synthesis of 12-hydroxy-A'^ '-(4-oxopentane-2-ylidene)-
octadecanohydrazide (XI) 
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Structural elucidation of the compound XI as 12-hydroxy-7V'-(4-oxopentane-2-
ylidene)octadecanohydrazide 
It was an ofF-white powder showing IR bands at 3327 (OH), 3205 (NH), 
1719 (0=C-CH3), 1658 (0=C-NH), 1452 cm'* (C=N). In 'H NMR diagnostic 
peaks at 6 10.35 (IH, s, NH, exchangeable with DjO), 4.13 (IH, m, C//-OH), 3.58 
(IH, br. s, OH, exchangeable with D2O), 2.04 (3H, s, CH3), 1.91 (2H, s, 
C/^ 2C02CH3) and 1.59 (3H, s, N=C-CH3) were observed. In ^^ C NMR characteristic 
peaks at 5 174.36 and 174.34 (COOCH3, CONH), 161.3 (C=N), 72.1 (CH-OH) and 
29.7 (COCH3) were found which also supported the structure. The MS spectrum of 
compound XI showed molecular ion peak at m/z 396, an intense peak at 297 and 
other fragment ions were also observed (detailed in experimental section). Elemental 
analysis was also in good agreement with the calculated values. Thus keeping in 
view the above observations the compound XI was assigned as 12-hydroxy-A'^ '-(4-
oxopentane-2-ylidene)octadecanohydrazide. 
Reaction of 9-hydroxyoctadecanoic hydrazide (IV) with acetylacetone 
Refluxing of 9-hydroxyoctadecanoic hydrazide (IV) with acetylacetone in 
absolute ethanol for 4 hrs with a catalytic amount of HCl and removing the excess 
solvent from the reaction mixture gave a solid product which was crystallized in 
ethanol to give a white powder. 
O 0 0 
II II II 
CH3—(CH2)8—CH—(CH2)7—C-NHNH2 + CH3—C—CH2—C~CH3 
OH 
(IV) 
c y. 
** 
0 O 
II H 
CH3—(CH2)8—CH—(CH2>7—C-NHN=C—CH2—C—CH3 
OH CH3 
(xn) 
Scheme 1.8: Synthesis of 9-hydroxy-//'-(4-oxopentane-2-ylidene)-
octadecanohydrazide. 
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Structural elucidation of the compound XII as 9-hydroxy-A'^ '-(4-oxopentane-2-
yIidene)octadecanohydrazide 
Compound XII was obtained as a white powder giving characteristic IR 
bands at 3325(OH), 3208 (NH), 1724 (0=C-CH3X 1660 (0=C-NH) and 1455 cm' 
(C=N). In 'H NMR spectrum diagnostic peaks at 6 10.35 (IH, s, NH, exchangeable 
with D2O), 4.11 (IH, m, C//-OH), 3.58 (IH, br. s, OH, exchangeable with D2O), 
2.04 (3H, s, CH3), 1.90 (2H, s, CH2COCH3) and 1.55 (3H, s, N=C-CH3) were 
observed. ^^ C NMR spectrum also supported the structure assigned by showing 
peaks at 6 174.37 and 174.34 (COCH3, CONH), 161.3 (C=N), 72.0 (CH-OH) and 
29.46 (COCH3). Molecular ion peak at m/z 396 and an intense peak at 297 were 
observed which also supported the structure assigned. Other fragment ions were also 
observed (detailed in experimental section). Elemental analysis was also in good 
agreement with that of calculated values. Based on above facts the compound XII 
was characterized as 9-hydroxy-A '^-(4-oxopentane-2-ylidene)octadecanohydrazide. 
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1.3EXPERIMENTA1 
Undecanoic (purity 98%) and (9Z)-octadec-9-enoic (oleic acid, 97%) acids 
were purchased from Fluka Chemicals (Buchs, Switzerland) {9Z,\2R)-\2-
Hydroxyoctadec-9-enoic (ricinolic acid, 98%) and (9/?,122)-9-hydroxyoctadec-]2-
enoic (isoricinolic acid, 98%) were isolated from Rtcinus communis and Wnghtia 
tmctoria seed oils, respectively, following Gunstone's partition procedure ^^  Methyl 
acetoacetate, acetylacetone and hydrazine hydrate (80%) were purchased from S d 
FINE-CHEM Ltd (Mumbai, India) Thin layer chromatography was done on glass 
plates (20 x 5 cm) with a layer of silca gel G (Merck, Mumbai, India, 0 5 mm 
thickness) Mixture of petroleum ether-diethyl ether- acetic acid (80 20 1, v/v) was 
used as mobile phase Column chromatography was carried out on silca gel (Merck, 
Mumbai, India, 60-120 mesh) IR spectra were obtained on a Shimadzu 8201 PCFT 
FT-IR spectrometer ' H N M R spectra were recorded at 300 MHz and "C NMR 
spectra were recorded at 75 MHz The chemical shifts (5) were measured relative to 
internal standard TMS Coupling constants were expressed in Hz The FAB mass 
spectra were recorded on a JEOL-SX I02/DA-600 mass spectrometer Melting 
points were taken in open capillaries and are uncorrected 
General procedure for the preparation of fatty acid hydrazides 
Methyl undec-10-enoate (0 1 mmol) was reacted with hydrazine hydrate 
(0 25 mmol) while stirring and refluxing in ethanol for 5 hrs The resulting solution 
was cooled and poured into crushed ice The solid thus obtained was filtered and 
recrystalized from ethanol to afford the corresponding undecanoic hydrazide (I) 
Similarly, octadecanoic hydrazide (II), 12-hydroxyoctadecanoic hydrazide (III) and 
9-hydroxyoctadecanoic hydrazide (IV) were obtained from methyl (9Z)-octadec-9-
enoate, methyl (9Z,12/?)-12-hydroxyoctadec-9-enoate and methyl (9/?,122)-9-
hydroxyoctadec-12-enoate, respectively 
Undecanoic hydrazide (I). White crystals, yield 80%, m p 90-92 °C (lit ^^  m p 
93-94 °C) 
IR (KBr, cm~ )^ 3210-3080 (NH-NH2), 1660 ((9=C-NH) 
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'HNMR(CDCl3) ; 5 8.74 (IH, s, NH). 3.93 (2H, s, NH2), 2.57 (2H, t ,y= 7.8 Hz, 
C / / H : O N H ) , 1.55 (2H, m, CT^^CHz-CO), 1,24 (14H, br. s, 
7xCH2),0.87(3H,deg.t,CH3). 
Octadecanoic hydrazide (II). White powder, yield 85%, m.p. 110-112 °C (]it.^ '^^ ° 
m.p. 112-114 °C). 
IR (KBr, cm"') : 3218-3080 (NH-NH2), 1660 (0=C-NH). 
^HNMRCCDCb) : 6 8.85 (IH, s, NH). 3.98 (2H, s.NHa), 2.57 (2H, t ,7= 7.8Hz, 
C//r-CONH), 1.57 (2H, m, C//2CH2-CO), 1.25 (28H, br, s, 
14xCH2),0.87(3H,deg.t,CH3). 
12-Hydroxyoctadecanoic hydrazide {US). White crystals, yield 75%, m.p. 112-
n4°c. 
IR (KBr, crn^) : 3327 (OH), 3278-3095 (NH-NH2), 1670 ((9=C-NH). 
' H N M R (CDCI3) : 5 8.70 (IH, s, NH), 4.11 (IH, m, CH-OH), 3.90 (2H, s, NH2X 
3.66 (IH, br. s, OH), 2.57 (2H, t, ^ = 7.8 Hz, O/^-CONH), 
1.61 (2H, m, C//2CH2-CO), 1.27 (26H, br. s, I3XCH2), 0.88 
(3H, deg. t, CH3). 
9-Hydroxyoctadecanoic hydrazide (IV). Off-white crystals, yield 70%, m.p. 112-
114 °C. 
IR (KBr, cm^') ; 3327 (OH), 3270-3095 (NH-NH2), 1669 (<9=C-NH). 
' H NMR (CDCI3) : 6 8.85 (IH, s, NH), 4.11 (IH, m, CH-OH), 3.90 (2H, s, NH2), 
3.66 (IH, br. s, OH), 2.57 (2H, t, 7 = 7.8 Hz, C/Z^CONH), 
1.61 (2H, m, C//2CH2-CO), 1.27 (26H, br. s, I3XCH2), 0,88 
(3H, deg. t, CH3). 
General procedure for the preparation of hydrazones 
Fatty acid hydrazide (0,1 mmol) and methyl acetoacetate (0.1 mmol) were 
refluxed in absolute ethanol (30 ml) for 3-4 hrs containing a few drops of HCl, The 
resulting solution was then concentrated and cooled. The solid thus separated was 
filtered and crystallized from ethanol, except for the oily compound (V), which was 
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chromatographed on silica gel (60-120 mesh) using petrol ether-diethyl ether (98:2, 
v/v) as eluent. 
Methyl 3-(2'-undecanoylhydrazono)butanoate (V). Oily, yield 86%. 
IR (neat, cm"') ; 3210 (NH), 1743 (0=C0CH3), 1660 (0-C-NH), 1449 
(C=N). 
^HNMR(CDCl3) : 6 10.35 (IH, s, NH, exchangeable with D2O), 3.66 (3H, s, 
OCH3X 2.30 (2H, X,J= 7.5 Hz,C//2-C0NH), 2.01 (2H, s, 
C//2CO2CH3), 1.61 (2H, m, C/f2CH2CO), 1.56 (3H, s, N=C-
CH3), 1.26 (14PI, br. s, 7XCH2), 0.87 (3H, deg. t, tenninal 
CH3). 
'^CNMR(CDCl3) : 5 174.7, 174.5, 159.2, 51.5, 34.2, 31.9, 29.8, 29.7, 29.5, 25 7, 
25.0, 22.7, 14.2 (three signals are hidden). 
MS (FAB) m/z {%) : 298 (M t, 3). 267 (50), 154 (100), 127 (25), 99 (20), 95 (45) 
Anal : Calcd for C16H30O3N2 (297.97): C, 64.40; H, 10.13; N, 9.39. 
Found: C, 64.18; H, 9.87; N, 9.08 %. 
Methyl 3-(2'-octadecanoylhydrazono)butanoate (VI). White powder, yield 78%, 
m.p. 45 °C. 
3207 (NH), 1736 (O^COCHa), 1658 (0=C-NH), 1455 
(C=N), 
6 10.35 (IH, s, NH, exchangeable with D2O), 3.66 (3H, s, 
OCH3), 2.30 (2H, X,J= 7.8 Hz, C//2CONH), 1.94 (2H, s, 
C//2CO2CH3), 1.61 (2H, m, C//2CH2-CO), 1.59 (3H, s, 
N=C-CH3), 1 25 (28H, br. s, I4XCH2). 0.88 (3H, deg. t, 
terminal CH3). 
5 174.8, 174.5, 159.1, 51.6, 34.2, 31.9, 29.8, 29.7, 29.6, 29 5, 
29.4,25.7,25.1,22.7, 14.1 (eight signals are hidden). 
IR (KBr, cm"') 
' H N M R (CDCI3) 
13 C NMR (CDCb) 
MS (FAB)/w/z(%) : 396 (M-, 3), 298 (100), 267 QO), 239 (12), 185 (7), 157 
(10), 143 (50), 99 (35). 
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Anal : Calcd for C23H44O3N2 (395.97): C, 69.65; H, 11.18; N, 7.06. 
Found; C, 69.59; H, 11.02; N, 6.98 %. 
IR (KBr, cm"^) 
' H N M R (CDCI3) 
Methyl 3-[2'-(12-hydroxyoctadecanoylhydrazono)]butanoate (VII). Off-white 
powder, yield 75%. m.p. 47 °C. 
3321 (OH), 3212 (NH), 1737 (0=C0CH3), 1660 (0-C-
NH), 1458 (C=N). 
5 10.34 (IH, s, NH, exchangeable with D2O), 3.98 (IH, m, 
C//-OH), 3.66 (3H, s, OCH3), 3.58 (IH, br. s, OH, 
exchangeable with D2O), 2.30 (2H, t, J = 7.5 Hz, 
C//2CONH), 1.91 (2H, s, C//2CO2CH3), 1.61 (2H, m, 
C^2CH2-CO). 1.59 (3H, s, N=C-C/fi), 1.27 (26H, br. s, 
I3XCH2), 0.88 (3H, deg. t. terminal CH3). 
5 174.44, 174.40, 159.2, 72.1, 51.5, 37.6, 34.2, 31.9, 29.8, 
29.7, 29.57, 29.55, 29.5, 29.2, 25.7, 25.0, 22. 8, 14.2 (five 
signals are hidden). 
'^C NMR (CDCI3) 
MS (FAB) m/z (%) 
Anal 
412 (M i, 2), 299 (25), 297 (100), 283 (30), 265 (70), 199 
(10), 154 (75), 98 (15). 
Calcd for C23H44O4N2 (411.96): C, 66.95; H, 10.75; N, 6.79. 
Found: C, 66.91; H, 10.55; N, 6.67 %. 
Methyl 3-[2'-(9-hydroxyoctadecanoylhydrazono)]butanoate (VIII). White 
powder, yield 75%, m.p. 43 °C. 
: 3327 (OH), 3214 (NH), 1737 (0=C0CH3), 1658 (0=C-
NH), 1459 (C=N). 
: 6 10.35 (IH, s, NH, exchangeable with D2O), 4.11 (IH, m, 
C//~OH), 3.66 (3H, s, OCH3), 3.58 (IH, br. s, OH, 
exchangeable with D2O), 2.30 (2H, t, y = 7.5 Hz, 
C//2CONHX 191 (2H, s, C^.,C02CH3), 1.61 (2H, m, 
CH2CH2CO), 1.55 (3H, s, N=C-C//j), 1.25 (26H, br. s, 
I3XCH2), 0.88 (3H, deg. t, terminal CH3). 
IR(KBr,cm-') 
'HNMR(CDCl3) 
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13 C NMR (CDCI3) 6 174.5, 174.4, 159.2, 72.0, 51.6, 37.6, 37.5, 34.1, 31.9, 
29.7, 29.6, 29.53, 29.50, 29.4, 29.2, 25.7, 25.0, 22.7, 14.1 
(four signals are hidden). 
M S (FAB) m/z (%) : 412 (M •, 4), 313 (30), 299 (100), 267 (20), 265 (70), 199 
(10), 143(10), 126 (25), 98 (15). 
Anal : Calcd for C23H44O4N2 (411.96): C, 66.95; H, 10.75; N, 
6.79. Found; C, 66.87; H, 10.52; N, 6.63 %. 
General procedure for preparation of hydrazides 
Fatty acid hydrazide (0.1 mmol) and acetylacetone (0.1 mmol) were refluxed 
in absolute ethanol (30 ml) for 4 hrs containing a few drops of HCI. The resulting 
solution was then concentrated and cooled at room temperature. The solid thus 
separated was filtered and crystallized from ethanol, except for the oily compound 
(DC), which was chromatographed on silica gel (60-120 mesh) using petrol ether-
diethyl ether (96:4, v/v) as eluent. 
A'^'-(4-Oxopentane-2-ylidene)undecanohydrazide (K). Oily, yield 80% 
IR (KBr, cm'') : 3205 (NH). I72I (C=0), 1664 ((9=C-NH), 1446 (C=N). 
' H NMR (CDCI3) : 6 10.33 (IH. s, NH, exchangeable with D2O), 2.30 (2H, t, J 
= 7.8 Hz, C//2CONH), 2.04 (3H, s, CH3), 194 (2H, s, 
C//2COCH3X 1-61 (2H, m, C//2CH2CO), 1.56 (3H, s, 
N=C-CH3), 1.25 (14H, br s, 7XCH2), 0.87 (3H, deg. t, 
terminal CH3). 
'^CNMR(CDCl3) : 6 174.4, 174.3, 161.3, 74.1, 51.4, 32.0, 29.7, 29.6, 29.4, 
29.2, 25.1, 22.8, 14.1 (three signals are hidden). 
M S (FAB) m/z (%) : 282 (M •, 3), 281 (65), 267 (40), 239 (15), 169 (10), 141 
(10), 137(100). 
Anal : Calcd for C16H30O2N2 (281.98): C, 68.04; H, 10.71; N, 
9.92. Found; C, 67.84; H, 10.37; N, 9.71 %. 
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A^'-(4-Oxopentane-2-ylidene)octadecanohydrazide (X). White crystals, yield 
70%, m.p. 43 °C. 
IR (KBr, cm" )^ : 3207 (NH), 1723 (C=0), 1662 (0=C-NH), 1443 (C=N). 
^H NMR (CDCI3) : 6 10.33 (IH, s, NH, exchangeable with D2O), 2.30 (2H, t, 
J = 7.8 Hz, C//2CONHX 2.04 (3H, s, CH3), 1.94 (2H, s, 
CH2COCH3), 1.64 (2H, m, C^5CH2CO), 1.59 (3H, s, 
N=C-CH3), 1.25 (28H, br s, HxCHj), 0.88 (3H, deg. t, 
terminal CH3). 
: 6 174.38, 174.36, 161.3, 51.4, 34.2, 32.1, 29.8, 29.63, 
29.58, 29.52, 29.47, 29.41, 29.3, 25.1, 22.7, 14.1 (seven 
signals are hidden). 
"CNMR(CDCl3) 
M S (FAB) m/z (%) : 380 (M ^  4), 281 (65), 267 (40), 239 (15), 169 (10), 141 
(10), 137(100). 
Anal : Calcd for C23H44O2N2 (379.98): C, 72.58; H, 11.65; N, 
7.36. Found: C, 72.51; H, 11.44; N, 7.23 %. 
12-Hydroxy-A^'-(4-oxopentane-2-yHdene)octadecanohydrazide (XI). Off-white 
powder, yield 70%, m.p. 44 °C. 
IR (KBr, cm" )^ 
'HNMR(CDCl3) 
13 C NMR (CDCI3) 
3327 (OH), 3205 (NH), 1719 (0=0), 1658 (0=C-NH), 
1452 (C=N). 
5 10.35 (IH, s, NH, exchangeable with D2O), 4.13 (IH, m, 
C/f-OH), 3.58 (IH, br. s, OH, exchangeable with D2O), 
2.32 (2H, t, y = 7.5 Hz, CHsCONHl 2.04 (3H, s, CH3), 
1.91 (2H, s, C//2COCH3), 1.64 (2H, m, CH2CH2COX 1.59 
(3H, s, N=C-CH3), 1.25 (26H, br. s, n^CHs), 0.88 (3H, 
deg. t, terminal CH3). 
6 174.36, 174.34, 161.3, 72.1, 51.4, 37.6, 37.5, 34.1, 32.0, 
29.7, 29.6, 29.5, 29.4, 29.3, 25.1, 22.7, 14.2 (six signals 
are hidden). 
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M S (FAB) m/z (%) ; 396 (M •, 4), 313 (10), 297 (100), 281 (20), 267 (10), 199 
(7), 171(15), 154(90), 140(9), 112 (8), 98 (20). 
Anal : Calcd for C23H44O3N2 (395.97): C, 69.65; H, 11.18, N, 
7.06. Found: C, 69.57; H, 10.98; N, 6.96 %. 
9-Hydroxy-A/^'-(4-oxopentane-2-ylidene)octadecanohydrazide (XII). White 
powder, yield 75%, m.p. 42 °C. 
: 3325 (OH), 3208 (NH), 1724 (C=0), 1660 (0-C-NH), 
1455 (C=N). 
: 6 10.35 (IH, s, NH, exchangeable with D2O), 4.11 (IH, m, 
C.//-OH), 3.58 (IH, br. s, OH, exchangeable with D2O), 
2.30 (2H, t. y = 7.5 Hz, Ci/^CONH), 2.04 (3H, s, CH3), 
1.90 (2H, s, C//2COCH3), 1.61 (2H, m, Ci/2CH2CO), 1.55 
(3H, s, N=C-CH3), 1.25 (26H, br. s, 13XCH2), 0.88 (3H, 
deg. t, terminal CH3). 
: 6 174.37, 174.34, 161.3, 72.0, 51.4, 37.6, 37.5, 34.2, 32.0, 
29.7, 29.63. 29.55, 29.50, 29.46, 29.42, 29.3, 25.0, 22.8, 
14.2 (four signals are hidden). 
IR(KBr, cm_i) 
^HNMR(CDCl3) 
•^CNMR(CDCl3) 
MS (FAB) m/z (%) 
Anal 
396 (M-, 5), 363 (7), 297 (100), 267 (30), 199 (10), 185 
(10), 140(15), 115(8), 98(20). 
Calcd for C23H44O3N2 (395.97); C, 69.65; H, 11.18; N, 
7.06. Found: C, 69.55; H, 10.95; N, 6.92 % 
v^ D*^ 
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2,5-(Disu6stituted-l3,4-Oxadiazoks 
2.1THE0RITIGAL 
Substituted 1,3,4-oxadiazoles are of considerable pharmaceutical and 
material interest, which is documented by a steadily increasing number of 
publications and patents. For instance, 2-amino-1,3,4-oxadiazoles act as muscle 
relaxants' and show antimitotic activity.^ Analgesic, anti-inflammatory, 
anticonvulsive, diuretic and antiemetic properties are exhibited by 5-aryl-2-
hydroxymethyl-l,3,4-oxadiazole derivatives,^ and 2-hydroxyphenyl-l,3,4-
oxadiazole acts as a hypnotic and as a sedative.'* 
Some substituted oxadiazoles serve as key elements with potential biological 
activities such as pesticidal,' antiperipheral vasomotility,^ CNS stimulant,^ 
insecticidal,^ bactericidal,^ hypoglycemic,'** herbicidal,'* and fungicidal activity.'^ 
l,3,4-oxadia2oles analogues have also been found to be associated with HTV 
activity.'^ Some material applications of l,3,4-oxadia2ole derivatives lie in the fields 
of photosensitizers''* and liquid crystals.'^ Therefore, the development of novel 
synthetic routes to achieve access to these molecules is of prime interest. 
The common synthetic approaches to oxadiazoles** involve cyclization of 
diacylhydrazines. A variety of reaction conditions influence the cyclization reaction. 
Typically, the reaction is promoted by heat and anhydrous reagents including thionyl 
chloride,'^ phosphorus oxychloride,^^ phosphorus pentoxide,'^ triphenylphosphine, ° 
and triflic anhydride.^' Alternative synthetic methods comprise reaction of 
carboxylic hydrazides with keteneylidene triphenylphosphorane or base-promoted 
cyclization reaction of trichloroacetic acid hydrazones.^^ 
Perez et al.^^ reported the transformation of A'^-(2-cyanoethyl)-//-
methylindole-2-carbohydrazide (46) into oxadiazolone (47a-d) and oxadiazolethione 
(48a-d) by its reaction with triphosgene and thiophosgene, respectively. 
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R 
Compound 
47a, 48a 
47b, 48b 
47c, 48c 
47d,48d 
47a-d 
R' 
H 
CH3 
H 
CH3 
R 
OCH3 
OH 
OCH3 
OH 
R 
48a-d 
5-Aryl-2-mercapto-l,3,4-oxadiazoIes (50a-d) was synthesized by treating 
potassium-S-aroyldithiocarbazates (49a-d) with KOH and pyridine. 
0 
X 
R N 
H 
Compound 
49a, 50a 
49b, 50b 
s 
49a-d 
R 
CfiHj 
3-F-C6H4 
N - N 
KOH >, ^ Jl^ J L . 
Pyridine 0 
50a-d 
Compound 
49c, 50c 
49d, 50d 
SH 
R 
2-CH3O-C6H4 
CeHii 
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Rahman et al}^ synthesized 5-(benzothiazole-2-yl-thiomethyl)-2-
pheny]amino-I,3,4-oxadiazole {53), 5-(benzothiazoIe-2-yKthiomethyI)-2-amino-
1,3,4-oxadiazole (54) and 5-(benzothiazole-2-yl-thiomethyl)-l,3,4-oxadiazole-2-
thione (55) by the oxidative cyclization of A^-(benzothiazole-2-yl-thioacetyl)-A'^ -
phenyl-3-thiosemicarbazide (52) and (benzothia2ole-2-yl-thio)acetic acid hydrazide 
(51), with following sequences of reactions. 
5-Arylamino-2-mercapto-l,3,4-oxadiazoles (58a-c) have been synthesized 
by Chande and coworker^ ^ by reaction of sodium -^(A -^
arylthiocarbamyl)thiocarbazinates (57) with carbonoxysulphide (COS) in ethanolic 
NaOH. 
A r ^ ^ ^ N / ^ " 2 - g g j - A r ^ J H ^ N ^ ^ 
H 
56 
H 
57 
N-N 
0 
S-Na ^tOH^ 
NaOH ^ ^ " 0 
58a-c 
SH 
Compound 
58a 
S8b 
58c 
R 
3-CH3C6H5 
3-CI-C6H5 
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1,3,4-Oxadiazoles (61a-e) with phenol (X=0) or thiophenol group (X=S) 
from salicylic hydrazide (59) were synthesized by stirring with MeSOsH in 
methanol for 10 min and then adding acetic anhydride or acid chloride while stirring 
at reflux temperature for 2-9 hrs depending upon the completion of reaction. 
NHNH2 MeSCH/toluene NHNH"^ R 
RCOClorACjO 
Compound R 
60a, 61a CH3 
60b, 61b CH2CI 
60c, 61c C2H5COO 
60d,61d C6H5 
60e,61e QHjNH 
Hirata etal.^^ reported the synthesis of substituted 5-[4-(benzyIoxy)-phenyl]-
3-(2-cyanoethyl)-l,3,4-oxadia2ol-2(3//)-one (64a-h) from substituted-1-[4-
(benzyloxy)benzoyl]-2-(2-cyanoethyl)hydrazide (63a-h). Compounds 63a-h were 
prepared from substituted-l-[4-(benzyIoxy)benzoyI]-2-(2-cyanoethyl)hydrazine 
(62a-h) 
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CN 
CONHNH-
^ ^ 
64a-b 
Compound 
62a, 63a, 64a 
62b, 63b, 64b 
62c, 63c, 64c 
62d, 63d, 64d 
X 
H 
H 
2-1 
2-1 
Y 
H 
I 
H 
I 
Compound 
62e, 63e, 64e 
62f, 63f, 64f 
62g, 63g, 64g 
62h, 63h, 64h 
X 
3-1 
3-1 
4-1 
4-1 
Y 
H 
I 
H 
I 
Loetchutinat et ai °^ synthesized 5-aryl-3-(4-hydroxyphenyl)-1,3,4-
oxadia2ole-2-(3//)-thiones (65) by cyclocondensation of 1-(4-hydroxyphenyl)-2-
aroylhydrazine with thiophosgene. 
HO 
0 
W 
NHNH-C / \ CSCl 
H,0 
2 - ^ HO N - N 
. / 0 
/ \ 
65 
2-ChIoro-5-(5-aryl-l,3,4-oxadiazole-2-yl-methyl)-pyridine (67a-e) were 
synthesized from 2-chloropyridine-5-acetic acid hydrazide (66) by refluxing with 
phosphorus oxychloride for 8 hrs.^' 
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NHNH2 CIOC 
CI ,/^N 
66 
Compound 
67a 
67b 
67c 
Khan et al synthesized 2,5-disubstituted-l,3,4-oxadiazoIe (70) from 3-
pyridyl hydrazide (68) and benzoic acid (69) by microwave irradiation taking 
alumina as soHd support and POCI3 as a dehydrating agent. 
O 
R 
O N - N 
68 69 70 
R== 3-pyridyI; R'- phenyl 
A solution of 3-chloro-2-(N-formylacid hydrazide)-benzo[b] thiophene (71) 
in xylene was refluxed with phosphorus pentaoxide for 1 hr to afford 2-(3-chloro-l-
benzothien-2-yl)-l,3,4-oxadiazole(72).^^ 
-CI .C! 
.fiQi, 
C—NH-NH-CH 
II II 
O 0 
71 72 
Demibras et al}^ synthesized 5-alkyl-2-[(5-{[(5-mercapto-l,3,4-oxadiazoI-2-
y])-methy]]thio}-l,3,4-thiadiazol-2-y])-methyl]-2,4-dihydro-3i/-l,2,4-tria2ol-3-ones 
(74a-c) by treating 2-({[(3-alkyl-5-oxo-4,5-dihydro-l/f-l,2,4-triazol-l-yl)-methyl]-
l,3,4-thiadiazol-2-yl}thio)-acetohydrazide derivatives (73a-c) with CS2/KOH. 
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N - N 
R 
N - N 
N - N 
NHNH^ 
N' 
H 
73a-c 
O 
N 
N 
h ^ 
R N 
H 
74a-c 
O 
SH 
Compound 
73a, 74a 
73b, 74b 
73c, 74c 
R 
CH3 
CH2C6H5 
CgHs 
Synthesis of 5-furan-2-yI-[l,3,4]-oxadiazoie-2-thiol (76) from furan-2-
carboxylic acid hydrazide (75) was reported by Koparir et al. 
O 
75 
^ Ethanol O 
76 
James et al}^ synthesized tetrasubstituted alkenyl-l,3,4-oxadiazoles (78a-f) 
by treating diacylhydrazides (77a-i) with hexachloroethane in acetonitrile in 
presence of Hunig's base and PPhs. A very fast cyclization occurred at room 
temperature. 
O 
HN 
o AH 
R 
/-Pr2NEt/CH3CN 
BocN. BocN 
77a-f 78a-f 
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Compound 
77a, 78a 
77b, 78b 
77c, 78c 
R 
c-Pr 
CHiBr 
OMe 
Compound 
77d, 78d 
77e, 78e 
77f, 78f 
R 
CH2OTBS 
C02Et 
H 
4-(5-Amino-[l,3,4]oxadi2ole-2-yl-inethylsulphonyl)chromen-2-ones (80a-c) 
were prepared by refluxing (2-oxo-2//^-chromen-4-methyIsuIphonyI)acetic acid 
hydrazide (79a-c) with cynogen bromide in methanol for 3 hrs.^^ 
R - -
0 
CH2-S—CH2-NH—NH2 
O 
CNB 
O N ' N 
CH2-S—CH2-^ / ^ 
O 
•NH2 
CH^OKR--
80a-c 
O 
Compound 
79a, 80a 
79b,80b 
79c, 80c 
R 
6-CH3 
7-CH3 
7,8-Benzo 
Cacic et al}^ synthesized 7-hydroxy-4-[(5-mercapto-l,3,4-oxadiazoie-2-
yI)methyl]-2H-chromen-2-one (82) by reacting (7-hydroxy-2-oxo-2H-chromen-4-yl) 
acetic acid hydrazide (81) with potassium hydroxide in ethanol followed by addition 
of carbon disulfide and refluxing for 6 hrs. 
O 
w 
CH2-C NH—NH2 
0 
CH2 4- .N 
N-
SH 
81 82 
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A series of 2-[(4-alkylthio/aIkylsulphnyl phenoxy)-methyl]-5-substituted-
l,3,4-oxadia2oles (84a-d) from 2-(4-alkylthio/alkylsulfonyl phenoxy)-
acetohydrazides (83) was reported by Karabasanagouda and coworker. ^ ^ 
OCH2CONHNH2 
y ArCOOH/POC V 
XR 
83 
SO2; R=CH3, C2H5 
lound Ar 
CeHj 
4-CH3C6H4 
^ 
1 N-N 
y 
XR 
84a-d 
Compounc 
84c 
84d 
Ar 
2-CIC6H4 
3-OCH3C6H4 
84a 
84b 
5-substituted-2-(2-niethyl-4-nitro-l-imidazomethyl)-l,3,4-oxadia2oles (86a-
f) have been prepared under microwave and reflux conditions using 2-methyl-4-
nitro-l-imidazo-acethydrazide (85), aromatic acid and phosphorus oxychloride as 
dehydrating agent.'"' 
POCl3,MW 
CH2CONHNH2 
Jl \ + RCOOH 
85 
Compound 
86a 
86b 
86c 
R 
CeHs 
4-CH3C6H4 
4-OCH3C6H4 
/"T" 
O2N 
% - ^ 
P0C1.,A ^ 
N' 
86a-f 
•CH3 
Compound R 
86d 4-CIC6H4 
86e 2-CH3C6H4 
86f CeHiN 
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Recently Nagalakshmi'*^ synthesized a series of 2,5-disubstituted-l,3,4-
oxadiazoles (88a-f) from 4-niethoxy-benzohydrazide (87) by refluxing with 
different aromatic acids in phosphorus oxychloride for 5-6 hrs. 
CH3O _XA 
87 
Compound 
88a 
88b 
88c 
-CONHNH2 + . 
AT 
C6H5 
4-CH3C6H4 
4-NO2C6H4 
ArCOOH 
pcx:i3 
A 
Compound 
88d 
SSe 
88f 
'«'°^C^o^ 
88a-f 
AT 
4-NH2C6H5 
4-OHC6H4 
C5H4N 
Prompted by these observations and as part of our continuing programme for 
the preparation of oleochemicals, it was considered of interest to incorporate 
oxadiazole moiety in fatty acids. Herein we report a simple method for the synthesis 
of 1,3,4-oxadiazoles having fatty acid chains. Furthermore, the increasing number of 
multidrug resistant pathogens has led us to screen the newly synthesized derivatives 
against the representative panel of baaeria (Chapter 6). 
Ar 
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2.2 RESULTS AND DISCUSSION 
The synthesis of 2,5-disubstituted 1,3,4-oxadiazoles was performed in 
several steps. In the first step fatty acid hydrazides which are the starting materials, 
were prepared according to literature method.'*^ Undec-10-enoic hydrazide (Xni), 
(9Z)-octadec-9-enoic hydrazide (XIV), (92,12R)-12-hydroxyoctadec-9-enoic 
hydrazide (XV) and (9^,]22)-9-hydroxyoctadeC'12-enoic hydrazide (XVI) were 
prepared fi-om methyl undec-10-enoate, methyl (92)-octadec-9-enoate, methyl 
(9Z,12/?)-12-hydroxyoctadec-9-enoate and methyl (97?,12Z)-9-hydroxyoctadec-12-
enoate respectively. 
5-(AlkenyI)-2-amino-l,3,4-oxadiazoles XVII-XX were obtained in moderate 
yields by reacting fatty acid hydrazides Xni-XV respectively with cyanogen 
bromide in dry methanol at 60°C. 2-(Alkenyl)'5-phenyl-l,3,4-oxadia2oles XXI-
XXIV were prepared by dehydrative cyclization of diacylhydrazide (formed in situ) 
by dehydrating agent, phosphorus oxychloride (POCI3). Comparison of the reaction 
time and the yield by varying the reagents is presented in Table 2.1. It was observed 
that benzoyl chloride was a better reactant than benzoic acid under inert atmospheric 
conditions, because benzoyl chloride leads to better yields and less reaction time. 
Thus, indicating that CI" is a better leaving group than OH' group. Also the HCl 
formed does not affect the dehydrating power of POCI3 necessary for cyclization of 
diacylhydrazide to 1,3,4-oxadiazole. 
Reaction of undec-10-enoic hydrazide (XIII) with cyanogen bromide 
A mixture of fatty acid hydrazide X n i and cyanogen bromide in dry 
methanol were refluxed at 60 *^C on oil bath (Scheme 2.1). The resulting solution 
was cooled and filtered. The filtrate was neutralized with sodium bicarbonate 
solution. The solid mass separated was fihered, washed with excess water, dried and 
recrystallized in chloroform-methanol to give a white powder. 
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Table 2.1. Reaction time and yields of various reactions by varying the reactant, 
Compound 
xvn 
xvra 
XIX 
XX 
XXI 
xxn 
xxm 
XXIV 
Reactant 
CNBr 
CNBr 
CNBr 
CNBr 
PhCOCl 
PhCOOH 
PhCOCl 
PhCOOH 
PhCOCl 
PhCOOH 
PhCOCl 
PhCOOH 
Yield (%) 
73 
77 
65 
60 
76 
69 
73 
60 
69 
55 
65 
58 
Reaction time (hrs) 
3 
3 
4 
4 
4 
6 
4 
7 
5 
7 
5 
7 
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C=CH—(CH2)8—C -NHNH2 
(xm) 
CH2=Cn~(CH2h—^ J"— NH2 
O' 
(xvn) 
Scheme 2.1: Synthesis of 5-(dec-9'-enoyI)-2-amino-l,3,4-oxadia2ole (XVII). 
Structural elucidation of the compound XVII as 5-(dec-9'-enoyl)-2-aniino-l,3,4-
oxadiazole 
Characteristic IR absorption bands of compound XVH were observed at 
3112 (NH2), 1585 (C=N) and 1187 cm-' (C-O-C). The ' H N M R showed diagnostic 
peaks at 5 4.90 (2H, br.s, NH2, exchangeable with D2OX 2.68 (2H, t, CH2 a to ring) 
and 1.69 (2H, m, CH2 p to ring) in addition to peaks of the normal fatty acid chain. 
The '^C NMR spectrum also supported the structure assigned by showing peaks at 6 
167.1 and 164.7 (C=N, C=N, exchangeable with each other). In mass spectrum 
molecular ion peak at m/z 224 was observed which correspond to the molecular 
formula C12H21N3O. Based on above facts the compound XVII was characterized as 
5-(dec-9'-enoyl)-2-amino-l,3,4-oxadiazole. 
Reaction of (9Z)-octadec-9-enoic hydrazide (XIV) with cyanogen bromide 
Fatty acid hydrazide XIV and cyanogen bromide were refluxed in dry 
methanol at 60 "^C on oil bath (Scheme 2.2). The resulting solution obtained was 
cooled, filtered and the filtrate was neutralized with sodium bicarbonate solution. 
The solid mass thus obtained was separated by filtration, washed with excess water, 
dried and recrystallized in chloroform-methanol to give white crystals. 
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o 
II 
CH3—(CH2)7—CH=CH~(CH2)7 C -NHNH2 
(XIV) 
2 
u 
D 
CH3—(CH2)7—CH=CH—(CH2>7—<^ >—NH2 
(XVIH) 
Scheme 2.2: Synthesis of (8'Z)-5-(heptadec-8'-enoyI)-2-amino-I,3,4-oxadiazoJe 
(xvm) 
Structural elucidation or the compound XVm as (S'Z)-5-(heptadec-8'-enoyl)-2-
amino-l,3,4-oxadiazole 
White crystals giving characteristic IR bands at 3118 (NH2X 1584 (C=N) and 
1174 cm"^  (C-O-C). The ' H N M R was more informative in assigning the structure. 
Diagnostic peaks at 6 4.86 (2H, br.s, NH2, exchangeable with D2O), 2.69 (2H, t, CH2 
a to ring) and 1.69 (2H, m, CH2 p to ring) were observed in addition to peaks of the 
normal fatty acid chain. The ^^C NMR spectrum also supported the structure 
assigned by showing peaks at 6 167.0 and 164.3, (C=N, C=N, exchangeable with 
each other). Mass spectrum gave molecular ion peak at m/z 321 which correspond to 
the molecular formula C19H35N3O. Based on above facts the compound XVni was 
characterized as (8'Z)-5-(heptadec-8'-enoyl)-2-amino-l,3,4-oxadiazole. 
Reaction of (9Z,12/?)-12-hydroxyoctadec-9-enoic hydrazide (XV) with cyanogen 
bromide 
A mixture of fatty acid hydrazide XV and cyanogen bromide were refluxed 
in dry methanol at 60 °C on oil bath (Scheme 2.3). After cooling the resulting 
solution it was filtered and the filtrate was neutralized with sodium bicarbonate 
solution to obtain a solid mass by filtration which was washed with excess water, 
dried and recrystallized in chloroform-methanol to give a white powder. 
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O 
II 
CH3—(CH2)5—CH—CH2—CH=CH—(CH2)7 C-NHNH2 
OH ^^^ 
o 
CH3—(CH2)5—CH—CH2—CH=CH—(CH2>r—C^ J ^ - N H 2 
OH 
(XIX) 
o-
Scheme 2.3: Synthesis of (8'Z,ll'^)-5-(ll'-hydroxyheptadec-8'-enoyl)-2-amino-
l,3,4-oxadia2ole(XIX) 
Structural elucidation of the compound XDC as (S'Z,!!'/?)-^!!'-
hydroxylieptadec-8*-enoyl)-2-amino-l,3,4-oxadiazole 
Compound XDC gave characteristic IR bands at 3281 (OH), 3112 (NH2), 
1581 (C=N) and 1187 cm"' (C-O-C). The ^H NMR peaks at 5 4.90 (2H, br.s, NH2, 
exchangeable with D2O), 2.89 (2H, t, CH2 a to ring) and 1.66 (2H, m, CH2 P to ring) 
were observed in addition to peaks of the normal fatty acid chain. The '"'C NMR 
spectrum also supported the structure assigned by showing characteristic peaks at 5 
166.8 and 163.5 (C=N, C=N, exchangeable with each other). In mass spectrum 
molecular ion peak at m/z 337 was observed which correspond to the molecular 
formula C19H35N3O2. Thus compound XIX was characterized as (8'Z,ir7?)-5-(ir-
hydroxyheptadec-8'-enoyl)-2-amino-1,3,4-oxadiazole. 
Reaction of (9i?,12^9-hydroxyoctatadec-12-enoic hydrazide (XVI) with 
cyanogen bromide 
Fatty acid hydrazide XVI and cyanogen bromide were refluxed at 60 C in 
dry methanol on oil bath (Scheme 2.4). Resulting solution was cooled and after 
cooling it was filtered and the filtrate was neutralized with sodium bicarbonate 
solution to obtain a solid mass by filtration which was washed with excess water, 
dried and recrystallized in chloroform-methanol to give white flakes. 
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0 
CH3—(CH2)4—CH=CH—(CH2)2—CH~(CH2)7—C-NHNH2 
OH 
(XVI) 
I 
u 
CH3~(CH2)4—CH=CH—(CH2)2—CH—(CH2)7 
OH 
(XX) 
Scheme 2.4: Synthesis of (8'/?,ll'Z)-5-(8'-hydroxyheptadec-ir-enoyI)-2-amino-
1,3,4 oxadiazole (XX) 
Structural elucidation of the compound XX as (8'/?,ll'Z)-5-(8'-
hydroxyheptadec-ir-enoyl)-2-amino-l,3,4-oxadiazole 
IR spectrum of compound XX showed diagonastic bands at 3281 (OH), 3122 
(NH2), 1584 (C=N) and 1184 cm'' (C-O-C). The ' H N M R was informative, 
characteristic peaks were observed at 6 4.91 (2H, br.s, NH2, exchangeable with 
D2O), 2.71 (2H, t, CH2 a to ring) and 1.72 (2H, m, CH2 p to ring) were observed. 
The ^^ C NMR spectrum also supported the structure assigned by showing 
characteristic peaks at 5 167.1 and 164.7 (C=N, C=N, exchangeable with each 
other). Molecular ion peak at m/z 337 was observed which correspond to the 
molecular formula C19H35N3O2. Based on the above observations compound XX 
was characterized as (8*7?, 11 'Z)-5-(8'-hydroxyheptadec-11 '-enoyl)-2-amino-1,3,4-
oxadiazole. 
Reaction of undec-10-enoic hydrazide (XIII) with benzoyl chloride/benzoic acid 
Fatty acid hydrazide XIII, benzoyl chloride/benzoic acid and phosphorus 
oxychloride in 1,2-dichloroethane were refluxed at 65 ''C under inert atmospheric 
conditions (Scheme 2.5). Excess solvent and POCI3 were removed under reduced 
pressure. The resulting solution was cooled to room temperature, poured into ice 
cold water and left over night. The solid mass separated was filtered, dried and 
recrystallized from methanol to get an off-white powder. 
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O 
CH2=CH—{CH2)8—C -NHNH2 
(xni) 
G 
'rri 
u 
2 i N 
CH2=CH—(CH2)8-<^ 
O 
(XXI) 
Scheme 2.5: Synthesis of 2-(dec-9'-enoyl)-5-phenyl-l,3,4-oxadiazole (XXI) 
Structural elucidation of the compound XXI as 2-(dec-9*-enoyl)-5-phenyl-l,3,4-
oxadiazole 
The IR spectrum of the compound XXI showed absorption bands at 1579 
(C=N) and 1154 cm*' (C-O-C). The ' H N M R was more informative in assigning the 
structure. Diagonastic peaks were observed at 5 7.50-8.04 (5H, m, Ph-H), 2.77 (2H, 
t, CH2 a to ring) and 1.76 (2H, m, CH2 P to ring). "C NMR spectrum also supported 
the structure by showing peaks at 5 168.2 and 153.0 (C=N, C=N) were observed. 
The mass spectrum showed molecular ion peak at m/z 284 corresponding to the 
molecular formula C18H24N2O. Based on these observations the compound XXI was 
characterized as 2-(dec-9'-enoyl)-5-phenyl-l,3,4-oxadiazole. 
Reaction of (92)-octadec-9-enoic hydrazide (XIV) with benzoyl 
chloride/benzoic acid 
Fatty acid hydrazide XIV, benzoyl chloride / benzoic acid and phosphorus 
oxychloride were refluxed in dichloroethane at 65°C under inert atmosphere 
(Scheme 2.6). The resulting solution was cooled to room temperature, poured into 
ice cold water and left over night. The solid mass separated was filtered, dried and 
recrystallized from methanol to get an off-white powder. 
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O 
11 
CH3—(CH2>7— CH=CH—(CH2>7—C -NHNH2 
(XIV) 
ffi 
0 
0 
o 
CH3—(CH2>, CH=CH—(CH2>7 
(xxn) 
Scheme 2 6 Synthesis of (8'Z)-2-(heptadec-8'-enoyI)-5-phenyl-l,3,4-oxadiazole 
(xxn) 
Structural elucidation of the compound XXn as (8*7)-2-(heptadec-8*-enoyl)-5-
phenyl-l^,4-oxadiazole 
OfF-white powder giving characteristic IR bands at 1571 (C-N) and 1182 
cm ' (C-O-C) The ^H NMR was more informative in assigning the structure 
Diagnostic peaks at 6 7 49-8 02 (5H, m, Ph-H), 2 79 (2H, t, CH2 a to ring) and 1 66 
(2H, m, CH2 p to ring) were observed in addition to peaks of the normal fatty acid 
chain The '^C NMR spectrum also supported the structure assigned by showing 
peaks at 5 168 4 and 152 2 (C=N, C=N) Mass spectrum gave molecular ion peak at 
m/z 382 which correspond to the molecular formula C25H38N2O Based on above 
facts the compound XXII was characterized as (S'Z)-2-(heptadec-8'-enoyl)-5-
phenyl-l,3,4-oxadiazole 
Reaction of (9Z,127?)-12-hydroxyoctadec-9-enoic hydrazide (XV) with benzoyl 
chloride/benzoic acid 
A mixture of fatty acid hydrazide XV, benzoyl chloride/benzoic acid and 
phosphorus oxychloride were refluxed in dichloroethane at 65°C (Scheme 2 7) 
After cooling the resulting solution, it was poured into ice cold water and left 
overnight The oily compound obtained was extracted with diethyl ether and 
chromatographed over silica gel using petroleum ether-diethyl ether (96 4v/v) as 
eluent 
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0 
II 
CH3—(CH2)5—CH—CH2— CH=CH—(CH2)7—C -NHNH2 
OH (XV) 
o 
o 
G O 
0, 
CH3—(CH2)5—CH—CH2—CH=CH—(CH2 
OH 
{xxin) 
Scheme 2.7: Synthesis of (8'Z,iri?)-2-(ll'-hydroxyheptadec-8'-enoyl)-5-phenyl-
1,3,4-oxadiazole (XXm) 
Structural elucidation of the compound XXm as (8'Z,ll*i?)-2-(ir-
hydroxyheptadec-8*-enoyl)-5-phenyM^,4-oxadiazole 
The oily compound XXIII gave characteristic IR bands at 3281 (OH), 1550 
(C=N) and 1174 cm-' (C-O-C). The ' H N M R peaks at 5 7.43-8.08 (5H, m, Ph-H), 
2.84 (2H, t, CH2 a to ring) and 1.67 (2H, m, CH2 P to ring) were observed in 
addition to peaks of the normal fatty acid chain. The '^C NMR spectrum also 
supported the structure assigned by showing characteristic peaks at 6 167.2 and 
153.0 (C=N, C=N). In mass spectrum molecular ion peak at m/z 398 was observed 
which correspond to the molecular formula CjsHsgNaOz. Thus compound XXIII 
was characterized as (8'Z,ir7?)-2-(ir-hydroxyheptadec-8'-enoyl)-5-phenyI-l,3,4-
oxadiazole. 
Reaction of (97?,12Z)-9-hydroxyoctadec-12-enoic hydrazide (XVI) with benzoyl 
chloride/benzoic acid 
Fatty acid hydrazide XVI, benzoyl chloride / benzoic acid and phosphorus 
oxychloride were refluxed at 65°C in dichloroethane (Scheme 2.8). Resulting 
solution was poured into ice cold water and left overnight. The oily compound 
obtained was extracted with diethyl ether and chromatographed over silica gel using 
petroleum ether-diethyl ether (96:4v/v) as eluent. 
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o 
CH3—(CH2)4—CH=CI^-<CH2)2—CH~(CH2)7—C-NHNH2 
OH 
(XVI) 
X 
i 
u 
0 
CH3—(CH2)4—CH=CI^-(CH2)2—CH—(CH2)r 
OH 
N N 
(XXIV) 
Scheme 2.8: Synthesis of (8'72,ll'Z)-2-(8'-hydroxyheptadec-ir-enoyl)-5-phenyl-
l,3,4-oxadiazole(XXIV). 
Structural elucidation of the compound XXIV as {%'R,\VZ)-1'{^'-
hydro3^heptadec-ll'-enoyl)-5-plienyl-l,3,4-oxadiazole 
Obtained as oily compound showing diagonastic IR bands at 3219 (OH), 
1594 (C=N) and 1180 cm"' (C-O-C). The ' H N M R was informative, characteristic 
peaks were observed at 6 7.43-7.95 (5H, m, Ph-H). 2.84 (2H, t, CH2 a to ring) and 
1.76 (2H, m, CH2 P to ring) were observed. The '^ C NMR spectrum also supported 
the structure assigned by showing characteristic peaks at 5 165.7 and 151.4 (C=N, 
C=N). Molecular ion peak M ^  at m/z 398 was observed which correspond to the 
molecular formula C25H38N2O2. Based on the above observations compound XXIV 
was characterized as (8'/?,irZ)-2-(8'-hydroxyheptadec-ir-enoyl)-5-phenyl-l,3,4-
oxadiazole. 
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2.3EXPERIMENTU 
Undec-lO-enoic hydrazide (XIII), (9Z)-octadec-9-enoic hydrazide (XIV), 
(9Z, 12R)-12-hydroxyoctadec-9-enoic hydrazide (XV) and (9R, 122)-9-
hydroxyoctadec-12-enoic hydrazide (XVI) were prepared from methyl undec-10-
enoate, methyl (9Z)-octadec-9-enoate, methyl (9Z,I2i?)-12-hydroxyoctadec-9-enoate 
and methyl {9R, 12Z)-9-hydroxyoctadec-12-enoate respectively following the 
procedure reported earlier.^ ^ 
Benzoic acid and Benzoyl chloride were purchased from Merk, Mumbai, 
India. Phosphorus oxychloride and hydrazine hydrate (80%) were purchased from S 
d FINE-CHEM Ltd. (Mumbai, India). Instruments used for recording the spectra are 
the same as reported in previous chapter (Page No. 24). 
General method for synthesis of 5-(alkenyl)-2-amino-l,3,4-oxadiazoles (XVII-
XX) 
A mixture of fatty acid hydrazide XIII (0.001 mol) and cyanogen bromide 
(0.0012 mol) in dry methanol were refluxed at 60°C on oil bath. The resulting 
solution was cooled and filtered. The filtrate was neutralized with sodium 
bicarbonate solution. The solid mass separated was filtered, washed with excess 
water, dried and recrystallized in chloroform-methanol to get XVn. Similarly 
compounds XVIII, XIX and XX were synthesized from fatty acid hydrazides XIV, 
XV and XVI respectively. 
5-(Dec-9'-enoyl)-2-amino-l^,4-oxadiazoles (XVn). White powder, m.p. 120-122 
°C. 
IR(KBr,cm-^) 3112(NH2), 1585(C=N)and 1187 cm'^  (C-O-C) 
'HNMR(CDCl3) : 6 5.81 (IH, m, CHz^C/f-CHj), 5.01 and 4.95 (2H, m, 
C/f2=CH), 4.90 (2H, br. s, NHj, D2O exchangeable), 2.68 
(2H, t, y = 7.2 Hz, CH2 a to ring), 2.03 (2H, m, CH2=CH-
CH2\ 1.69 (2H, m, CH2 P to ring). 1.26 (lOH, br. s. 
(CH2)5). 
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^^ C NMR (CDCI3) : 
i v. > i n . 
6 167.1, 164.7, 139.0, 11^4.1, 31.9, 29.7 " 0 1 ^ signal 
hidden", 29.4 "one signal hidderi",-29.^-^tvvo, signals 
hidden". ^-•^^^.^^^^'^ 
IR(KBr, cm') 
^HNMRCCDCb) 
M S (FAB) m/z {%) : 224 (M •, 100), 205 (45), 167 (32), 139 (20), 112 (42), 97 
(55). 
(8*2)-5-(Heptadec-8*-enoyl)- 2-ainino-l,3,4-oxadiazoles (XVIII). White crystals, 
m.p. 133-135 "C. 
3118 (NH2), 1584 (C=N) and 1174 cm"' (C-O-C) 
5 5.41 (2H, m, CH2-CH=CH-CK2X 4.86 (2H, br. s, NH2, 
D2O exchangeable), 2.69 (2H, t, 7 = 7.5Hz, CH2 a to ring), 
2.03 (4H, m, CH2'CH2=CU-CH2), 1.69 (2H, m, CH2 P to 
ring), 1.25 (20H, br. s, (CH2)io), 0.88 (3H, dist. t, terminus 
CH3). 
6 167.0, 164.3, 131.2, 125.5, 31.9 "one signal hidden", 
31.7, 29.7 "one signal hidden", 29.6, 29.5. 29.4 "three 
signals hidden", 29.2, 29.1, 22.7, 14.4. 
*^CNMR(CDCl3) 
M S (FAB) m/z (%) : 321 (M •, 15), 304 (20), 237(15), 224 (100), 182 (35), 167 
(22), 154(45), 112(30), 99(35). 
(8%ir^)-5-(ir-Hydroxyheptadec-8'-enoyl)- 2-amino-l,3,4-oxadiazoIes (XIX). 
White powder, m.p. 137-139 °C. 
IR (KBr, cm') 
'HNMR(CDCl3) 
328l(OH), 3112 (NH2), 1581 (C=N) and 1187 cm"' 
(C^O-C). 
5 5.47 (2H, m, CH2-CH=CH-CH2l 4.90 (2H, br. s, NH2, 
D2O exchangeable), 3.66 (IH, m, CH-OK), 2.89 (2H, t, J 
= 'J.lUz, CH2 a to ring), 2.17 (IH, br. s, CH-OH. D2O 
exchangeable), 2.07 (4H, m, CH2-CH2=CH-CH2\ 1.66 
(2H, m, CH2 (3 to ring), 1.27 (18H, br. s, (^2)9), 0.88 (3H, 
dist. t, terminus CH3). 
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^^ C NMR (CDCI3) 
MS (FAB) m/z (%) 
6 166.8, 163.5, 131.2, 125.5. 77.1, 31.9, 31.8, 29.7 "one 
signal hidden", 29.6, 29.2, "three signals hidden", 25.5 
"two signals hidden", 22.6, 14.2. 
337 (M-, 25), 322 (100), 304 (22), 254 (25), 252 (32), 
222 (40), 196 (34), 182 (25), 168 (22), 155 (24), 112 (25), 
99(10). 
(8*i?,irZ)-5-(8'-Hydroxyheptadec-ir-enoyl)- 2-amino-l,3,4-oxadiazoIes (XX). 
White flakes, m.p. 131-133 °C. 
IR (KBr, cm"^ ) 
^HNMR(CDCl3) 
'^CNMR(CDCl3) 
3281 (OH), 3122(NH2), 1584(C=N) and 1184 cm'^  (C-0-
C). 
5 5.45 (2H, m, CHj-C^^OZ-CHj), 4.91 (2H, br. s, NH2, 
D2O exchangeable), 3.66 (IH, m, CH-OH), 2.71 (2H, t, J 
= 7.2Hz, CH2 a to ring), 2.15 (IH, br. s, CH-OH, D2O 
exchangeable), 2.04 (4H, m, CH2-Cli2=CH-CH2l 1.72 
(2H, m, CH2 p to ring), 1.25 (18H, br. s, (CH2)9), 0.88 (3H, 
dist. t, terminus CH3). 
5 167.1, 164.7, 133.4, 127.3, 77.4, 31.9, 31.7, 29.7 "one 
signal hidden", 29.6, 29.4, "two signals hidden", 29.2, 
25.5, "two signals hidden", 22.7, 14.3. 
MS (FAB)/w/z (%) : 337 (M-, 22), 322 (100), 320 (23), 254 (30), 224 (35), 
196 (34), 168 (15), 155 (20), 137 (32), 126 (20), 112 (44), 
97 (25). 
General method for synthesis of 2-(alkenyl)-5-phenyl-l,3,4-oxadiazole (XI-XIV) 
A mixture of fatty acid hydrazide XIII (0.001 mol), benzoyl chloride or 
benzoic acid (0.001 mol) and phosphorus oxychloride (5 ml) in 1,2-dichloroethane 
were refluxed at 65*^ 0 under inert atmospheric conditions. Excess solvent and POCI3 
were removed under reduced pressure. The resulting solution was cooled to room 
temperature, poured into ice cold water and left over night. The solid mass separated 
was filtered, dried and recrystallized from methanol to get compound XXI. Similarly 
compounds XXII, XXin and XXIV were prepared from fatty acid hydrazides XIV, 
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XV and XVI respectively. Compounds XXm and XXFV were extracted in ether 
and washed with excess cold water, dried and chromatographed over silica gel using 
petroleum ether-diethyl ether (96;4v/v) as eluent. 
2-(Dec-9'-enoyl)-5-phenyl-l,3,4-oxadiazoIe (XXI). Off-white powder, mp 107-
109 *^ C. 
IR(KBr, cm') 
^HNMR(CDCl3) 
'^C NMR (CDCI3) 
1579 (C=N) and 1154 cm-' (C-O-C). 
6 7.50-8.04 (5H, m, Ph-H), 5.76 (IH, m, CH2=C^-CH2), 
5.03 and 4.99 (2H, m, C/Z^^CH), 2.77 (2H, X,J=12 Hz, 
CH2 a to ring), 2.07 (2H, m, CH2=CH-a/2), 1.76 (2H, m, 
CH2 P to ring), 1.24 (lOH, br. s, (CH2)5). 
5 168.2, 153.0, 133.4, 133.2, 130.0, 129.8, 127.9, 114.2, 
33.7, 29.3, 29.1, 28.9 "one signal hidden", 28.4 "two 
signals hidden". 
MS(FAB)/w/z(%) : 284 (M-, 24), 257 (20), 242 (15), 215 (10), 207 (100), 
139(25), 112(16), 97(20). 
(8'Z)-2-(Heptatadec-8'-enoyl)-5-phenyI-l,3,4-oxadiazole (XXII). Off-white 
crystals, m.p. 195-197 °C. 
IR(KBr, cm') 
'HNMR(CDCl3) 
'^CNMR(CDCl3) 
MS (FAB) m/z (%) 
1571(C=N) and 1182 cm'' (C-O-C) 
5 7.49-8.02 (5H, m, Ph-H), 5.48 (2H, m, CH2-CH=CH-
CH2), 2.79 (2H, t, y = 7.5Hz, CH2 a to ring), 1.99 (4H, m, 
CH2-CH2=CH-CH2l 1.66 (2H, m, CH2 p to ring), 1.24 
(20H, br. s, (CH2)]o), 0.87 (3H, dist. t, terminus CH3X , 
6 168.4, 152.2, 133.5, 130.4, 129.3, 125.6, 123.2, "one 
signal hidden", 38.6, 38.4, 31.8, 31.4, 29.2, 28.9, 28.7, 
28.4, 28.2, "three signals hidden", 27.9, 22.6, 14.0. 
382 (M-, 100), 367 (25), 353 (35), 311 (10), 269 (20), 
229 (15), 215 (15), 187 (23), 173 (20), 145 (15), 113 (35), 
99(15). 
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(8'Z,n'^)-2-(ir-Hydroxyheptadec-8*-enoyl)-5-phenyl-l,3,4-oxadiazoIe 
(XXm). Oily compound. 
IR (KBr, cm') 
'HNMRCCDCy 
'^CNMR(CDCl3) 
3281 (OH), 1550 (C=N) and 1174 cm'' (C-O-C). 
5 7.43-8.08 (5H, m, Ph-H), 5.37 (2H, m, Cll2-CH=CH-
CHz), 3.60 (IH, m, C//-OH), 2.84 (2H, t, J= 7.2H2, CHja 
to ring). 2.26 (IH, br. s, CH-OH, D2O exchangeable), 2.02 
(4H, m, CH2-CH2=CH-CH2l 1.67 (2H, m, CH2 P to ring), 
1.25 (18H, br. s, (CH2)9), 0.86 (3H, dist. t, terminus CH3). 
6 167.2, 153.0, 139.8, 139.0, 133.5, 130.0, 129.8. 127.9, 
77.1. 38.6, 38.4, 33.5, 31.7, 30.2, 29.9 "one signal hidden", 
29.3, 28.7 "two signals hidden", 28.3, 22.4, 14.4. 
MS (FAB) m/z (%) : 398 (M-. 90), 383(100), 357(23), 339 (25). 327 (10), 257 
(30), 254 (25), 243 (49). 229 (36), 2] 5 (30), J 73 (25), J 60 
(22), 137(24), 112(40), 97(30). 
(8'/?,ll'^ -2-(8*-Hydroxyheptadec-ir-enoyl)-5-phenyI-l,3,4-oxadiazole(XXIV). 
Oily compound. 
: 3219 (OH), 1594(C=N) and 1180 cm-*(C-0-C). 
6 7.43-7.95 (5H, m, Ph-H), 5.35 (2H, m, CH2-CH=CH' 
CU2I 3.79 (IH, m, C//-OH), 2.84 (2H. t,J= 7.2Hz, CH2 a 
to ring), 2.26(1H. br. s, CH-OH. D2O exchangeable), 2.09 
(4H, m, CH2'CU2=^CH-CH2), 1.76 (2H, m, CH2 P to ring), 
1.13 (18H. br. s, (CH2)9), 0.80 (3H, dist. t, terminus CH3). 
5 165.7, 151.4, 139.1, 139.0. 133.0, 130.7, 129.4, 127.6, 
77.3. 38.6. 36.4, 30.4, 31.8. 29.8, 29.6, 29.4 "two signals 
hidden", 28.9 "one signal hidden", 25.9, 22.2, 14.3. 
IR(KBr, cm') 
'HNMR(CDCl3) 
13 C NMR (CDCI3) 
MS (FAB) m/z (%) 398 (M-, 20), 381 (100), 369 (22), 357 (20), 341 (35), 
327 (15), 321 (25), 271 (30), 257 (45), 243 (15), 229 (15), 
215 (30), 201 (10), 187 (25), 165 (15), 152 (25), 145 (15), 
138 (28), 98 (15). 
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3.1 THEORETICAL 
Thiadiazole is a five membered heterocyclic ring system having one sulphur 
and two nitrogen atoms. Depending on the position of the nitrogen atoms in the ring 
with respect to the sulphur atom number 1, there are three types of thiadiazoles 
mentioned below: 
a. 
b. 
c. 
1,2,3-Thiadiazole 
1,2,4-Thiadiazole 
1,3,4-Thiadiazole 
O 
(a) 
I) 
(b) (c) 
The therapeutic effects of compounds containing 1,3,4-thiadiazole ring have 
been studied for many pathological conditions which include antibacterial/ 
antifimgal, antimicobacterial,^ ''* antidepressant/ anti-inflammatory/'^ and 
analgesic. Antibacterial diseases are very common all over the world. Currently 
used antimicrobial agents are not effective due to resistance developed by microbes, 
and therefore it is an ongoing effort to synthesize new antimicrobial agents. Over 
and above there is no permanent structure and activity relationship. Recently the 
importance of-N=C=S linkage has been well stressed.^  It has been found that this 
linkage is responsible for various biological activities in many compounds 
containing sulphur, such as dithiocarbamates, thiourea and thiosemicarbazides."^ 
Giri, et al}^ reported the formation of 2-arylamino-5-(2,6-dichlorophenyl)-
1,3,4-thiadiazoles (90) from thiosemicarbazide (89) in the presence of cone. H2SO4. 
CI 
S 
II 
CONHNH-C-NH 
89 
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Synthesized 2-arylamino-5-(o-hydroxyphenyl)-l,3,4-thiadiazoles (92a-d) 
from the l-salicoyl-4-arylthiosemicarbazides (91a-d) by treating it with cone. H2SO4 
in absolute ethanol was reported by Chaban et al. '^ 
OH 
CONHNH—C- N H - Ar Cone H^ SO, 20vy4 
^ ^ / 
91a-d 92a-d 
NHAr 
Compound 
91a, 92a 
91b,92b 
AT 
CeHs 
4-CI-C6H4 
Compound 
91c, 92c 
91d, 92d 
Ar 
4-Br-C6H4 
4-CH3O-C6H4 
Gawande and Shingare^^ reported that 4-aryl-l-(4-aryl-2-methylthiazoIe-5-
carbonyl)-thiosemicarbazides (93a-d) on cyclization with cone, sulphuric acid gave 
5-arylamino-2-(4-aryl-2-methylthiazol-5-yl)-l,3,4-thiadiazoles(94a,b). 
W NH \ _ / 
Compound 
93a, 94a 
93b,94b 
93c, 94c 
93d,94d 
R 
H 
NO2 
H 
NO2 
R' 
H 
Br 
Ci 
Me 
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Thiosemicarbazide (95) has been reported as versatile synthetic 
intermediates, for the preparation of many heterocyclic moieties e.g. 2-amino-5-(2'-
thienyl)[l,3,4]-thiadiazole (96) is synthesized in strong acidic medium.^ '* 
O S 
W (I Cone. H2SO. 
C - N H - N H - C - N H 2 ^ - ^ -
N - N 
NH. 
95 96 
Giri et al}^ further prepared 2-amino-5-(p-chIorophenyI)-l,3,4-thiadiazole 
(98) by cyclodehydration of appropriate 4-arylacetothiosemicarbazide (97) with 
conc.H2S04. 
N - N 
CONHNH-C-NH2 Cone. H^SO^ 
97 
NH2 
Synthesis of 5-(6'-nitrobenzimidazoIe-1 -ylmethyI)-4-phenylamino-1,3,4-
thiadiazole (100) from l-A^-(6-nitrobenzimidazole-l-cabonyimethyl)-4-phenyl-
3-thiosemicarbazide (99) in good yield was reported by Pengfei et al.^^ 
CH2-C-NH-NH-C-NH—Ph 
1! II 
O S 
99 
Xinping et al.^'' synthesized 6-aryI-3-(5-methylisoxazole-3-yl)-S-
triazolo[3,4-b]-l,3,4-thiadiazoIes (102a-d) and 6,6'-bis(3-(5-methylisoxazoIe-3-yl)-
S-triazoIef3,4-b]-l,3,4-thiadiazoIe) (103) from 4-amino-5-mercapto-3-(5-
methylisoxazole-3-yl)-l,2,4-triazoIe (101) by treating with different aromatic acids 
and oxalic acid in presence of POCI3 respectively. 
64 
2JOisu6stituUif'l,3,4-7fiiadiazo&s 
HgC^ ^O 
AiCOOH 
N ~ N 
N 
. . ^ NH2 
SH 
101 
Oxalic acid 
POCU POCl, 
N - N 
H3C" ^O 
102a-d 
N 
103 
N - N n 
N 
\ 
N 
-^2 
Compound 
102a 
102b 
102c 
102d 
AT 
4-Br-C6H4 
CeHj 
4-NO2-C6H4 
4-CH3O-C6H4 
6-Aryl-3-cinchophenyI-l,2,4-triazolo[3,4-b]-l,3,4-thiadiazoles (105a,b) 
from 3-cinchophenyl-4-amino-5-thio-l,2,4-triazole (104) by treating with aromatic 
1 fi 
acid in POCI3 was reported by Pengfei et al. 
N - N 
1 ^ y—SH AiCOOH ^ N 
N 
NH2 
POCl, 
104 
Compound 
105a 
105b 
105 a, b 
AT 
4-CI-C6H4 
4-hT-C6H4 
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Nasr and Mostafa^ ^ utilized dipotassium salt of glataric acid bis-
(hydrazinocarbodithioc acid) (106) to synthesize double headed 1.3,4-thiadiazoline 
(107). 
CONHNHCSK 
—OH 
H O -
MO— 
—OH 
CONHNHCSK 
S 
106 
O.IMH^SO^ 
HN 
^ ^ ^ 
—OH 
HO— 
HO— 
—OH 
107 
Synthesis of 2-amino-5-aryloxymethyI-l,3,4-thiadiazoIes (llOa-d) under 
microwave conditions from thiosemicarbazide (109) and aryloxyacetic acid (108) in 
excellent yields was reported by Zheng et ai.^° 
N-N 
ArOCH2COOH + N H J - C - N H - N H 2 ^-^-^^^ > ArOH^C 
^ PEG-OP(<9)Cl2 ^ ' - ' " 2 ^ 
108 109 
S' NH2 
llOa-d 
Compound 
110a 
llOb 
110c 
llOd 
Ar 
CeHs 
2-CH3C6H4 
4-CIC6H4 
1-Naphthyl 
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Aamir et al^ reported synthesis of 5-[2-(4-i-butylpheny])ethy]]-2alkyl/ary]-
aniino-l,3,4-thiadiazoles (112a,b) from thiosemicarbazide (llla,b) by gradually 
adding it to a cold solution of concentrated sulphuric acid. 
CONHNH-CNHR ^-^^^^ 
llla,b 
Compound 
Ilia, U2a 
111b, 112b 
112a,b 
R 
-NHCH2CH2CH2CH3 
-NH-CsHii 
Aryl-N-{[({4-[2-(2-chlorophenyI)-4-oxo-(3-hydroquinazolin-3-yl)]-phenyl}-
carbonylamino)-amino]-thioxomethyl}-amides (llla-e) when stirred in 
concentrated sulphuric acid gave aryl-N-5-{4-[2-(2-chlorophenyl)-4-oxo-(3-
hydroquinazolin-3-yi)]-phenyl}-l,3,4-thiadiazole-2-yl-amides (112a-e) in excellent 
yields.^' 
O SO 
II II 
CNHNH—CNHC-Ar 
O 
= / N - N 
^ N H C - A r 
N^ "R 
112a-e 
Compound 
Ilia,112a 
nib, n2b 
111c, 112c 
Hid, 112d 
l l l e , 112e 
Ar 
CfiHs 
CeHs CH2 
2-CI-C6H4 
2-NO2-C6H4 
4-CI-C6H4 
R 
2-CI-C6H4 
2- CI-C6H4 
2- CI-C6H4 
2- CI-C6H4 
2- CI-C6H4 
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Pintilie et al synthesized a series of 2-[l-{3-nitrobenzoylamino)-3-
(methyithio)]-propyl-5-(alkyl/phenylamino)-l,3,4-thiadiazoIes (114a-e) from 1-[N-
(3-nitrobenzoyl)-D,L-methionyl]-4-alkyi/phenyl-thiosemicarbazides (113a-e) by 
stirring at room temperature with concentrated sulphuric acid. 
H3CS-C2H4~CH-CONHNHC-NHR 
NH 
I 
CO 
NO2 
113a-e 
N - N 
H3CS—C2H4—CH—( 
NH 
I 
CO 
H S^O^ 
NHR 
NO2 
114a-e 
Compound 
113a, 114a 
113b,114b 
113c, n 4 c 
113d, 114d 
113e, 114e 
R 
CH3 
CeHs 
4-CH3C6H4 
4-Br-C6H4 
CH2-CH=CH2 
Recently synthesis of 5-[(biphenyl-4-yIoxy)methyl]-2-alkyl/aryl amino-
l,3,4-thiadia2oles (116a-d) from V[2-(biphenyi-4-yloxy)ethanoyl]-A'^-alkyI/aryI-
thiosemicarbazides (115a-d) was reported by Kumar et al}^ 
\ /r\ // 
OCHzCONHNHCNHAr 
115a-d 
N - N 
0 C H 2 ^ 
116a-d 
AT 
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Compound 
115a, 116a 
115b,116b 
115c, 116c 
115d, 116d 
AT 
CeHs 
4-F-C6H4 
2-CI-C6H4 
4-CI-C6H4 
Keeping in mind the practicai applications of 1,3,4-tiiiadiazoles, we 
considered the synthesis of hitherto new thiadiazoles bearing long alkenyl and 
hydroxyl-alkenyl chain and their in-vitro antibacterial activity. 
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3.2 RESUITS AND DISCUSSION 
Synthesis of 1,3,4-thiadiazoles from fatty acid hydrazides was performed in 
two steps. Benzoylisothiocynate a versatile reagent for synthesis of different 
thiosemicarbazides '^* was prepared according to literature method. '^ Fatty acid 
hydrazides Xni-XVI were prepared according to literature method. ^ ^ Fatty acid 
hydrazides were dissolved in minimum amount of ethyl acetate and added portion 
wise to benzoylisothiocynate solution while stirring at reflux temperature for 3 hrs. 
Excess solvent was removed and the precipitated compounds were filtered and 
recrystallized from benzene-chloroform to give thiosemicarbazides. 
Thiosemicarbazides XXV-XXVin were treated with concentrated sulphuric 
acid at 0°C in an ice bath with constant stirring for 1 hr and reaction mixture was 
poured into 50 ml ice water. The product was precipitated, filtered and washed with 
excess cold water to afford 1,3,4-thiadiazoles XXIX-XXXII in quantitative yields. It 
was also observed that sulphuric acid was a better dehydrating agent than acetic 
anhydride, which takes more reaction time and poor yields. 
Reaction of undec-10-enoic hydrazide (XIII) with benzoylisothiocynate 
Fatty acid hydrazide XIII was dissolved in minimum amount of ethyl acetate 
and added portion wise to benzoylisothiocynate solution while stirring at reflux 
temperature for 3 hrs (Scheme3.1). Excess solvent was removed and the precipitated 
compound was filtered and recrystallized from benzene-chloroform to give a white 
powder. 
O 
II 
CH2=CH—(CH2)8—C -NHNH2 
(xin) 
o i s o 
II II II 
CH2=CH—(CH2)8—C—NHNH-C—NH-C 
(XXV) 
Scheme 3.1: Synthesis of l-(undec-10-enoyl)-4-benzoylthiosemicarbazides (XXV). 
f \ 
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Structural elucidation of the compound XXV as l-(undec-10-enoyl)-4-
benzoylthiosemicarbazides 
Compound XXV showed characteristic IR bands at 3226 (NH-NH, NH), 
1667 (C=0) and 1300 cm'' (C=S). H^ NMR was more informative in assigning the 
structure showing peaks at 6 13.02 (s, IH, NH) and 9.18 (br. s, 2H, NH-NH). In '^ C 
NMR peaks at 5 168.2 (C=S). 165.4 (C=0) and 160.8 (C=0) were observed. 
Elemental analysis and mass spectral data [m/z= 384 (M+Na)^] established its 
molecular formula C19H27N3O2S. Based on the above facts compound XXV was 
characterized as l-(undec-10-enoyl)-4-benzoyhhiosemicarbazides. 
Reaction of (9Z)-octadec-9-enoic hydrazide (XIV) with benzoylisothiocynate 
Fatty acid hydrazide XIV after dissolving in minimum amount of ethyl 
acetate was added portion wise to benzoylisothiocynate solution while stirring at 
reflux temperature for 3 hrs (Scheme 3.2). Excess solvent was removed under 
reduced pressure and the solid obtained was filtered and recrystallized from 
benzene-chloroform to give a white powder. 
O 
II 
CH3—(CH2>7—CH=:CH—(CH2)7 C -NHNH2 
(XIV) 
Q-^-N=C=S 
O S O 
II II II 
CH3—(CH2)7—CH=CH—(CH2)7—C—NHNH-C—NH-C 
(XXVI) 
Scheme 3.2: Synthesis of l-[(9Z)-octadec-9-enoyl]-4-benzoylthiosemicarbazides 
(XXVI). 
structural elucidation of the compound XXVI as l-[(9Z)-octadec-9-enoyl]-4-
benzoylthiosemicarbazides 
Characteristic IR bands at 3220 (NH-NH, NH), 1661 (C=0) and 1303 cm"' 
(C=S). In 'H NMR characteristic signals were observed at 6 13.20 (s, IH, NH) and 
/ \ 
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9.18 (br. s, 2H, NH-NH) along with long chain alkenoyl signals. '^ C NMR 
diagnostic peaks at 5 167.4 (C=S), 164.7 (C=0) and 154.3 (C=0) were observed. 
Elemental analysis and mass spectral data [m/z= 482 (M+Na)^] established its 
molecular formula C26H41N3O2S. Thus compound XXVI was characterized as 1-
[(9Z)-octadec-9-enoyl]-4-benzoylthiosemicarbazides. 
Reaction of (9Z42J?)-12-hydroxyoctadec-9-enoic hydrazide (XV) with 
benzoylisothiocynate 
Fatty acid hydrazide XV was dissolved in minimum amount of ethyl acetate 
and then added in portions to benzoylisothiocynate solution while stirring at reflux 
temperature for 3 hrs (Scheme 3.3). Excess solvent was removed under reduced 
pressure and the solid obtained was filtered and recrystallized from benzene-
chloroform to give an ofF-white powder. 
0 
w 
CH3—(CH2)5—CH--CH2—CH=CH—(CH2)7—C-NHNH2 
OH (XV) 
Q so 
CH3—{CH2)5—CH—CH2—CH=CH—(CH2)7—C—NHNH-C—NH-C—^ ^ 
OH 
(XXVII) 
Scheme 3.3: Synthesis of l-[(9Z.12/?)-12-hydroxyoctadec-9-enyl]-4-
benzoylthiosemicarbazides (XXVII) 
Structural elucidation of the compound XXVn as i-[{9Z,l2R)-n-
hydroxyoctadec-9-enyI]-4-benzoylthio$emicarbazides 
Characteristic IR bands at 3357 (OH), 3222 (NH-NH, NH), 1661 (C=0) and 
1303 cm'' (C=S). In ' H NMR characteristic peaks at 5 13.25 (s, IH, NH) and 9.19 
(br. s, 2H, NH-NH) were observed. '^ C NMR characteristic peaks at 6 166.2 (C=S), 
163.3 (C=0) and 159.9 (C=0) were observed. Elemental analysis and mass spectral 
data [m/z= 498 (M+Na)^] established its molecular formula C26H41N3O3S. Thus 
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compound XXVII was characterized as l-[(9Z,12R)-12-hydroxyoctadec-9-enyl]-4-
benzoylthiosemicarbazides. 
Reaction of (9i?,122)-9-hydroxyoctadec-12-cnoic hydrazide (XVI) with 
benzoylisothiocynate 
Fatty acid hydrazide XVI after dissolving in minimum amount of ethyl 
acetate was added in portions to benzoylisothiocynate solution while stirring at 
reflux temperature for 3 hrs (Scheme 3.4). Excess solvent was removed and the solid 
obtained was filtered and recrystallized from benzene-chloroform to give an off-
white powder. 
O 
CH3—(CH2)4—CH=CH—(CH2)2—CH—(CH2)7—C-NHNH2 
OH 
(XVI) 
-C—N=C=S 
Q s o 
CH3—(CH2)4—CH=CH—(CH2)2—CH—(CH2>7—C—NHNH-C—NH-C—^ ^ 
OH 
(XXVIII) 
Scheme 3.4: Synthesis of l-[(97?,l2Z)-9-hydroxyoctadec-12-enyl]-4-
benzoylthiosemicarbazides (XXVIII) 
Structural elucidation of the compound XXVm as l-[(9/?,12Z)-9-
hydroxyoctadec-12-enylJ-4-benzoylthio$emicarbazides 
JR spectrum gave diagnostic bands at 3352 (OH), 3180 (NH-mi, NH), 1668 
(C=0) and 1303 cm'^  (C=S). Characteristic peaks were observed in ' H N M R 
spectrum at 6 13.05 (s, IH, NH) 9.11 (br. s, 2H, NH-NH) and 3.61 (m, IH, C//-OH). 
In '^C NMR peaks at 5 167.6 (C=SX 163.2 (C=0) and 159.0 (C=0) were observed. 
Elemental analysis and mass spectral data [m/z= 498 (M+Na)""] established its 
molecular formula C26H41N3O3S. Based on these observations compound XXVIII 
was characterized as 1 -[(9/?, l2Z)-9-hydroxyoctadec-12-enyl]-4-
benzoylthiosemicarbazides. 
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Intramolecular cyclization of l-(undec-10-enoyl)-4-benzoylthioseiiiicarbazides 
(XXV) in concentrated sulphuric acid 
l-(Undec-10-enoyl)-4-benzoyIthioseniicarbazides (XXV) was treated with 
concentrated sulphuric acid at 0°C in an ice bath with constant stirring for 1 hr. The 
reaction mixture was poured into 50 mL ice water. The produa was precipitated, 
filtered and washed with excess cold water to afford a white powder in quantitative 
yield (Scheme 3.5). 
O S O 
II II [l 
CH2=CH—(CH2)8—C—NHNH-C—NH-C 
(XXV) 
6 
o 
O 
N-N 0 
C H 2 = C H — ( C H 2 ) ^ ^ > - N H - C ^ ^ 
(XXIX) 
Scheme 3.5: Synthesis of 2-benzamido-5-(dec-9-enyl)-l,3,4-thiadiazole (XXIX) 
Structural elucidation of the compound XXDC as 2-benzamido-5-(dec-9-enyl)-
1,3,4-thiadiazole 
Significant IR bands at 3181 (NH), 1664 (C=0), 1541 (C=N) and 707 cm"' 
(C-S-C) were observed. H^ NMR peak at 6 8.32 (s, IH, NH) was observed in 
addition to peaks of normal fatty acid chain. In '^ C NMR peaks at 6 165.2 (C=S), 
and 153.0 (C-N) were observed. Elemental analysis and mass spectral data [m/z= 
366 (M+Na)^] established its molecular formula C19H25N3OS. Based on these 
observations compound XXIX was characterized as 2-benzamido-5-(dec-9-enyl)-
l,3,4-thiadia2ole. 
Intramolecular cyclization of l-[(9Z)-octadec-9-enoyl]-4-benzoylthio-
semicarbazides (XXVT) in concentrated sulphuric acid 
l-[(92)-octadec-9-enoyl]-4-benzoylthiosemicarbazides (XXVI) on treatment 
with concentrated sulphuric acid at 0°C in an ice bath with constant stirring for 1 hr 
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and pouring the reaction mixture into SO mL ice water a white mass was precipitated 
which was filtered and washed with excess cold water to afford a white powder in 
quantitative yield (Scheme 3.6). 
O S O 
CH3—(CH2)7—CH=CH—(CH2>7—C—NHNH-C—NH-C ^ ^ 
(XXVI) 
N - N 
CH3—(CH2)7—CH=CH—(CH2>7—L V N H - C 
S 
(XXX) 
Scheme 3.6: Synthesis of 2-benzamido-5-[(8Z)-heptadec-8-enyl]-l,3,4-thiadiazole 
(XXX) 
Structural elucidation of the compound XXX as 2-benzamido-5-K8Z)-heptadec-
8-enyI]-l^,4-thiadiazoIe 
Characteristic IR bands at 3181 (NH), 1663 (C=0), 1540 (C=N) and 700 
cm^ (C-S-C) were observed. ^H NMR diagnostic peak at 5 8.26 (s, IH, NH) was 
observed in addition to peaks of normal fatty acid chain. In "C NMR peaks at 5 
165.4 (C=S), and 158.0 (C=N) were observed. Elemental analysis and mass spectral 
data [m/z= 464 (M+Na)^] established its molecular formula C26H39N3OS. Based on 
these observations compound XXX was characterized as 2-benzamido-5-[(8Z)-
heptadec-8-enyI]-I,3,4-thiadia2ole. 
Intramolecular cyclization of l-[(9Z,12R)-12-liydroxyoctadec-9-enyl]-4-
benzoylthiosemicarbazides (XXVH) in concentrsiteA sulphuric acid 
l-[(9Z,12R)-12-Hydroxyoctadec-9-enyl]-4-benzoylthiosemicarbazides 
(XXVn) was stirred with concentrated sulphuric acid at O^ C in an ice bath for 1 hr. 
The reaction mixture was poured into 50 mL ice water. The product was 
precipitated, filtered and washed with excess cold water to afford a white powder in 
quantitative yield (Scheme 3.7). 
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0 S 0 
CH3—(CH2)5—CH~CH2—CH=CH—(CH2)7—C--NH^fH-C-NH-C^ \ 
OH 
(XXVII) 
CH3—(CH2)5—CH—CH2—CH=CH—(CH2)7—i^ J ^ ^ f H - C - ^ ^ 
(XXXI) 
OH 
N - N o 
Scheme 3.7: Synthesis of 2-benzamido-5-[(8Z,llR).ll-hyd^oxyheptadec-8-enyl]-
l,3,4-thiadiazole (XXXI) 
Structural elucidation of the compound XXXI as 2-benzanjido-5-J(8Z,llR)-ll-
h^droxyheptadec-S-enylJ-1^3^4-thiadiazole 
IR bands at 3357 (OH), 3222 (NH). 1661 (C=0), 1543 (C=N) and 701 cm"' 
(C-S-C) were observed. 'H NMR characteristic peak at 5 8.31 (s, IH, NH) was 
observed in addition to peaks of normal fatty acid chain. In '^ C NMR peaks at 6 
163.2 (C=S), and 159.9 (C=N) were observed. Elemental analysis and mass spectral 
data [m/z= 480 (M+Na)^] established its molecular formula C26H39N3O2S. Based on 
these observations compound XXXI was characterized as 2-benzamido-5-
[(8Z,11R)-1 l-hydroxyheptadec-8-enyI]-l,3,4-thiadiazole. 
Intramolecular cyclization of l-((9R,12Z)-9-hydroxyoctadec-12-enyl]-4-
benzoylthiosemicarbazides (XXVni) in concentrated sulphuric acid 
1 -[(9R, 12Z)-9-Hydroxyoctadec-12-enyl]-4-benzoylthiosemicarbazides 
(XXVin) on treatment with concentrated sulphuric acid at O'^ C in an ice bath with 
constant stirring for 1 hr and pouring the reaction mixture into 50 mL ice water a 
mass was precipitated which was filtered and washed with excess cold water to 
afford a off-white powder in quantitative yield (Scheme 3.8). 
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Q s o 
CH3—(CH2)4—CH=CH—(CH2)2—CH—(CH2)7—C—NHNH-C—NH-C-^ 
OH 
(XXVIII) 
N - N Q 
CH3—(CH2)4—CH=CH—(CHzh—CH—(CHsh ' ^ ^ S - N H - C - ^ ^ 
OH 
(XXXII) 
Scheme 3.8: Synthesis of 2-ben2amido-5-[(8R,llZ)-8-hydroxyheptadec-ll-enyl]-
l,3,4-thiadiazole (XXXII) 
Structural elucidation of the compound XXXII as 2-benzamido-5-[(8R,llZ)-S-
hydroxylieptadec-n-enyI]-l,3,4-thiadiazole 
Characteristic IR bands at 3352 (OH), 3180 (NH), 1668 (C=0), 1543 (C=N) 
and 69^ cm"^  (C-S-C) were observed. ' H N M R diagnostic peak at S 8.29 (s, IH, NH) 
was observed in addition to peaks of normal fatty acid chain. In "^'C NMR peaks at 6 
163.2 (C=S), and 159.0 (C=N) were observed. Elemental analysis and mass spectral 
data [m/z= 480 (M+Na)" ]^ established its molecular formula C26H39N3O2S. Based on 
these observations compound XXXII was characterized as 2-benzamido-5-
[(8R,llZ)-8-hydroxyh( ieptadec-ll-enyl]-l,3,4-thiadiazole, . ^oa Ai«tf/-X^ 
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3.3EXPERIMENTU 
Benzoylisothiocynate a versatile reagent for synthesis of different 
thiosemicaibazides was prepared according to literature method. '^ Fatty acid 
hydrazides Xni-XVI were prepared according to method described in our previous 
paper,^ ^ Ammonium thiocynate and Benzoyl chloride were purchased from Merk, 
Mumbai, India. Hydrazine hydrate (80%) was purchased from S d FINE-CHEM 
Ltd. (Mumbai, India). ^ H NMR were recorded at 400 MHz and ^^ C NMR were 
recorded at 100 MHz. Melting points were taken in open capillaries and are 
uncorrected. 
General method for synthesis of l-(alkenoyl)-4-benzoylthiosemicarbazides 
(xxv-xxm). 
Fatty acid hydrazide XUI (0.001 mol) was dissolved in minimum amount of 
ethyl acetate and added portion wise to benzoylisothiocynate solution (O.OOl mol) 
while stirring at reflux temperature for 3 hrs. Excess solvent was removed and the 
precipitated compound was filtered and recrystallized from benzene-chloroform to 
to get XXV. Similarly compounds XXVI, XXVH and XXVIH were synthesized 
from fatty acid hydrazides XIV, XV and XVI respectivelly. 
l-(Undec-10-enoyl)-4-benzoylthiosemicarbazides (XXV). White powder, yield 
86%, m.p. 87-89°C. 
IR (KBr, cm"') : 3226 (NH-NH, NH), 1667 (C=0) and 1300 (C=S). 
H^ NMR (CDCI3) : 5 13.02 (s, IH, NH), 9.18 (br. s, 2H, NH-NH), 8.19 (d, 2H, 
y= 7.4 Hz, Ar-H-276"), 7.62 (t, IH, J = 7.2 Hz, Ar-H-4"), 
7,53 (t, 2H, y = 7.4 Hz, Ar-H-375"), 5.80 (tdd, IH, 
•^.-v.r ^^ ^ ' ^- . ,=^00 Hz, J,.,^=17.8 Hz, 
CH2=C/0. 5.00 (dd, IH, J,^^,=\0.0 Hz, j„,.„,=2.8 Hz, 
//zC=CH), 4.94 (dd, IH, y;,^ _«=17.8 Hz, J,,., =2.% Hz, 
HE^-^CH-), 3.05 (t, 2H, J = 7.6 Hz, CH2-CO), 2.03 (m, 
2H, CH2=CH-C//2), 1.83 (m, 2H, C//2CH2-CO), 1.45-1 25 
(br. s, lOH, (CH2)5). 
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'^CNMR(CDCl3) : 5 168.2, 165.4, 160.8. 139.2, 133.2, 131.3, 128.9, 128.6, 
114.2, 33.8, 29.9, 29.6, 29.3. 29.2, 29.1, 29.0, 28.9. 
: 384 [M+Na]^ MS (ESI) m/z 
Anal Calcd for C19H27N3O2S: C 63.17, H 7.47, N 11.62. Found' 
C 63.14, H 7.43, N 11.64%. 
l-[(9Z)-Octadec-9-enoyl]-4-benzoylthiosemicarbazides (XXVI). White powder, 
yield 83%, m.p. 93-95°C. 
IR (KBr, cm^') : 3220 (NH-NH, NH), 1661 (C=0) and 1303 (C=S). 
^HNMR(CDCl3) : 6 13.20 (s, IH, NH), 9.18 (br. s, 2H, NH-NH), 8.10 (d, 2H, 
/ = 7.4 Hz, Ar-H-276"), 7.62 (t, IH. J= 12 Hz, Ar-H-4"), 
7.53 (t, 2H, y = 7.4 Hz, Ar-H-375"), 5.32 (m, 2H, CH2-
CH=CH-CH2l 3.04 (t, 2H, J = 7.8 Hz, CH2-CO), 2.36 (m, 
4H, CN2-CH2^CH-CH2X 1.82 (m, 2H, CH2-CH2'CO), 
1.37-1.25 (br. s, 20H, (CH2)io), 0.89 (dist. t, 3H, terminus 
CH3). 
5 167.4, 164.7, 154.3, 139.2, 137.3, 133.2, 131.5, 128.8, 
129.0, 31.9, 29.7, 29.6, 29.4 "three signals are hidden", 
29.2 "three signals are hidden", 29.1, 26.6, 22.7, 14.2. 
482 [M+Na]^ 
"CNMR(CDCl3) 
MS (ESI) m/z 
Anal Calculated for C26H41N3O2S: C 67.98, H 8.92, N 9.14. 
Found: C 67.94, H 8.90, N 9.17 %. 
l-[(9Z,12R)-12-Hydroxyoctadec-9-enyl]-4-benzoyIthioseinicarbazides (XXVII). 
Off-white powder, yield 79%, m.p. 95-97^0. 
IR (KBr, cm"') 
'HNMR(CDCl3) 
3357 (OH), 3222 (NH-NH, NH), 1661 (C=0) and 1303 
(C=S). 
6 13.25 (s, IH, NH), 9.19 (br. s, 2H, NH-NH), 8.14 (d, 2H, 
J= 1.6 Hz, Ar-H-2'76"), 7.63 (t, IH, J= 7.2 Hz, Ar-H-4"), 
7.53 (t, 2H, y = 7.4 Hz, Ar-H-375"), 5.37 (m, 2H, CH2-
CH=CH~CH2l 3.59 (m, IH, C/f-OH), 3.05 (t, 2H, 7 = 7.6 
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13 C NMR {CDCI3) 
MS (ESI) m/z 
Anal 
Hz, CH2-CO), 2.36 (m, 4H, CH2-CH2=CH-CH2), 1.83 (m, 
2H, CHrCH2-C0\ 1.72 (s. IH, OH), 1.44-1.28 (br s, 
18H, (CH2)9), 0.88 (dist. t, 3H, terminus CH3) 
6 166,2, 163.3, 159.9. 138.7 "one signal hidden", 132.2, 
128.1, 128.0, 127.8, 70.7, 40.1, 39.9, 39.7, 39.4, 39.2, 31.3, 
30.4. 29.4, 29.2, 29.0. 28.8, 26.1, 22.0, 14.0. 
498 [M+Na]^ 
Calculated for C26H41N3O3S: C 65.69, H 8.62, N 8.83. 
Found; C 65.63, H 8.59, N 8.86%. 
l-[(9R,12Z)-9-Hydroxyoctadec-12-enyl]-4-benzoylthiosemicarbazides 
(XXVni). Off-white powder, yield 73%, m.p. 96-98°C. 
IR(KBr.cm"') : 3352 (OH), 3180 (NH-NH. NH). 1668 (C=0) and 1303 
(C=S). 
; 5 13.05 (s, IH. NH), 9.11 (br. s, 2H, NH-NH), 8.18 (d, 2H, 
y = 7.4 Hz. Ar-H-276"), 7.63 (t, IH, 7 = 7.2 Hz, Ar-H-4"), 
7.54 (t, 2H, y = 7.4 Hz, Ar-H-3'75"), 5.38 (m, 2H. CH2-
CH=CH-CH2l 3.61 (m. IH, CH-OHl 3.05 (t, 2H. J= 1.6 
Viz, CH2-CO), 2.26 (m, 4H. CH2-CB.r=Cn-CH2\ 1.86 (m. 
2H, C^2-CH2-CO), 1.68 (s, IH. OH), 1.40-1.25 (br. s, 
18H, (CH2)9), 0.87 (dist. t, 3H, terminus CH3). 
: 6 167.6, 163.2, 159.0, 138.4, 137.6, 131.2, 128.7, 128.3, 
125.5, 70.56. 40.1, 39.9, 36.3. 24.8, 31.3. 29.1, 29.0, 28.9, 
28.8,28.5.28.4,25.1,22.3,14.01. 
498[M+Na]^ 
Calculated for C26H41N3O3S: C 65.69, H 8.62, N 8.83. 
Found: C 65.66, H 8.58, N 8.87 %. 
'HNMR(CDCl3) 
'^CNMR(CDCl3) 
MS (ESI) m/z 
Anal 
80 
2,S-<Disu6stitutecf-l,3,4-11iia£azoles 
General method for synthesis of 2-benzamido-5-(alkenyl)-l,3,4-thiadiazole 
(xxK-xxxn). 
l-(Undec-10-enoyl)-4-benzoylthiosemicarbazides (XXV) was treated with 
concentrated sulphuric acid at 0°C in an ice bath with constant stirring for 1 hr. The 
reaction mixture was poured into 50 mL ice water. The product (XXIX) was 
precipitated, filtered and washed with excess cold water to afford a white powder in 
quantitative yield. Similarly compounds XXX, XXXI and XXXII were synthesized 
from I-(aIkenoyI)-4-benzoylthiosemicarbazides XXVI, XXVn and XXVHI 
respectivelly. 
2-Benzamido-5-(dec-9-enyl)-l,3,4-thiadiazoIe (XXIX). White powder, yield 82%, 
m.p. 91-92°C. 
: 3181 (NH), 1664 (C=0), 1541 (C=N) and 707(C-S-C). 
; 6 8.32 (s, IH, NH), 7.60 (d, 2H, J = 7.2 Hz, Ar-H-2"/6"), 
7.54 (t, IH, y = 7.0 Hz, Ar-H-4"), 7.43 (t, 2H, J = 7.2 Hz, 
IR(KBr, cm'^ ) 
^HNMR(CDa3) 
^^ C >MR (CDCI3) 
MS (ESI) m/z 
Anal 
Ar-H-3"/5"), 5.81 (tdd. IH, j ^ , ^ ^ = 6.8 Hz, J;,_;,^ =10.0 
Hz, J„_„^^\1.6 Hz, CH2=C/r-). 4.98 (dd, IH, ^^_^=10.0 
Hz, ^,.„,=2.6 Hz, ^zC=CH), 4.94 (dd, IH, ^,.^=17.6 
Hz. JM,-Hr 2-6 Hz, iy£C=CH-), 3.02 (t, 2H, y = 7.4 Hz, 
CH2-CO), 2.11 (m, 2H, CH2=CH-CH2), 182 (m, 2H, 
C//2CH2-CO), 1.40-1.22 (br. s, lOH, (^2)5) 
6 165.2, 153.0 "one signal hidden", 139.1, 133.4, 131.3, 
129.8, 127.9, 114.2,33.7,29.1,28.9,28.8,28.7,28.4,26.0, 
25.8. 
366 [M+Na]^ 
Calculated for C19H25N3OS: C 66.48, H 7.28, N 12.23. 
Found: C 66.44, H 7.25, N 12.26%. 
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2-Benzamido-5-[(82)-heptadec-8-enyl]-l,3,4-thiadiazole (XXX). White powder, 
yield 78%, m.p.l01-103°C. 
-1-IR (KBr, cm"') 
'HNMR(CDCl3) 
^^ C NMR (CDCI3) 
: 3181 (NH), 1663 (C=0). 1540 (C=N) and 700(C-S-C). 
: 6 8.26 (s, IH, NH), 7.63 (d, 2H, J = 7.2 Hz, Ar-H-276"), 
7.59 (t, IH, y = 7,0 Hz, Ar-H-4"), 7.50 (t, 2H, 7 = 7.4 Hz, 
Ar-H-3'75"), 5.30 (m, 2H, CH2-CH=CH-Cn2X 3.04 (t, 
2H, J = 1.6 Hz, CH2-CO), 2.36 (m, 4H, CH2-CB.2=CH-
CH2I 1.85 (m, 2H, CHrCKi-COl 1.44-1.25 (br. s, 20H, 
(CH2)io), 0.87 (dist. t, 3H, terminus CH3). 
: 6 165.4, 158.0 "one signal hidden", 139.1, 137.2, 133.2, 
131.3. 128.8, 128.6. 31.9, 29.9. 29.7, 29.5"two signals are 
hidden". 29.4"two signals are hidden", 29.3, 29.1, 28.7, 
26.4, 22.7, 14.2. 
: 464[M+Na]"'. 
: Calculated for C26H39N3OS: C 70.75, H 8.83, N 9.51. 
Found: C 70.72, H 8.80, N 9.54%. 
2-Benzainido-5-[(8Z,llR)-ll-hydroxyheptadec-8-enyl]-l,3,4-thiadiazole 
(XXXI). White powder, yield 79%, m.p. 104-105°C. 
MS (ESI) m/z 
Anal 
-1-IR (KBr, cm'') 
^H NMR (CDCI3) 
13 C NMR (CDCI3) 
3357 (OH), 3222 (NH), 1661 (C=0), 1543 (C=N) and 701 
(C-S-C). 
5 8.31 (s, IH, NH), 7.62 (d, 2H, J= 7.2 Hz, Ar-H-276"), 
7.53 (t, IH, y = 7.0 Hz, Ar-H-4"), 7.41 (t, 2H, J= 7.2 Hz, 
Ar-H-375"), 5.37 (m, 2H, CHi-CH^CH-CHi), 3.59 (m, 
IH, C/f-OH), 3.06 (t, 2H, y = 7.6 Hz, CH2-CO), 2.38 (m, 
4H, CH2'CH2=CH-CH2l 1.81 (m, 2H, C//2-CH2-CO). 1.72 
(s, IH, OH), 1.50-1.25 (br. s, 18H, (CH2)9), 0.88 (dist. t, 
3H, terminus CH3). 
6 163.2, 159.9 "one signal hidden", 138.7 "one signal 
hidden", 132.2, 128.1, 128.0, 127.8, 70.7, 40.1, 39.9, 39.7, 
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39.4, 39.2. 31.3, 30.4, 29.4. 29.2, 29.0, 28.8, 26.1, 22.0, 
14.0. 
MS (ESI) m/z 
Anal 
480 [M+Na]^ 
Calculated for C26H39N3O2S: C 68.28, H 8.52, N 9.18. 
Found: C 68.25, H 8.48, N 9.21%. 
' H N M R (CPCI3) 
2-Benzamido-5-[(8R,llZ)-8-hydroxyheptadec-ll-enyl]-l,3,4-thiadiazoIe 
(XXXn). Off-white powder, yield 73%. m.p. 105-106°C. 
IR (KBr, cm^ )^ : 3352 (OH), 3180 (NH), 1668 (C-0), 1543 (C=N) and 698 
(C-S-C). 
: 6 8.29 (s, IH, NH), 7.64 (d, 2H, 7 = 7.2 Hz, Ar-H-276"), 
7.52 (t, IH, y = 7.0 Hz, Ar-H-4"), 7.43 (t, 2H, 7 = 7.2 Hz. 
Ar-H-3'75"), 5.38 (m, 2H, CHj-C/ZHT^-CHz), 3.61 (m, 
IH, C//-OH), 3.06 (t, 2H, y = 7.6 Hz, CH2-CO), 2.24 (m, 
4H, C^rCH2=CH-C^2), 1.86 (m, 2H, C/^^CHs-CO), 1.68 
(s, IH, OH), 1.40-1.25 (br. s, 18H, (CH2)9). 0.86 (dist. t, 
3H, terminus CH3). 
: 6 163.2, 159.0 "one signal hidden", 138.4, 137.6, 131.2, 
128.7, 128.3, 125.5, 70.56, 40.1, 39.9, 36.3, 24.8, 31.3, 
29.1, 29.0, 28.9, 28.8, 28.5, 28.4, 25.1, 22.3, 14.01. 
: 480[M+Na]^ 
: Calculated for C26H39N3O2S: C 68.28, H 8.52, N 9.18. 
Found: C 68.24, H 8.47, N 9.22%. 
'^CNMR(CDCl3) 
MS (ESI) m/z 
Anal 
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Synthesis of 1,2,4-
Tfiazotes anc[4-0j(p 
1,3'TliiazoCidines 
l,2,4-<Ttiazoles afuf4-0^1,3-tfttazoG£nes 
4.1 THEORETICAL 
The therapeutic effects of 1,2,4-triazole ring has been studied for a number 
of pathological conditions which include anti-inflammatory,^'^ ulcerogenic/ 
antibacterial/ antifungal/ and anticancer agents/ The scientific literature reveals 
that these activities are due to the presence of -NH-C(S)-NH- function in a moiecule 
and change in activity depends upon the nature of the substituents/ Oxothiazolidine 
derivatives have been found to possess antibacteriar and antitubercular activities/ 
Screening the literature reveals that oxothiazolidines also exhibit antinociceptive/ 
anticancer and anti-AIDS (HIV-1) activities/^ 
Reid et al}^ synthesized 5-substituted-4-amino-3-mercapto-l,2,4-triazoles 
(118a-d) by cyclizing methyl 3-aroyldithiocarbazates (117a-d) with hydrazine 
utilizing Hoggarth method. 
0 S N - N 
II II N2H4 / ^ 
Af—C-NH-NH-C—SCH3 ^ A r ^ ^ N ^ 
NH2 
117a-d nSa-d 
Compound Ar 
UTa, 118a CeHj 
117b, 118b 4-FC6H4 
117c, 118c 2-BrC6H4 
117d, 118d 2-CH3OC6H4 
Giri et al}^ reported the formation of 4-phenyl-5-(2,6-dichlorophenyl)-3-
mercapto-1,2,4-triazole (120) from thiosemicarbazide (119) in the presence of cone. 
NaOH. 
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N - N 
Synthesis of 3-(a-aryloxypropionyl)-4-aryI-5-mercapto-l,2,4-triazoles 
(122a-d) from l-(a-aryloxypropionyl)-4-arylthiosemicarbazides (121a-d) was 
reported by Srivastava et al.'^ 
R 4 -
Compound 
121a, 122a 
121b, 122b 
121c, 122c 
121d,122d 
CH3 0 S , , 
' 0 - C H — C - N H - N H - C - N H — ( } 
121a-d 
CH3 N - N 
SH 
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5-{2/4-Anisoxymethyl)-4-aryl-3-mercapto-l,2,4-triazoles (124a,b) were 
synthesized from 2/4-anisoxyacetyI-4-arylthiosemicarbazides (123a,b) by refluxing 
in 2N NaOH solution for 2 hrs,'" 
R— O S 
• O - C H 2 — C - N H - N H - C - N H - R ' 
123a,b 
. ^ ^ N 
o 
o 
s 
N - N 
Compound R R' 
123a, 124a 4-MeO CeHs 
123b, 124b 2-MeO 4-CH3-C6H4 
Gawande and Shingare^^ reported that 4-aryl-l-(4-aryl-2-methylthiazoIe-5-
carbonyl)- thiosemicarbazides (125a-c) on cyclization with sod. hydroxide and 
iodine gave 4-aryl-3-(4-aryl-2-methylthiazol-5-yl)-5-mercapto-l,2,4-triazoles 
(126a-c) 
R 
0 S 
II II 
C - N H - N H - C - N H -
125a-c 
NaOH N 
CH3' s 
126a-c 
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Compound 
125a, 126a 
125b, 126b 
125c, 126c 
R 
H 
NO2 
H 
R' 
Br 
CI 
OMe 
l-(4-Substituted-4//-l,2,4-triazole-3-thione-5-yl)methyl-l//-benzotriazoles 
(128a-c) were synthesized from 4-substituted-l-(l-carbonylmethyl-l//-
benzotriazole) thiosemicarbazides (127a-c) by treating it with cone. NaOH.^^ 
O S 
II II 
CH2—C-NH-NHC-NHAr 
127a-c 
NaOH N N-NH 
C H 2 - ^ )=S 
N 
I 
128a-c Ar 
Compound 
127a, 128a 
127b, 128b 
127c, 128c 
R 
n-C4H9 
CeHs 
4-CH3C6H4 
El-Borai et al}'' proposed the synthesis of l-//-2-mercapto-5-(2'-thienyl)-
1,3,4-triazole (130) from thiosemicarbazide (129) in basic medium. 
O S 
C - N H - N H - C - N H 2 ^ " ^ » 
129 130 
N - N 
N 
] 
H 
SH 
5-(6'-Nitro benzimidazoIe-l-ylmethyI)-4-phenyI-3-mercapto-I,2,4-triazole 
(132) was synthesized from l-A^-(6-nitrobenzimidazole-l-cabonyImethyl)-4-phenyI-
3-thiosemicarbazide (131) by Xu et al}^ 
89 
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CH2—C-NH-NH-C-NH 
131 
> 
i 
Xu et al}^ further reported synthesis of bis(4-amino-5-mercapto-l,2,4-
triazole-3-yl)alkanes (135) by heating thiocarbohydrazide (133) and aliphatic 
carboxylic acid (134) above their melting point. 
NH2NHCNHNH2 + H02C(CH2)nC02H 
133 
NH-N 
I 
NH2 
N-NH 
V 
I 
a. 
134 
(CH2)n N 
I 
NH2 
SH 
N - N 
I 
NH2 
N - N 
(CH2)n N- SH 
NH2 
135 
4-Allyl-5-aryl-l,2,4-triazoles (138a-d) were synthesized from 1-substituted 
benzoyl/phenacetyl-4-allylthiosemicarbazides (136a-d) by refluxing with 2M 
NaOH and 4-Allyl/Amino-5-aryl-l,2,4-triazoles (139a-d) were synthesized from 
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potassium salt of substituted dithiocarbazinic acids (137a-d) by refluxing with 
hydrazine hydrate followed by acidification with hydrochloric acid.' 
O O 
Ar—C-NHNH-C-NHNH-CH2CH=CH2 A r — C - N H N H - C - S ' K ' 
136a-d 
2M NaOH 
HCl 
N-NH 
CH2CH=CH2 
138a-d 
Compound 
136a, 137a, 138a, 139a 
136b, 137b, 138b, 139b 
136c, 137c, 138c, 139c 
136d,137d,138d, 139d 
137a-d 
Ar 
NH2NH2 
HCI 
N-NH 
N 
I 
NH2 
139a-d 
AT 
2-OH-C6H4 
4-OH-C6H4 
2-OH-C6H4-CH2 
2-C2H5O-C6H4-CH2 
Cansiz et al. ^ ° converted 1 -(2-furoyl/phenyl)-4-substituted 
thiosemicarbazides (140a-d)/(141a-d) into 5-(fijran-2-yl/benzyl)-4-(aryl)-4^-1,2,4-
triazole-3-thiols (142a-d)/(143a-d) respectively on treatment with 2NNaOH. 
O 
O S 
II II 
C—NHNH-C-NHNHAr 
140a-d 
2NNaOH 
F 
N-N 
\ / 
O S 
II II 
CH2—C—NHNH-C~NHAr 
141a-d 
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Compound 
140a, 141a, 142a, 143a 
140b, 141b, 142b, 143b 
140c, 141c, 142c, 143c 
140d, 141d,142d, 143d 
AT 
CeHs 
4- OCH3-C6H4 
4- CI-C6H4 
4-CH3.C6H4 
lH-4,5-<iihydro-3-(3-hydroxy-2-napthyl)-4-substituted-l,2,4-triazole-5-
thiones (145a-d) were synthesized from thiosemicarbazide (144a-d) by refluxing 
with 2N NaOH followed by treatment with hydrochloric acid.^ 
O S 
C-NHNH-C-NHAr NaOR 
HCI 
144a-d 
Compound 
144a, 145a 
144b, 145b 
144c, 14Sc 
144d, 145d 
145a-d 
R 
4-Br-C6H4 
4-CI-C6H4 
3-CF3-C6H4 
4-OCH3-C6H4 
Holla et al}^ synthesized 4-amino-5-(6-chloropyridin-3-yl-methyl)-4H-
l,2,4-triazole-3-thiol (147) from potassium sah of substituted dithiocarbazinic acids 
(146) and hydrazine hydrate. 
C-NHNH-C-S-K^ ^ ^ ^ ^ »^  CI 
146 
N - N 
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3-(4-MethyIphenoxymethyI)-4-phenyl-5-thione-1,2,4-triazole (149) was 
synthesized from thiosemicarbazide (148) by refluxing with NaOH followed by 
treatment with hydrochloric acid.^ ^ 
H 
N-N 
O 
O-CH2 
s ^^ =^  
o N 
\ ^ 148 
\ / 
149 
\ ^ 
Shah ei ai synthesized the 4-thiazoHdinones (151a-c) from hydrazone 
(150a-c) by refluxing with thioglycolic acid in dry benzene. 
/ \ •CH2CNHN=CHArHSgi2COOH^/ \-CH2CNH-N 
150a-c 151a-c 
AT 
Compound 
150a, 151a 
150b,151b 
150c, 151c 
150d,151d 
Synthesis of 
phenyl)-4-thiazolidinone 
3-(4'-methyl-2 
(153a ,b) 
AT 
C6H5 
2-OHC6H4 
4-CI-C6H4 
4-CH3OC6H4 
'-quinolinyl)ox 
from J sub stituted-2-(4-methy 1-2-
quinoIinyOoxyacetylhydrazone (I52a,b) was reported by Kidwai et al?^ by the 
microwave reaction. 
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CH3 
N-
0 
0CH2CNHN=CHAr HSCHsCOOH^  
M.W 
0 
152a-b 
Compound 
152a, 153a 
152b,153b 
OCH2 
153a-b 
CNH-N Ar 
0 
AT 
4-CI-C6H4 
4-NO2-C6H4 
Ling et al. synthesized 2-imino-3-(4-arylthiazol-2-yl)-thiazolidin-4-ones 
(155a,b) from 2-chloroacetamido-4-arylthiazoles (154a,b) by reacting with 
potassium thiocyanate in refluxing acetone. 
AT 
N O 
H 
154a,b 
Compound 
154a, 155a 
154b,155b 
AT 
ci_Ksai^ 
N 
lS5a,b 
AT 
CeHs 
CI-C6H4 
O 
Feray et al. synthesized 4-thiazolidinones (157a-d); which are substituted 
at the 2-position by the reaction of mercaptoacids with aldimines (156a-d). 
N 
H 
CH=N 
SH 
R^^ .S. 
H—CX)QH Q<^^ 
156a-d 157a-d X 
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Compound 
156a, 157a 
156b, 157b 
156c, 157c 
156d,157d 
R 
H 
CHa 
H 
CHa 
X 
H 
H 
CeHj 
CeHs 
4-Acetyithiosemicarbazone-4'-acetyldiphenyl sulphide (158) on reaction with 
ethylchloroacetate in the presence of fused AcONa gave 4-(4"-thiazoHdinone-2"-
acetyiazino)-4'-acetyidiphenyl sulphide (159)." 
O 
CH3—C / \ ^ ^^-C=NHN-C-NH2 
158 
O 
II 
CH3—C 
CH3 
AcONa 
Ethyl chloroacetate 
/ ^ / V_._ 
159 
C=NHN 
I 
CH3 S 
H 
N O 
Russowsky and Neto reported that the coupling reaction between 
piperidine-2-thione (160) and 2-bromo-2-phenylmethyIacetate (161) afforded the fi-
enaminocarbonyl compound (162) and in most of the cases bicyclic thiazolidinone 
(163) was produced. 
H 
160 
OMe 
CH2Cl2,24his 
Et^N 
Ph3P,rt,18his 
H 
Ph + 
COsMe 
162 163 
2,3-Diaryl-l,3-thia2olidin-4-ones (166a,b) was synthesized by reacting an 
aromatic aldehyde (165) with an equimolar amount of (hetero) aromatic amine 
(164) in the presence of an excess of thioglycolic acid.^^ 
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R' 
X 
/ ^ Y 
+ 
R 
R^  
X SHCHzCOOt^  
^ 
R^ ^ I "NHs " N / 'Y^ NH2 
O 
164 165 
R^/^V 
166a,b 
R^  
CI 
F 
R^  
H 
CI 
Compound X Y R^  R^  
166a CH CH CH3 H 
166b N N OCH3 H 
Srivastava et al}^ reported the one-pot procedure for the synthesis of 1-thia-
4-aza ^/>o[4,5]-decan-3-one (168a-d), by the reaction of cyclohexanone (167) with 
substituted amine, substituted thioglycolic acid and dicyclohexylcarbodiimide 
(DCC) in dry THF at room temperature. 
O 
SH 
R^—CH—aX)H 
^ 
R*-NH2 
167 168a-d 
Compound 
168a 
168b 
168c 
168d 
R' 
PhCHz 
CgHn 
PhCH2 
CgHi? 
R^  
H 
H 
CH3 
CH3 
Synthesis of 2-(I,2,4-benzotriazole)acetohydrazido-l,3-thia2oHdin-4-one 
(170) from 2-(l,2,4-benzotriazole-l-yI-acetate)-hydrazine carbothioamide (169) and 
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chloroacetic acid in presence of sodium acetate in ethanol was reported by Ojha et 
al.^' 
CICH N-^  
H 
H 
.N 
H 
N 
170 
O 
Gadre et al. synthesized 6-N-2-(aryl)-thiazolin-4-one-3-yl-carboxyamido-
2,5-bis-(4-methoxyphenyl)-3H-pyridizine-3-ones (172a-c) and 6-N-2-(aryl)-5-
methyI-thiazolin-4-one-3-yl-carboxyamido-2,5-bis-(4-methoxyphenyl)-3H-
pyridizine-3-ones (173a-c) from 6-N-2-(arylidene)-hydrazinocarbonyI-2,5-bis-(4-
methoxyphenyl)-3H-pyridizine-3-ones (171) on reacting with thioglycolic acid and 
thiolactic acid respectively. 
OCH3 
OCH3 
Thioglycolic acid^^^^^^^ N 
NHNH=CHAr 
Thiolactic acid 
OCH 
OCH3 
171 
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Compound 
172a, 173a 
172b,173b 
172c, 173c 
AT 
3-C/C6H4 
4-CIC6H4 
4-OCH3C6H4 
Recently Tomascikova et al?^ synthesized 4-(acridin-9-yl)-5-niethyl/phenyl-
2,4-dihydro[l,2,4]triazole-3-thione (175a,b) and Methyl[2-(acridin-9-ylimino)-3-
(acetyl/benzoyl amino)-4-oxothiazoIidm-5-yIidin]acetate (176a,b) from 4-(acridin-
9-yl)-l-(acetyl/ben2oyI)-thiosemicarbazide(174a,b). 
R 
OMe 
175a,b 
Compound 
174a, 175a, 176a 
174b, 175b, 176b 
Keeping in mind the practical utility of 1,2,4-triazoles and 4-oxo-l,3-
thiazolidines an attempt was made to synthesize fatty acid derivatives containing 
these heterocyclic rings. 
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4.2 RESULTS AND DISCUSSION 
Fatty acid hydrazides XIII-XVI, which are the required starting materials, 
were prepared from fatty alkenoates following the literature method reported 
previously.^'' Reacting fatty acid hydrazides with phenyl isothiocynate in dry 
benzene for 5 hrs under reflux and removing excess solvent under reduced pressure 
gave thiosemicarbazide XXXin-XXXVI. Although the compounds XXXin and 
XXXIV are reported in literature^^ but they have been not characterized fully. 
Thiosemicarbazide XXXIU-XXXVI were subjected to intramolecular cyclization in 
alkaline medium (2M, NaOH) followed by acidification with HCl to give 1,2,4-
triazoles XXXVII-XL. Since l,2,4-triazole-3-thione may exist in thiol-thione 
tautomeric forms^ *^ ^ our investigations showed that in this case thione structure 
dominates. Structure of triazole XXXVII and XXXVin appeared in literature^^ 
without spectral data. 
Cyclization of thiosemicarbazide XXXIH-XXXVI with 
chloroacetylchloride in chloroform gave 4-oxo-l,3-thiazolidine XLI-XLIV. Earlier 
works ' show that oxothiazolidines were prepared from different substituted 
thiosemicarbazides (other than fatty thiosemicarbazides) by reacting them with 
chloroacetic acid and anhydrous sodium acetate under drastic conditions like high 
temperature, more reaction time and use of high boiling point solvents e.g. acetic 
acid. In present study chloroacetylchloride was used to overcome all these 
lachrymatory conditions. 
Reaction of undec-10-enoic hydrazide (XIII) with phenyl isothiocynate 
Fatty acid hydrazide Xin and phenyl isothiocynate were refluxed in dry 
benzene for 5 hrs. The resulting solution was then concentrated by removing the 
excess solvent under reduced pressure (Scheme 4.1). The solid thus separated was 
filtered, dried and recrystallized in mixture of benzene-chloroform to get a white 
powder. 
99 
1,2,4-lriazoks amf4-Oj(p-l,3-tfiiazoBdines 
0 
II 
CH2=CH—{CH3)8—C -NHNH2 
(xm) 
o ' s 
II \\ 
CH2=CH—(CH2)8—C—NHNH-C~NH 
(XXXIII) 
Scheme 4.1: Synthesis of 4-phenyI-l-(undec-10-enoyl)-thiosemicarbazide 
(xxxm). 
Structural elucidation of the compound XXXm as 4-phenyl-l-(undec-10-
enoyl)-thiosemicarbazide 
Compound XXXffl showed IR bands at 3226 (NH), 1667 (C=0) and 1238 
cm was more informative, characteristic peaks were observed at 5 
8.92 (2H, br. s, CO-N/m//-CS), 8.42 (IH, s, CS-NH-Ai) and 7.37-7.07 (5H, m, Ar-
H). In '^ C NMR peaks at 5 165.4 {C=0), 160.8 {C=S) were observed. Detailed H^ 
NMR and ^^ C NMR spectral data are given in experimental section. Based on the 
above facts compound XXXHI was characterized as 4-phenyl-l-(undec-10-enoyl)-
thiosemicarbazide. 
Reaction of (9^-octadec-9-enoic hydrazide (XIV) with phenyl isothiocynate 
Fatty acid hydrazide XIV and phenyl isothiocynate were refluxed for 5 hrs 
in dry benzene. The reaction mixture was concentrated by removing the excess 
solvent (Scheme 4.2). The solid mass thus separated was filtered, dried and 
recrystallized in mixture of benzene-chloroform to obtain white crystals. 
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O 
CH3—(CH2)7—CH=CH—(CH2>7—C -NHNH2 
(XIV) 
N=C=S 
O 
CH3—(CH2)7—CH=CH—(CH2}7—C—NHNH-C—NH—/ \ 
(XXXIV) 
Scheme 4.2: Synthesis of (9Z)-4-phenyl-l-(octacIec-9-enoyl)-thiosemicarbazide 
(XXXIV). 
Structural elucidation of the compound XXXIV as (9Z)-4-phenyl-l-(octadec-9-
eBoyiy^hiosemicarbazide 
Characteristic IR bands at 3213 (NH), 1661 (C=0) and 1242 cm'' (C=S). In 
' H N M R characteristic peaks were observed at 6 8.65 (2H, br. s, CO-NHNH-CS\ 
8.40 (IH, s, CS-N//-Ar) and 7.34-7.17 (5H, m, Ar^H). In "C NMR peaks at 5 165.4 
(C=0), 160.8 (C=S) were observed. Elemental analysis established its molecular 
formula as C25H41N3OS. Based on the above facts compound XXXIV was 
characterized as (9Z)-4-phenyl-l-(octadec-9-enoyl)-thiosemicarbazide. 
Reaction of (9Z,12./?)-12-hydroxyoctadec-9-enoic hydrazide (XV) with phenyl 
isothiocynate 
A mixture of fatty acid hydrazide XV and phenyl isothiocynate were 
refluxed in dry benzene for 5 hrs. The resulting solution was concentrated by 
removing the excess solvent under reduced pressure (Scheme 4.3). The solid thus 
separated was filtered, dried and recrystallized in mixture of benzene-chloroform to 
get a white powder. 
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O 
CH3—(CH2)5—CH—CH2—CH=CH—(CH2)7—C-NHNH2 
OH (XV) 
N=C=S 
O 
CH3—{CH2)5—CH—CH2—CH=CH—(CH2)7—C—NHNH-C—NH—/ ^ 
^^ (XXXV) 
Scheme 4.3: Synthesis of (9Z,12J?)-4-phenyl-l-(12-hydroxyoctadec-9-enoyl)-
thiosemicaibazide (XXXV). 
Structural elucidation of the compound XXXV as (9Z,12/;)-4-phenyM-(12-
hydroxyoctadec-9-enoyl)-thiosemicarbazide 
Compound XXXV showed IR bands at 3293 (OH), 3222 (NH). 1661 (C=0) 
and 1236 cm' '^  (C=S). ^H NMR was more informative, characteristic peaks were 
observed at 5 8.94 (2H, br. s, CO-^HNN-CSX 8.65 (IH, s, CS-N^-Ar) and 7.55-
7.29 (5H, m, Ar-H). In '^C NMR peaks at 6 163.2 (C=0), 159.9 (C=S) were 
observed. Elemental analysis established its molecular formula as C25H41N3O2S. 
Based on the above facts compound XXXV was characterized as (9Z,127?)-4-
phenyl-l-(12-hydroxyoctadec-9-enoyl)-thiosemicarba2ide. 
Reaction Reaction of (9i?,12Z)-9-hydroxyoctadec-12-enoic hydrazide (XVI) 
with phenyl isothiocynate 
Fatty acid hydrazide XVI and phenyl isothiocynate (0.02 mol) were refluxed 
for 5 hrs in dry benzene. The reaction mixture was concentrated by removing the 
excess solvent (Scheme 4.4). The solid mass thus separated was fihered, dried and 
recrystallized in mixture of benzene-chloroform to obtain a white powder. 
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o 
CH3—(CH2)4—CH=CH—(CH2)2—CH—(CH2)7 C-NHNHj 
OH 
(XVI) 
Q s 
CH3—(CH2)4—CH=CH—(CH2)2—CH—(CH2)7—C—NHNH-C—NH—f )^ 
OH ^ 
(XXXVI) 
Scheme 4.4; Synthesis of (9i?,12Z)-4-phenyI-l-(12-hydroxyoctadec-9-enoyl)-
thiosemicarbazide (XXXVT). 
Structural elucidation of the compound XXXVI as (9^,lZZ)-4-phenyI-l-(9-
hydroxyoctadec-12-enoyl)-thioseniicarbazide 
Compound XXXVI showed IR bands at 3287 (OH). 3180 (NH), 1668 
(C=0) and 1228 cm"^  (C=S). H^ NMR was more informative, characteristic peaks 
were observed at 5 8.76 (2H, br. s. CO-NHNH-CS), 8.12 (IH, s, CS-N//-Ar) and 
7.56-7.32 (5H, m, Ar-H). In "C NMR peaks at 5 163.2 (C=0), 159.0 (C=S) were 
observed. Elemental analysis established its molecular formula as C25H41N3O2S 
Based on the above facts compound XXXVI was characterized as (9i?,12Z)-4-
phenyl-1 -(9-hydroxyoctadec-12-enoyl)-thiosemicarbazide. 
Intramolecular cyclization of 4-phenyl-l-(undec-10-enoyl)-thiosemicarbazide 
(xxxni) 
Thiosemicarbazide XXXin was subjected to intramolecular cyclization in 
alkaline medium (2M, NaOH) under reflux for 6 hrs (Scheme 4.5). The reaction 
mixture was cooled and acidified with HCl to give a crude product which was 
crystallized in mixture of chloroform and petroleum ether to give a white powder. 
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0 
CH2=CH—(CH2)8—C—NH^fH-C—NH—( ^ 
(XXXIU) 
CH2=CH—(CH2)8-
(XXX vn) 
N-NH 
6 
Scheme 4.5: Synthesis of 5-(dec-9-enyl)-4-phenyI-3-thion-2//^-l,2,4-triazoIe 
(xxxvn). 
Structural elucidation of the compound XXXVn as 5-(dec-9-enyl)-4-phenyI-3-
thion-2W-1,2,4-triazole 
Compound XXXVH gave diagnostic IR bands at 3181 (NH), 1541 (C=N) 
and 1243 cm"' (C=S) and no peak was observed around 2600-2550 cm' indicating 
the abscence of thiol form. The 'H NMR was more informative in assigning the 
structure. In addition to peaks of fatty acid chain other characteristic peaks were 
observed at 5 11.39 (IH, s, NH), 7.55-7.31 (5H, m, Ar-H). In '^ C NMR peaks at 5 
168.2 (C=S), 153.0 (C=N) were observed. Elemental analysis and mass spectral data 
established its molecular formula CigHjjNjS. Based on the above facts compound 
XXXVI was characterized as 5-(dec-9-enyl)-4-phenyl-3-thion-2//-l,2,4-triazole. 
Intermolecular cyclization of (9Z)-4-phenyI-l-(octadec-9-enoyl)-
thiosemicarbazide (XXXIV) 
Thiosemicarbazide XXXIV was subjected to intermolecular cyclization in 
alkaline medium (2M, NaOH) under reflux for 6 hrs (Scheme 4.6). After cooling the 
reaction mixture it was acidified with HCl to give a crude product which was 
recrystaliized in mixture of chloroform and petroleum-ether to give white crystals. 
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0 
CH3~(CH2>7—CH=CH—(CH2>7—C—NHNH-C—NH—/ ^ 
(XXXIV) 
N - N H 
CH3—(CH2>7—CH=CH—(CH2>7—(I > = S 
(xxxvin) 
Scheme 4.6: Synthesis of (8Z)-5-(heptadec-8-enyl)-4-phenyl-3-thion-1.2.4-M-
triazole (XXXVffl). 
Structural elucidation of the compound XXXVUl as {SZ)-S-{lieptadec-S-€nyl)-
4-phenyl-3-thioa-2£r-l,2,4-triazole 
IR spectrum gave peaks at 3181 (NH). 1540 (C=N) and 1247 cm'' (C=S). In 
' H N M R peaks at 6 11.39 (IH, s, NH) and 7.59-7.31 (5H, m, Ar-H) and in '^ C 
NMR peaks at 167.1 (C=S) and 153.5 (C=N) were observed. Elemental analysis and 
mass spectral data established its molecular formula C25H39N3S- Thus compound 
XXXVni was characterized as (8Z)-5-(heptadec-8-enyl)-4-phenyI-3-thion-2^-
1,2,4-triazole. 
Intramolecular cyclization of (9Z,12^)-4-phenyl-I-(12-hydroxyoctadec-9-
enoyl)-thiosemicarbazide (XXXV) 
Thiosemicarbazide XXXV was subjected to intramolecular cyclization in 
alkaline medium (2M, NaOH) under reflux followed by acidification with HCl to 
give a crude product which was crystallized in mixture of chloroform and 
petroleum-ether to give semisolid compound (Scheme 4.7). 
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0 S 
CH3—(CH2)5—CH—CH2—CH=CH—(CH2)7—C—NHNH-C—NH—/ \ 
^ (XXXV) 
IN — i N n 
CH3—(CH2)5—CH—CH2—CH=CH—(CH2>7—<^ / ^ ^ ^ ^ 
- N H 
N' OH 
(XXXIX) 
Scheme 4.7: Synthesis of (8Z,1 li?)-5-(l l-hydroxyheptadec-8-enyl)-4-phenyl-3-
thion-2^-l,2,4-triazoIe (XXXIX). 
Structural elucidation of the compound XXXIX as (8Z,ll/;)-5-(ll-
hydroxyheptadec-8-enyl)-4-phenyl-3-thion-2H-l,2,4-triazole 
Diagnostic IR bands at 3307 (OH), 3182 (NH), 1504 (C=N) and 1248 cm"' 
(C=S) were observed. In ' H N M R diagnostic peaks at 6 11.39 (IH, s, NH), 7.55-
7.29 (5H, m, Ar-H) and in '^C NMR peaks at 6 163.2 (C=S), 159.9 (C=N) were 
observed. Elemental analysis and mass spectral data established its molecular 
formula C25H39N3OS. Thus compound XXXIX was characterized as (8Z,ll./?)-5-
(ll-hydroxyheptadec-8-enyl)-4-phenyl-3-thion-2//-l,2,4-triazole 
Intramolecular cyclization of (97?,12Z)-4-phenyl-l-(9"hydroxyoctadec-12-
enoyl)-thiosemicarbazide (XXXVI) 
Thiosemicarbazide XXXVI was subjected to intermolecular cyclization in 
alkaline medium (2M, NaOH) under reflux for 6 hrs followed by acidification with 
HCl to give a crude product which was crystallized in chloroform and petroleum-
ether to give white powder (Scheme 4.8). 
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CH3—(CH2)4—CH=CH—(CH2)2—CH—(CH2)7—C—NHNH-C—NH—/ \ 
OH \ — / 
(XXXVI) 
.2j-^ = N-NH 
CH3—(CH2)4—CH=CH—(CH2)2—CH—(CH2)7-^ 
(XL) 
Scheme 4.8: Synthesis of (8i?,llZ)-5-(8-hydroxyheptadec-ll-enyl)-4-phenyl-3-
thion-2/^-I,2,4-tria2ole (XL). 
Structural elucidation of the compound XL as (8/7,1 l-^5-(8-hydroxyheptadec-
ll-enyl)-4-phenyl-3-tliion-2H-l,2,4-triazole 
Compound XL gave diagnostic IR bands at 3297 (OH), 3182 (NH), 1504 
(C=N) and 1247 cm'* (C=S). In *H NMR peaks at 5 10.96 (IH, s, NH) and 7.43-7.30 
(5H, m, Ar-H) were observed. In '^ C NMR peaks at 6 167.7 (C=S) and 159.9 (C=N) 
were observed. Elemental analysis and mass spectral data established its molecular 
formula C25H39N3OS. Based on the above facts compound XL was characterized as 
(8i?,llZ)-5-(8-hydroxyheptadec-ll-enyl)-4-phenyl-3-thion-2//-l,2,4-triazole. 
Reaction of 4-phenyl-l-(undec-10-enoyl)-thioscmicarbazide (XXXUI) with 
chloroacetyl chloride 
A mixture of thiosemicarbazide XXXin and chloroacetyl chloride were 
refluxed in chloroform for 6 hrs. Excess solvent was distilled off under reduced 
pressure and the solid obtained was filtered and recrystallized in mixture of 
dimethyl formamide (DMF)-water to obtain a white powder. 
^ ^ ^ ^ 
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CH2=CH—(CH2)8—C—NHNH-C—NH—'^ ^^  
(xxxm) 
o 
o 
s 
0 
-NH N CH2=CH—(CH2)8-
(XLI) O 
Scheme 4.9; Synthesis of N-[4-oxo-2-(phenylimino)-l,3-thiazo]idin-3-yl]undec-10-
enamide (XLI). 
Structural elucidation of the compound XLI as N-[4-oxo-2-(phenylimino)-13-
thiazolidin-3-yl]uadec-10-enamide 
The IR spectrum of compound XLI showed absorption bands at 3226 (NH), 
1660 (C=0), 1496 (C=N) and 666 cm"^  (C-S-C). The ' H N M R characteristic peaks 
were observed at 6 8.65 (IH, s, NH), 7.39-7.07 (5H, m, Ar-H) and 2.93 (2H, s, CH2 
ring). In '^ C NMR peaks at 5 174.3 (C=0, ring), 164.1 (C=0) and 153.4 (C=N) 
were observed. Elemental analysis and mass spectral data established its molecular 
formula C20H27N3O2S. Based on the above facts compound XLI was characterized 
asN-[4-oxo-2-(phenylimino)-l,3-thiazolidin-3-yl]undec-10-enamide. 
Reaction of (92)-4-phenyl-l-(octadec-9-enoyI)-thiosemicarbazide (XXXIV) 
with chloroacetyl chloride 
A mixture of thiosemicarbazide XXXIV and chloroacetyl chloride were 
refluxed in chloroform for 6 hrs. Excess solvent was removed under reduced 
pressure and the solid obtained was filtered and recrystallized in mixture of DMF-
water to obtain a dirty white powder. 
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Scheme 4.10: Synthesis of (9Z)-N-[4-oxo-2-(phenyIimino)-l,3-thia2oHdin-3-yl]-
octadec-9-enainide (XLII). 
Structural elucidation of the compound XLII as (9Z)-N-[4-oxo-2-
(phenyninino)-l,3-thiazoUdin-3-yl]-octadec-9-enamide 
The IR spectrum of compound XLII showed absorption bands at 3222 
(NH), 1666 (C=OX 1491 (C=N) and 668 cm"' (C-S-C). The ' H N M R characteristic 
peaks were observed at 6 8.65 (IH, s, NH), 7.59-7.28 (5H, m, Ar-H) and 2.91 (2H, 
s, CH2 ring). In '^C NMR peaks at 5 174.4 (C=0, ring), 167.5 (C=0) and 164.0 
(C=N) were observed. Elemental analysis and mass spectral data established its 
molecular formula C27H41N3O2S. Based on the above facts compound XLII was 
characterized as (9Z)-N-[4-oxo-2-(phenylimino)-l,3-thiazolidin-3-yl]-octadec-9-
enamide. 
Reaction of (9Z,12^)-4-phenyI-l-(12-hydroxyoctadec-9-enoyl)-
thiosemicarbazide (XXXV) with chloroacetyl chloride 
Thiosemicarbazide XXXV and chloroacetyl chloride were refluxed in 
chloroform for 6 hrs. Excess solvent was removed under reduced pressure and the 
solid obtained was filtered and recrystallized in mixture of DMF-water to obtain a 
white powder. 
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Scheme 4.11: Synthesis of (9Z,12/2)-N-[4-oxo-2-(phenylimmo)-l,3-thiazolidin-3-
yl]-12-hydroxyoctadec-9-enamide(XLIII). 
Structural elucidation of the compound XLm as (9Z,12/;)-N-[4-oxo-2-
(phenylimino)-l,3-thiazolidin-3-yl]-12-hydroxyoctadec-9-enamide 
Compound XLHI showed IR absorption bands at 3308 (OH), 3226 (NH), 
1666 (C=0), 1491 (C=N) and 667 cm' (C-S-C). The ' H N M R peaks at 6 8.40 (IH, 
s, NH), 7.55-7.31 (5H, m, Ar-H) and 2.96 (2H, s, CH2 ring) and in '^C NMR peaks 
at 5 174.9 (C=0, ring), 167.5 (C=0) and 164.0 (C=N) were observed. Elemental 
analysis and mass spectral data estabHshed its molecular formula C27H41N3O3S. 
Based on the above facts compound XLIII was characterized as (9Z,12/?)-N-[4-
oxo-2-(phenylimino)-l,3-thia2olidin-3-yl]-12-hydroxyoctadec-9-enamide. 
Reaction of (9/?,12Z)-4-phenyH-(9-hydroxyoctadec-12-enoyI)-
thiosemicarbazide (XXXVI) with chloroacetyl chloride 
Thiosemicarbazide XXXVI and chloroacetyl chloride were refluxed in 
chloroform for 6 hrs. Excess solvent was removed under reduced pressure and the 
solid obtained was filtered and recrystallized in mixture of DMF-water to obtain a 
white powder. 
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Scheme 4.12: Synthesis of (97?,12Z)-N-[4-oxo-2-(phenyIimino)-l,3-thiazolidin-3-
yl]-9-hydroxyoctadec-12-enamide (XLIV). 
Structural elucidation of the compound XLIV as (9i;,12Z)-N-[4-oxo-2-
(phenylimino)-l^-thiazolidin-3-y|]-9-hydroxyoctadec-12-enaniide 
IR absorption bands at 3287 (OH), 3228 (NH), 1666 (C=0), 1491 (C=N) 
and 667 cm"^  (C-S-C). The ' H N M R characteristic peaks at 6 8.80 (IH, s, NH), 7.46-
7.30 (5H, m, Ar-H) and 2.96 (2H, s, CH2 ring) were observed. In "C NMR peaks at 
6 174.6 (C=0, ring), 167.3 (C=0) and 164.7 (C=N) were observed. Elemental 
analysis and mass spectral data established its molecular formula C27H41N3O3S. 
Based on the above facts compound XLIV was characterized as (9^, 12Z)-N-[4-oxo-
2-(phenylimino)-l,3-thiazolidin-3-yI]-9-hydroxyoctadec-I2-enamide. 
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4.3EXPERIMENTA1 
Phenyl isothiocynate was purchased from Merck, Mumbai, India 
Chloroacetychloride and hydrazine hydrate (80%) were purchased from S d FINE-
CHEM Ltd (Mumbai, India) Thin layer chromatography was done on glass plates 
(20x5 cm) with a layer of silica gel G (Merck, Mumbai, India, 0 5mm thickness) 
Mixture of petroleum ether-ethyl acetate-acetic acid (80 20 l,v/v) were used as 
developing solvents Column chromatography was carried out on silica gel (Merck, 
Mumbai, India, 60-120 mesh) Rest of the chemicals and instruments used are 
reported in chapter I (page No 24) 
General procedure for synthesis of 4-phenyl-l-(alkenoyl)-thioseniicarbazide 
xxxm-xxxvi 
Fatty acid hydrazide Xin (0 02 mol) and phenyl isothiocynate (0 02 mol) 
were refluxed in dry benzene (30 mL) for 5 hrs The resulting solution was then 
concentrated by removing the excess solvent by distillation under reduced pressure 
The solid thus separated was filtered, dried and recrystallized in mixture of benzene-
chloroform to get XXXm. Similarly compounds XXXIV, XXXV and XXXVI were 
synthesized from fatty acid hydrazides XIV, XV and XVI respectivelly 
4-Phenyl-l-(undec-10-enoyI)-thiosemicarbazide (XXXni) White powder, yield 
78%, mp 105-107''C 
IR (KBr, cm-^) 3226 (NH), 1667 (C=0), 1238 (C=S) 
'H N M R (CDCI3) 6 8 92 (2H, br s, CO-N//N/^-CS), 8 42 (IH, s, CS-iW-Ar), 
7 37-7 07 (5H, m, Ar-H), 5 81 (tdd, IH, J^ _,^ ^^  = 6 6 Hz, 
J„_„^ =10 2 Hz. y^ ;,^ =17 2 Hz, Cn2=CH-\ 5 01 (IH, dd, 
J^^_„ =10 2 Hz, J^^ ^^=2 1 Hz, //zC=CH), 4 92 (IH, dd, 
^H,^H ==17 2 Hz, Jj,^_„^ =21 Hz, /^ £C-CH-), 2 35 (2H, t, 
y = 7 5 Hz, CH2-CO). 2 02 (2H, m, CH2=CH-C^2), 1 72 
(2H, m, C^2CH2-CO),l 26 (lOH, br s, (CH2)5) 
'^ C N M R (CDCI3) 6 165 4, 160 8, 139 2, 133 2, 1313, 128 9, 128 6, 114 2, 
33 8, 29 9, 29 6, 29 3, 29 2, 29 1, 29 0, 28 9 
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Anal : Calcd for C18H27N3OS: C 64.87, H 8.10, N 12.60, S 9.62. 
Found: C 64.79, H 8.04, N 12.63, S 9.56 %. 
(9Z)-4-Pheny|-l-(octadec-9-enoyl)-thiosemicarbazide (XXXIV) White crystals, 
yield 85%, m.p. 114-117 °C. 
IR (KBr, cm*') 
'HNMR(CDCl3) 
'^C NMR (CDCI3) 
Anal 
3213 (NH), 1661 (C=0), 1242 (C=S). 
6 8.65 (2H, br. s, CO-N//N//-CS), 8.40 (IH, s, CS-N^Z-Ar), 
7.34-7.17 (5H, m, Ar-H), 5.31 (2H, m, CH2-C//=C//-CH2), 
2.32 (2H, t, J = 7.5 Hz, CH2-CO). 2.01 (4H, m, CH2-
CH=CH-C//2), 1.68 (2H, m, C/r2-CH2-CO),1.26 (20H, br. s, 
(CH2)io), 0.88 (3H, dist. t, terminus CH3). 
6 165.4, 160.8, 139.2, 137.3, 133.2, 131.3, 128.8, 128.6, 
31.9, 29.9, 29.8, 29.7, 29.5, 29.4 "three signals are hidden", 
29.3 "two signals are hidden", 29.1, 22.7, 14.2. 
Calcd for C25H41N3OS: C 69.61, H 9.50, N 9.37, S 7.43. 
Found: C 69.56, H 9.41, N 9.77, S 7.37 %. 
(9Z,12/?)-4-Phenyl-l-(12-hydroxyoctadec-9-enoyl)-thiosemicarbazide (XXXV). 
White powder, yield 73%, m.p. 151-152 ''C. 
IR (KBr, cm-^ ) 
^H NMR (CDCI3) 
13 C NMR (CDCI3) 
Anal 
3293 (OH), 3222 (NH), 1661 (C=0), 1236 (C=S). 
6 8.94 (2H, br. s, CO-N^WH-CS), 8.65 (IH, s, CS-N//-Ar), 
7.55-7.29 (5H, m, Ar-H), 5.51-5.43 (2H, m, CH2'CH=CH-
CH2), 3.59 (IH, m, CH-OK), 2.31 (2H, t, 7 = 7.5 Hz, CH2-
CO), 2.21 (IH, br. s, CH-0//), 2.00 (4H, m, CH2-CH=CH-
CH2), 1.72 (2H, m, Ci/2-CH2-CO),1.25 (18H, br. s, (CH2)9), 
0.87 (3H, dist. t, terminus CH3). 
6 163.2, 159.9, 138.7 "one signal hidden", 132.2, 128.1, 
128.0, 127.0, 70.7, 40.1, 39.9, 39.7, 39.5, 39.3, 31.3, 30.4, 
29.1, 29.0, 28.8, 28.6, 25.1, 22.0, 13.6. 
Calcd for C25H41N3O2S: C 67.12, H 9.16, N 9.38, S 7.16. 
Found: C 67.04, H 9.04, N 9.43, S 7.06%. 
113 
1,2,4-lnazoles <md4-Oxp-l,3-tfiiazoR£nes 
(9/?,12Z)-4-Phenyl-l-(9-hydroxyoctadec-12-enoyl)-thiosemicarbazide (XXXVI) 
White powder, yield 75%, m.p. 152-153 °C. 
IR (KBr, cm"') 
' H N M R (CDCb) 
'^ C NMR (CDCI3) 
Anal 
3287 (OH). 3180 (NH), 1668 (C=0), 1228 (C=S). 
6 8.76 (2H, br. s, CO-N//NH-CS), 8.12 (IH, s, CS-N//-Ar), 
7.56-7.35 (5H, m, Ar-H). 5.37-5.14 (2H, m, CH^-CH^CH-
CH2), 3.54 (IH, m, C/f-OH), 2.38 (2H. t, J = 7.5 Hz, CH2-
CO), 2.11 (IH, br. s, CH-OH), 2.02 (4H, m, C/f^-CH^CH-
CH2\ 1.67 (2H, m, C^2-CH2-CO),1.26 (18H, br. s, (CH2)9X 
0.86 (3H, dist. t, terminus CH3). 
5 163.2, 159.0, 138.4, 137.6, 131.2, 128.7, 128.3, 125.5. 
70.56, 40.1, 39.9, 36.3, 24.8, 31.3, 29,1, 29.0, 28.9, 28.8, 
28.5,28.4,25.1,22.3, 14.01. 
Calcd for C25H41N3O2S: C 67.12, H 9.16, N 9.38, S 7.16. 
Found: C 67.00, H 9.07, N 9.45, S 7.09%. 
General procedure for synthesis of 5-(alkenyl)-4-phenyl-3-thion-2/^-l,2,4-
triazoIeXXXVn-XL 
Thiosemicarbazide XXXm (0.01 mol) was dissolved in 30 mL of 2M NaOH 
solution and heated under reflux for 6 hrs. After cooling, the reaction mixture was 
acidified with HCl. Crude product was precipitated, filtered and washed with 
distilled water. The solid thus separated was dried and recrystallized in chloroform 
and petroleum ether to get a white powder XXXVn. Similarly compounds 
XXXVni, XXXIX and XL were prepared from thiosemicarbazide XXXIV, XXXV 
and XXXVI respectively. 
5.(dec-9-enyI)-4-phenyl-3-thion-2^-l,2,4-triazoIe (XXXVII). White powder, 
yield 76%, m.p. 85-87 "C. 
IR (KBr, cm"') : 3I8I (NH), 1541 (C=N), 1243 (C=S). 
'HNMR(CDCl3) : 6 11.39 (IH, s, NH), 7.55-7.31 (5H, m, Ar-H), 5.81 (tdd, 
^^^-^H-'cnr ^-S ^ > A-/ / . =10 2 Hz, y^_;,^=17.8 Hz, 
CH2=CH-l 5,00 (IH, dd, J..^-\0.2 Hz, 7 . „ = 2.2 
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^^CNMR(CDCl3) 
Hz, //zC=CH), 4 92 (IH, dd, J„^_^=\7.S Hz, ^„_/,^ = 
2 2 Hz, /f£C=CH-), 2 43 (2H, t, J = 7 5 Hz, CH2- a to 
ring), 2 03 (2H, m, CH2=CH-C/^2), 1 64 (2H, m, CH2- p to 
ring), 127 (10H,br s, (^2)5) 
5 168 2, 153 0, 139 1, 133 4, 130 0, 129 8, 127 9, 114 2, 
33 7, 31 9, 29.1, 28.9 "one signal hidden", 28 8, 28 7,26 0 
MS (FAB) m/z (%) 316 ([M+1] •, 100), 274 (20), 261 (10), 246 (17), 232 (10), 
218 (25), 204 (50), 191 (36), 176(15) 
Anal Calcd for C18H25N3S C 68.56, H 7 92, N 13 33, S 10 16 
Found C 68 43, H 7.83. N 13 41. S 10 02% 
(87)-5-(heptadec-8-enyI)-4-phenyI-3-thioii-2^-l,2,4-triazoIe (XXXVDI). White 
crystals, yield 85%, m.p 88-90 °C 
IR (KBr, cm-^ ) • 3181 (NH), 1540 (C=N), 1247 (C=S) 
H^ NMR (CDCI3) . 6 11 39 (IH, s, NH). 7 59-7 31 (5H, m, Ar-H), 5 53 (2H, 
m, CH2-C7/=a/-CH2), 2 46 (2H. t, y = 7 5 Hz, CH2- a to 
ring), 2 04 (4H, m, CH2-Cli=C}i-CH2l 1 70 (2H, m, CH2-
P to ring). 1 25 (20H, br. s, (CH2)joX 0 87 (3H, dist t, 
terminus CH3) 
'^C NMR (CDCI3) 6 167 1, 153 5, 139 0 "one signal hidden", 1315, 129 0, 
126 8, 124 1, 37 1, 31.9, 29 7 "two signals are hidden", 
29 6, 29 4 "three signals are hidden", 29 2, 29 1, 26 6, 
22 6, 14 0 
MS (FAB) m/z (%) 
Anal 
414 ([M+1] •, 100), 398 (15), 356 (10), 327 (15), 301 
(15), 274 (20), 260 (24), 246 (15), 232 (15), 218 (20), 204 
(45), 191 (55), 177(10) 
Calcd for C25H39N3S C 72 63, H 9 43, N 10 16, S 7 75 
Found C 72 49, H 9 30, N 10 27, S 7 66% 
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(8^,ll^)-5-(n-hydroiyheptadec-8-enyl)-4-pheflyl-3-thion-2/M,2,4-triazole 
(XXXIX). Semisolid, yield 67%. 
IR (KBr, cm'^) 
'HNMR(CDCl3) 
'^C NMR (CDCI3) 
MS(FAB)m/z(%) 
Anal 
3307 (OH), 3182 (NH). 1504 (C=N), 1248 (C=S). 
6 11.39 (IH, s, NH), 7.55-7.29 (5H, m, Ar-H), 5.51 (2H, 
m, CH2-CH=CH-CH2), 3.59 (IH, m, C//-OH), 2.46 (2H, t, 
y = 7.5 Hz, CH2- atoring), 2.17 (IH, br. s, CH-OH), 2.11 
(4H. m, CH2-Cn=CH-CH2l 1.72 (2H, m, CH2- p to ring), 
1.25 (18H, br. s, (CH2)9), 0.87 (3H, dist. t, terminus CH3). 
5 163.2, 159.9, 139.8, 139.0, 131.2, 129.0, 126.8, 125.5, 
70.5, 39.9, 39.7, 31.3, 29.4, 29.1, 29.0, 28.8, 28.5, 28.4, 
28.3,26.7,25.8,22.0, 13.6. 
430 ([M+1] • , 55 ), 412 (100), 397 (10), 354 (15), 327 
(15), 332 (10), 314 (15), 274 (25), 260 (30), 232 (17), 218 
(15), 213(14), 204 (30), 190(50), 175 (13). 
Calcd for C25H39N3OS: C 69.93, H 9.08, N 9.78, S 7.46. 
Found; C 69.78, H 8.96, N 9.88, S 7.35%. 
(8/J,llZ)-5-(8-hydroxyheptadec-ll-enyl)-4-phenyl-3-thion-2f/-l,2,4-triazoIe 
(XL). White powder, yield 77%, m.p 198 °C. 
.-i> IR (KBr, cm*') 
'HNMR(CDCl3) 
'^CNMR(CDCl3) 
3297 (OH), 3182 (NH), 1504 (C=N), 1247 (C=S). 
5 10.96 (IH, s, NH), 7.43-7.30 (5H, m, Ar-H), 5.38 (2H, 
m, CH2-CH^CH-CH2), 3.57 (IH, m, C//-OH), 2.45 (2H, t, 
y= 7.5 Hz, CH2- a to ring), 2.15 (IH, br. s, CH-OH), 2.13 
(4H, m, CH2'CH=CH-CH2X 1.68 (2H, m, CH2- p to ring), 
1.24 (18H, br. s, (^2)9), 0.88 (3H, dist. t, terminus CH3). 
6 167.7, 159.9, 139.1 "one signal hidden", 130.0, 129 8, 
127.9, 125.5, 70.4, 38.6, 34.1, 32.0, 29.7, 29.6, 29.5, 29.4 
"one signal hidden", 29.3, 29.2, 28.8, 25.0, 22.6, 14.0. 
MS (FAB)m/z(%) : 430 ([M+1] • , 40), 412 (100), 383 (10), 356 (15), 342 
(15), 327 (13), 313 (lOl 302 (35), 274 (23), 260 (25), 246 
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(18), 232 (18), 218 (15). 211(10), 204 (35), 191 (25), 176 
(15), 155(18), 111(16X97(20), 
Anal : Calcd for C25H39N3OS: C 69.93, H 9.08, N 9.78, S 7.46. 
Found: C 69.82, H 9.01, N 9.83, S 7.37% 
General procedure for synthesis of N-[4-oxo-2-(phenyIimmo)-l,3-thiazolidin-3-
yl]-alkenamide XLI-XLIV 
A mixture of thiosemicarbazide XXXin (0.01 mol) and chloroacetylchloride 
(0.01 mol) were refluxed in chloroform (50 mL) for 6 hrs. Excess solvent was 
removed by distillation under reduced pressure and the solid obtained was filtered 
and washed with ethanol and recrystallized in mixture of DMF-water to obtain 
compound XLI. Similarly compounds XLII, XLIU and XLIV were prepared fi-om 
thiosemicarbazide XXXIV, XXXV and XXXVI respectively. 
N-[4-oxo-2-(phenyliinino)-l,3-thiazolidin-3-yI]undec-10-enamide (XLI). White 
powder, yield 70%, m.p. 175-177 °C. 
.-ii IR(KBr,cm') 
'HNMR(CDa3) 
'^CNMR(CDCi3) 
MS (FAB) m/z (%) 
Anal 
3226 (NH), 1660 (C=0), 1496 (C=N), 666 (C-S-C). 
5 8.65 (IH, s, NH), 7.39-7.07 (5H, m, Ar-H), 5.77 (tdd, 
IH, J,.^cH, = 6-6 ^^ ^H-H, =10-2 Hz, ^_^,=17.1 Hz, 
CH2==C/f-), 5.01 (IH, dd, ^^_;,=10.2 Hz, ^ , . ; , ,=2.1 
Hz, ^2C=CH), 4.92 (IH, dd, ^ ,_^=17.1 Hz, ^^_^^ = 
2.1 Hz, y/fC^CH-), 2.93 (2H, s, CH2 ring), 2.33 (2H, t, J 
= 7.5 Hz, CH2-CO), 2.04 (2H, m, CH2=CH-C//2), 164 
(2H, m, a^2CH2-CO),1.26 (lOH, br. s, (CH2)5). 
5 174.3, 164.1, 153.4, 139.0, 130.8, 129.0, 127.9, 125.6, 
114.4, 37.1, 33.7, 28.9 "two signals signals hidden", 28.7 
"two signals signals hidden", 25.8. 
374 ([M+1] •, 15), 281 (17), 241 (100), 183 (15), 167 
(26), 139 (32), 111 (8), 97 (12), 91 (20). 
Calcd for C20H27N3O2S: C 64.35, H 7.23, N 11.25, S 8.58 
Found: C 64.27, H 7.18, N 11.33, S 8.41%. 
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(9Z)-N-[4-oxo-2-(phenylimino)-l^thiazolidin-3-yl]-octadec-9-enamide (XLII) 
Dirty white powder, yield 73%, m.p. 184-186 °C. 
IR (KBr, cm-') 
'HNMRCCDCy 
'^CNMR(CDCl3) 
3222 (NH), 1666 (C=0), 1491 (C=N), 668 (C-S-C). 
6 8.65 (IH. s, NH), 7.59-7.28 (5H, m, Ar-H), 5.32 (2H, 
m, CH2-C^=C//-CH2), 2.91 (2H, s, CH2 ring), 2.32 (2H, 
t, J = 7.5 Hz, CH2-CO). 2.02 (4H, m, Ci/2-CH=CH-C//2), 
1.64 (2H, m, CH2Cni'COl\.26 (20H, br. s, (CH2)io), 
0.88 (3H, dist. t, terminus CH3). 
6 174.4, 167.5, 164.0, 131.2, 131.1, 129.8, 126.1, 125.5, 
124.3, 37.1, 33.7, 29.7, 29.6, 29.4, 29.2, 29.1, 28.9 "three 
signals signals hidden", 28.7 "one signal hidden", 26.0, 
22.7, 14.1. 
MS (FAB) m/z (%) : 472 ([M+1] ',10), 394 (18), 380 (15), 318 (17), 304(15), 
281 (20), 265 (17), 237 (27), 223 (17), 209 (15), 195 
(25), 181 (15), 167 (20), 153 (32), 139 (32), 113 (12), 97 
(100). 
Anal : Calcd for C27H41N3O2S: C 68.79, H 8.69, N 8.91, S 6.80. 
Found: C 68.54, H 8.61. N 8.99, S 6.68%. 
(9Z,I2^)-N-[4-oxo-2-(phenyliiiiino)-l,5-thiazoIidin-3-ylJ-12-hydroxyoctadec-9-
enamide (XLIII). White powder, yield 68%, m.p. 155-157 °C. 
IR(KBr, cm-') : 3308 (OH), 3226 (NH), 1666 (C=0),1491 (C=N), 667 
(C-S-C). 
'HNMR(CDCl3) 6 8.40 (IH, s, NH), 7.55-7.31 (5H, m, Ar-H), 5.55 (2H, 
m, CH2-C//=C//-CH2), 3.59 (IH, m, C//-OH), 2.96 (2H, 
s, CH2 ring), 2.31 (2H, t, 7 = 7.5 Hz, CH2-CO), 2.21 (IH, 
br. s, CH-0//), 2.00 (4H, m, CH2-Cn=Cn-CH2), 1.67 
(2H, m, C//2CH2-CO),1.26 (18H, br. s, (CH2)9), 0.88 
(3H, dist. t, terminus CH3). 
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'^ C NMR (CDCI3) 
MS (FAB) m/z (%) 
Anal 
6 174.9, 167.5, 164.0, 131.2, 131.1, 129.8, 126.1, 125.5, 
124.3, 72.0, 37.1, 33.7, 29.7, 29.6, 29.4, 29.2, 29.1, 28.9 
"three signals signals hidden", 28.7, 26.0, 22.4, 14 2 
488 ([M+1] ^ 11), 470(13), 412 (14), 396 (10), 297 
(100), 281 (20), 265 (35), 236 (8), 208 (12), 194 (15), 
181 (15), 154(12), 138(12), 112 (28), 97 (40). 
Calcd for C27H41N3O3S: C 66.54, H 8.41, N 8.62, S 6.57. 
Found: C 66.41, H 8.29, N 8.71, S 6.47%. 
(9/?,12Z)-N-[4-oxo-2-(pfaenyHmino)-l^thiazolidm-3-yII-9-hydroxyoctadec-12-
enamide (XLIV). White powder, yield 73%, m.p. 156-158 °C. 
IR(KBr,cm*) 
*HNMR(CDCl3) 
^^CNMR(CDCl3) 
MS(FAB)m/r(%) 
Anal 
3287 (OH), 3228 (NH), 1666 (C=0), 1491 (C=N), 667 
(C-S-C). 
6 8.8 (IH, s, NH), 7.46-7.30 (5H, m, Ar-H), 5.37 (2H, m, 
CH2'CH=CH-Cli2l 3.54 (IH, m, OZ-OH), 2.96 (2H, s, 
CH2 ring), 2.30 (2H, t, J = 7.5 Hz, CH2-CO), 2.12 (IH, 
br. S, CH-OH), 2.02 (4H, m, CH2-CH=CH-CH2l 1.58 
(2H, m, C^^CH2-CO),1.26 (18H, br. s, (CHih), 0.88 
(3H, dist. t, terminus CH3). 
5 174.6, 167.3, 164.7, 139.4, 134.1, 129.8, 126.1, 125.5, 
124.3, 72.0, 34.1, 31.7, 29.4, 29.2, 29.1, 28.9, 28.7, 28.4 
"three signals signals hidden", 28.3, 25.6, 22 0, 14.0. 
488 ([M+1] •, 14), 470(11), 396 (10), 297 (100), 281 
(25), 263 (28), 222 (8), 207 (10), 152 (12), 138 (20), 111 
(16), 97 (32), 82 (35). 
Calcd for C27H41N3O3S: C 66.54, H 8.41, N 8.62, S 6 57. 
Found: C 66.44, H 8.32, N 8.68, S 6.51%. 
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5.1 THEORETICAL 
Cholesterol is a steroid alcohol that is essentially insoluble in aqueous 
solutions. In mammals, it is usually solubilized by its association with other lipids, 
such as phospholipids or bile acids; thus, most cholesterol is found in cell 
membranes, plasma lipoproteins, and bile.^ Cholesterol can be esterified with a fatty 
acid to form cholesteryl esters.^ The latter form discrete lipid droplets in cells, 
especially in cells of steroidogenic tissues, and in the lipid core of low-density 
lipoproteins in blood.'' Most cholesterols are synthesized by the liver and other 
tissues, including the adrenal glands and reproductive organs. Some cholesterol is 
absorbed from dietary sources. The most common sterol of eukaryotes is a key 
constituent of cell membranes and works as the precursor of bile acids, 
cholecalciferol (vitamin D) and steroid hormones including Cortisol, cortisone, 
aldosterone and sex hormone progesterone in vertebrates.'* 
A number of investigations have demonstrated that a variety of modified 
fatty acids are promising molecules in cancer prevention and have potential in the 
treatment of cancers. " Fatty acids-ester analogs have received very little attention 
despite the fact that such molecules have been found to be associated with diverse 
biological activities such as antioxidant,* antifeedant,^ anti-inflammatory,'° 
antiparasitic,^' antimicrobial'^ and neuroprotective.'^ Some fatty esters have been 
also found very effective for treatment of dermatitis,''* cardiovascular, hepatic and 
renal disorders" Thus fatty acids-esters may lead to a new route to potential 
pharmaceutical molecules. 
A'iA^-Dicyclohexylcarbodiiamide (DCC) is used as a dehydrating/activating 
agent in organic synthesis'^ and is extensively used for building the peptide and 
amide linkages" In the earlier studies it has been reported that direct use of DCC 
promotes esterification of primary and secondary alcohols under very mild 
conditions while tertiary alcohols result in poor yields.'^ A number of methods'^ 
reported for esterification of fatty acids (FA) either require acidic or basic 
conditions or application of the heat. Literature reveals that fatty acids have not 
been esterified with cholesterol in presence of DCC. Therefore, the development of 
novel synthetic routes to achieve access to these molecules is of great interest. 
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The purpose of this study was to find the novel bioactivity of cholesteryl 
esters. It was discussed that cholesterol derivatives could have antimicrobial 
activity.^° In view of the significance of long-chain fatty acids as potential 
pharmacophores; we report the synthesis and spectral studies of new cholesterol 
analogs containing Cll and C18 fatty acids along with their in vitro evaluation 
against a panel of Gram-positive, Gram-negative strains of bacteria and some strains 
of fiingus (Chapter 6). 
Khorana et al^^ observed that DCC reacts with mono-(177) and di-(178) 
esters of phosphoric acid at room temperature to yield corresponding di- (179) and 
tetra- (180) esters of pyrophosphoric acid, with th precipitation of dicyclohexylurea 
(181). 
0 
2 R 0 — P — 0 H + Cf iHi—N=C=N-C6Hi i 
OH 
177 
O 0 
o 
R O — P — O — P — O R + C 6 H ] ] - N H - C - N H - C 6 H i i 
OH OH 
179 
0 
181 
2(RO)2P—OH + C g H n — N = C = N - C 6 H n 
178 
O O 
II II 
( R 0 ) 2 P ~ 0 — P(0R)2 
180 
O 
+ C 6 H l - N H - C - ^ f H - C 6 H l l 
181 
Neelakantan and coworkers^^ prepared Lichen depsides e.g 3-methyl 
evernate (182) by condensation of aromatic acids and phenolic compounds with 
DCC. 
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H3CO 
H3CO 
COOCH3 
COOCHi 
Later, Hassner et alP have introduced a modification of the DCC-mediated 
esterification, which consists in the addition of a catalytic amount of 4-
dimethylamino pyridine (DMAP) to a mixture of acid (182), alcohol (183) and 
carbodiiamide. 
O 
II 
R—C—OH + R'—0H+ CeHii—N=C=N-C6Hii 
(182) (183) 
CH3 0^^ ""' CH3 
o o 
II II 
R—C-OR' + CfiHu-NH-C-NH—CeHn 
(184) 
tert-Butylethyl fumarate (187) was synthesized by reacting monoester of 
(£)-2-butenedioic acid (185) with tert-butyl alcohol (186), using DCC-mediated 
esterification. 24 
aooc 
H 
> — ( 
185 
COOH H 
+ t-BuOH DCC / 
H DMAP EtOOC 
186 
COOBu 
H 
187 
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Sonpatki etal^^ developed improved method by synthesizing new keto-ester 
(190) with DCC in presence of DMAP. 
Br 
Br-
) (i) Succinic anhydride 
a (ii)18%aq. HCl 
188 
O 
II 
C—CH2CH2COOC12H25 
190 
^ Br 
O 
II 
C—CH2CH2COOH 
189 
Dodecan-1-ol 
^ DCC. DMAP 
CH2CI2 
Employing the same method Dardel et ai^ synthesized liquid crystalline 
promoter (192). 
HO-(CH2)io-0 
191 
DCC/DMAP H 
COOH 
CH2CI2 \ / / \ // ON 
HO—(CH2),o—O C O O ^ ^ ^ ^ ^ C N 
192 
7-Boc-aminoacyloxy-3-phenoxy-2-trifluoromethylehromones (194) was 
synthesized from 7-hydroxy-3-phenoxy-2-trifluoromethylehromones (193) and Boc-
protected amino acid using DCC and a catalytic amount of DMAP. 
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MegC 
Greeling and coworkers'^  synthesized natural compounds like 
hydroxytyrosol (195) which was reacted with three equivalents of steric acid and 
DCC in presence of DMAP to give a triester (196). 
O 
0-C-(CH2)i6-CH3 
OH 
195 
+ 3CH3-
OH 
-(CH2)i6-
f \ 0 V k^/C—(CH2),6-CH3 
""•"C—{CH2),6-CH3 
c > 196 
Four new organosilane compounds (199a^d) containing cholesteryl group 
were synthesized by esterification of 3,3,5,5-tetramethyl-3,5-disila-4-oxa-
cyclohexane-1-carboxylic acid (197) and co-hydroxyalkyl cholesteryl carbonate 
(198a-d) in the presence of DCC and DMAP.^ ^ 
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\ 
y 
Si— 
/Si— 
CH3 CH3 
197 
CH3^V"3 
CHCOOH 
Si-
0 / 
\ 
Si-
CH3 CH3 
\ 
+ 
0 
HO(CH2CH2)nOCO 
DCCDMAP 
0 
/ 
,CHCOO(CH2CH2)nOCO—k^^x^^ 
199a-d 
n=l-4 
Berezovskaya and coworkers^' synthesized geraniol-azidothymidine 
succinate (202) by condensing azidothymidine (201) and geraniol monosuccinate 
(200) in anhydrous ethyl acetate, DCC and DMAP. 
0 
OH + HO 
0 
200 202 
Compound R 
200,202 CH3-CH2-C(CH3)=CH-CH2-CH2-C(CH3)=CH-CH2-CH2 
Falc'o et al.^° synthesized 4-benzyloxybenzyl crotonate (205) by condensing 
4-benzyloxybenzylaicohol (203) and crotonic acid (204) in presence of DCC and 
DMAP. 
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DCC.DMA^ 
205 
Aryl esters of 4-methyl- and 4-methoxy-2-(4-butoxyphenyl)-5 
pyrimidinecarboxylic acids (207a-b) were synthesized from 2-(4-butoxyphenyl)-4-
methyI/methoxy-5-pyrimidinecarboxylic acid (206a-b), phenols, DCC and DMAP, 
as a catalyst. *^ 
BuO 
203a-b 
COOH 4-HO-Ar DCCJ»»IAP -BuO COO-AT 
204a-d 
Compound 
206a, 207a 
206b, 207b 
206a, 207c 
206b,207d 
R 
CH3 
OCH3 
CH3 
OCH3 
AT 
4-BU-C6H4 
4-BU-C6H4 
4-CN-C6H4 
4-CN-C6H4 
.32 Abd-El-Aziz and coworkers reported the fiinctionalization of azo dye 
moieties with organoiron complexes via condensation reactions of 
cyclopentadienyliron complex (208) containing a carboxylic group with the terminal 
hydroxy! group of the benzothiazole azo dye (209) resulting in the formation of the 
organoiron benzothiazole complex (210) using DCC and DMAP. 
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CK 
Fe^ 'PFe" 
^ 
208 
CL 
O 
Fe^Fe" 
^ 
O 
11 
C—OH OH 
+ 
N 
DCX;DMAP 
o 
C - Q 
210 
209 
N N 
N 
Reaction of l-(4-hydroxyphenyl)-2-octen-l-one (211) with aromatic acids in 
the presence of DCC and a catalytic amount of DMAP gave excellent yields of 
esters (212a-d). 33 
C5H11 ArCOOH CsHii 
212a-d 
Compound 
212a 
212b 
212c 
212d 
AT 
4-F-C6H4 
4-NC-C6H4 
4-C3H7-C6H4 
4-C6H13-C6H4 
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Mustafa et al^^ synthesized fatty acid esters of podophyllotoxin (215a-d) by 
reacting an co-hydroxy fatty acid (214a-d) and podophyllotoxin (213) in dry 
dichloromethane, DMAP and DCC. 
^ % . 
O + R C O O H ^ p ^ 
214a-d ^ ^ 
H3CO OCH3 
OCH3 
213 
H3CO' J OCH3 
OCH3 
215a-d 
Compound 
214a,215a 
214b,215b 
214c, 215c 
214d,215d 
R 
(CH2)9-OH 
(CH2)n-0H 
(CH2)i4-OH 
(CH2)i5-OH 
16-Bromohexadecanoic acid (216), benzyl alcohol (217a-d) and DMAP 
were stirred in dry ether under argon atmosphere. DCC was added in a few portions 
in solid state and the mixture was stirred at room temperature to give 4-substituted-
aryl 16-bromohexadecanoate (218a-d).^^ 
Br 
0 
216 
Compound 
217a, 218a 
217b, 218b 
217c, 218c 
217d,218d 
^ DMAP Bi-^ 
217a-d 
Ar 
4-OCH3-C6H4 
4-NO2-C6H4 
4-CN-C6H4 
4-CI-C6H4 
0 
218a-d 
O—CH2—Ar 
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Tuchnaya et al^^ reported the synthesis of mixed disuccinates of 1,12-
dodecanediol, 3'-azido- 3-deoxythymidine (221a) and 1,12-dodecanedioI, 2 , 3 -
didehydro-3'-deoxythymidine (221b) using DMAP and DCC. 
219a,b 
DCC 
DMAP 
221a,b 
Compound 
219a,221a f^H 
R 
O 
Compound 
219b^21b 
R 
O 
NH 
O' N 
N y 
A mixture of 4'-0-demethyl-4p-(4 "-nitroanilino)-4-desoxypodophyllotoxin 
(222), artesunate (223), DMAP and DCC in dried dichloromethane was stirred for 6 
hrs at 0°C to get 12a-deoxoartenusinyl ester 4'-0-demethyl-4p-(4 "-nitroanilino)-4-
desoxypodophyllotoxin (224).^ ^ 
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NHAr 
+ 
^ ^ ^ 
H3CO j OCH3 HO 
OH 
222 223 
Compound Ar 
222,224 4-NO2-C6H4 
Liu et al^^ stirred a mixture of acid (226a-c), podophyllotoxin (213) or 4 -
demethyl epipodophyllotoxin (225), DMAP, in anhydrous dichloromethane for 5 
min at room temperature under nitrogen. DCC was added and the reaction mixture 
was stirred for 2 hrs to obtain the target compounds (227a-f|-
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OH 
P + HOOCAr _BCC^ 
226a-c 
DMAP 
^S. 
H3C0 1 OCH3 
OR 
213,225 
Compound 
213, 226a, 227a 
225, 226a, 227b 
213, 226b, 227c 
225, 226b, 227d 
213, 226c, 227e 
225, 226c, 227f 
R 
H 
CH3 
H 
CH3 
H 
CH3 
H3CO 
AT 
4-C5H4N 
4-C5H4N 
3-(2-Cl)-C5H3N 
3-{2-Cl)-C5H3N 
3-(6-CI)-C5H3N 
3-(6-Cl)-C5H3N 
OCH3 
OR 
227a-f 
Recently Ponedel'kina et al. reported the reaction of azidothymidine (201) 
with succinic anhydride (228) in the presence of DMAP to give azidothymidine 
hemisuccinate (229). To activate the carboxy group, hemisuccinate (229) was 
transformed into corresponding N -hydroxysuccinimide ester (231) via reaction 
with an equimolar amount of A'-hydroxysuccinimide (230) and DCC at 0-20 °C for 
10-20 min. 
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0 
NH 
HO 
^ 
O 
+ o 
o 
DMAP. 
HOOC(CH2)2COO 
N3' 
201 228 229 
229 + 
O 
NOH PCC > 
O 
230 
O 
N—OCO(CH2)2COO 
\ 
o 
231 
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5.2. RESULTS AND DISCUSSION 
Fatty acids and their derivatives are reported as antimicrobial agents. ^  It has 
been suggested that fatty acid may increase antimicrobial activity of certain organic 
moieties.*"* The present study is based on the synthesis and spectral studies of 
cholesterol derivatives derived from different fatty acids. Six fatty acids; undec-10-
enioc (XLV), 10,11-dibromoundecanoic (XLVI), 10,11-epoxyundecanoic acid 
(XLVn), (9Z)-octadec-9-enoic (XLVHI), (9Z,12^)-12-hydroxyoctadec-9-enoic 
(XLIX) and (9i?,12Z)-9-hydroxyoctadec-12-enoic (L) acids were condensed with 
the C3 p-hydroxy group of cholesterol (LI) and 5a,6p-dibromocholesterol (Lit) 
with the help of DCC in the presence of a catalytic amount of DMAP to produce 
Lni-LX in quantitative yield. The products LIII-LX were purified on a silica gel 
column with n-hexane/ethyl acetate as eluent. The signals of the fatty acid and 
cholesterol moieties in the 'H and '^ C NMR spectra of compounds LIQ-LX were 
successfiilly assigned. Change in the nature of fatty acid at p-Cs has not significantly 
influenced the pattern of proton and carbon signals of the cholesterol. 
Reaction of undec-10-enoic acid (XLV) with cholesterol (LI) 
Reaction of undec-10-enioc acid (XLV) with cholesterol (LI) in presence of 
DCC with catalytic amount of DMAP gave ester LDI (Scheme 5.1). 
O 
CH2=CH—(CH2)8—C-OH + 
(XLV) 
O 
CH2=CH—(CH2)8—C—O 
(LDI) 
Scheme 5.1: Synthesis of 3p-cholesterylundec-10'-enoate (LIII). 
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Structural elucidation of the compound LID as 3p-cholesterylundec-10'-enoate 
Compound LIII revealed characteristic IR band at 1732 cm"' (ester C=0 
stretching). The four olefmic protons, CirH2=CioH and Cg-H were observed at 6 
5.81 (tdd, IH, ^;,..^^^ = 6.7Hz, ^_;,^=10.1 Hz, ^_^^ =16.9 Hz, CH2=C//-), 5.36 
(d, IH, J = 4.8 Hz, Cfi-H), 4.98 (dd, IH, J„^_„=\0.\ Hz, y^^_^^=2.8 Hz, 
//zC=CH), 4.93 (dd, IH, J^ _^=16.9 Hz, J„ „„ = 2.8 Hz, H^=CR-) in ' H N M R 
and correlated with observations at 5 114.23, 122.67, 139.77, 139.27 in ^^ C NMR 
respectively. A multiplet at 6 4.61 was observed for C3P-H and correlated with 
observation at 5 73.75 in "C NMR. Characteristic peak at 5 174.07 (ester C=0) was 
recorded in *^ C NMR. The ESI-MS was also in agreement by showing characteristic 
molecular ion peak. Based on these observations compound LID was characterized 
as 3p-cholesterylundec-10'-enoate. 
Reaction of undec-10-enoic acid (XLV) with 5a,6p-dibromocholesterol (LII) 
Undec-10-enioc (XLV), DCC, and 5a,6p-dibromocholesterol (HI) in 
dichloromethane with catalytic amount of DMAP were stirred mechanically at room 
temperature until esterification was complete. Reaction mixture on workup and 
purification over column of silica geJ afforded ester LIV (Scheme 5.2). 
O 
C H 2 = C H — ( C H 2 ) 8 — C - O H + 
(XLV) 
O 
C H 2 = C H — ( C H 2 ) 8 — C — O 
(LIV) Br 
Scheme 5.2: Synthesis of 5a,6p-dibromo-3p-cholesterylundec-10'-enoate (LFV). 
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Structural elucidation of the compound LIV as 5a,6p-dlbromo-3p-
cholesterylundec-lO'-enoate 
Characteristic IR band at 1738 cm~' (ester C=0 stretching). Olefinic protons, 
Cii H2K:IOH were observed at 5 5.73 (tdd, IH, J^,^^ = 6.7 Hz, J„_„^ =10.1 Hz. 
'^H-H,= 16.9 Hz, CH2=C^-), 4.95 (dd, IH, J^^_^ = 10.1 Hz, Jfj,-H,= 2.8 Hz, 
//zC-CH), 4.88 (dd, IH, Jf,^_„ = 16.9 Hz, J^.-H^ = 28 Hz, Hf<2=CH) in 'H NMR 
and correlated with observations at 5 114.23, 139.25 in '^ C NMR respectively. A 
multiplet at 6 4.75 was observed for Csp-H and correlated with observation at 5 
71.79 in ^^ C NMR and a characteristic peak at 5 173.27 (ester C=0) was also 
recorded. Besides few other proton signals characteristic peak at 3.63 (t, IH, 7 = 4.8 
Hz, Ce-H) was observed. The ESI-MS showed three molecular ion peaks indicating 
two different isotopes of bromine. Thus compound LIV was characterized as 5a,6p-
dibromo-3p-cholesterylundec-10'-enoate. 
Reaction of 10,11-dibronioundecanoic acid (XLVI) with cholesterol (LI) 
Mixture of 10,11-dibromoundecanoic acid (XLVI), DCC, and cholesterol 
(LI) in dichloromethane with catalytic amount of DMAP was stirred mechanically at 
room temperature to obtain ester LV (Scheme 5.3). 
O 
H2C-CH—(CH2)8-
Br Br 
(XLVI) 
: - 0 H + 
H2C-CH—(CH2)8—C 
Br Br (LV) 
Scheme 5.3: Synthesis of 10',ir-dibromo-3p-cholesterylundecanoate(LV). 
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Structural elucidation of the compound LV as 10',ir-dibromo-3p-
cholesterylundecanoate 
Compound LV revealed IR band at 1732 cm"^  (ester C=0 stretching). 
Characteristic peaks were observed in ' H NMR at 5 5.36 (d, IH, J = 4.8 Hz, Ce-H), 
4.16 (m, IH, Cio-H), 3.85 (dd, 2H, y= 10.0 Hz, 7=2.4 Hz, Cn-Hz). A multiplet at 
6 4.61 was observed for Csp-H and correlated with observation at 5 73.77 in '^ C 
NMR. In '^ C NMR characteristic peak at 5 173.27 (ester C=0), 139.75 and 122.68 
were recorded. The ESI-MS was also in agreement showing three molecular ion 
peaks indicating two different isotopes of bromine. Based on these observations 
compound LV was characterized as 10', 11 '-dibromo-3p-choIesterylundecanoate. 
Reaction of 10,11-dibromoundecanoic acid (XLVI) with 5a,6p-
dibromocholesterol (LII) 
A solution of 10,11-dibromoundecanoic acid (XLVI), DCC, and 5a,6p-
dibromocholesterol (LII) in dichloromethane with catalytic amount of DMAP were 
stirred mechanically at room temperature until esterification was completed to get 
ester LVI (Scheme 5.4). 
O 
H2C-CH—(CH2)8-
Br Br 
(XLVI) 
: - 0 H + 
o 
II 
H2C—CH—(CH2)8—C—O 
Br Br (LVI) 
Scheme 5.4: Synthesis of 5a,6p,10',ir-tetrabromo-3p-cholesterylundecanoate 
(LVI). 
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Structural elucidation of the compound LVI as 5a,6p,10',ir-tetrabronio-3p-
cholesterylundecanoate 
Compound LVI revealed characteristic IR band at 1732 cm"' (ester C=0 
stretching). A multiplet at 5 4.82 was observed for Csp-H and correlated with 
observation at 5 71.79 in '"^ C NMR. Besides few other proton signals characteristic 
peak at 6 4.16 (m, IH, Cio-H), 3.84 (dd, 2H, J = 10.0 Hz, J= 2.4 Hz. C11-H2) and 
3.63 (t, IH, y = 4.8 Hz, Ce-H) were observed. In '^ C NMR characteristic peak at 6 
173.18 (ester C=0) was recorded. The ESI-MS was also in supported the structure 
assigned by showing five molecular ion peaks indicating two different isotopes of 
bromine. Thus compound LVI was characterized as 5a,6p,10',ir-tetrabromo-3p-
cholesterylundecanoate. 
Reaction of 10,11-epoxyundecanoic acid (XLVII) with cholesterol (LI) 
Mixture of 10,11-epoxyundecanoic acid (XLVII), DCC, and cholesterol (LI) 
in dichloromethane with catalytic amount of DMAP was stirred mechanically at 
room temperature. Reaction mixture on workup and purification over column of 
silica gel afforded ester LVn (Scheme 5.5). 
0 
HsC-^CH—(CH2)8—C-OH + 
^ (XLVn) 
O 
H2C—CH—(CH2)8—C—O 
V (Lvn) 
Scheme 5.5: Synthesis of 10', 11 '-epoxy-3 p-cholesterylundecanoate (LVII). 
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Structural elucidation of the compound LVn as 10',ir-epoxy-3p-
cholesterylundecanoate 
Compound LVn revealed characteristic IR band at 1732 cm~' (ester C=0 
stretching). Characteristic peaks at 6 5.36 (d, IH, J = 4.4 Hz, Ce-H), 2.90 (m, IH, 
Cio-H) and 2.75 (dd, 2H, J= 10.1 H2, 7=2.6 Hz, C11-H2) were observed in 'H 
NMR. A multiplet at 6 4.61 was observed for Csp-H and correlated with observation 
at 5 73.77 in '^ C NMR. In '^ C NMR characteristic peak at 6 173.18 (ester C=0) was 
recorded. The ESI-MS was also in agreement showing characteristic peak. Based on 
these observations compound LVn was characterized as 10,11 '-epoxy-3p-
cholesterylundecanoate. 
Reaction of (9Z)-octadec-9-enoic acid (XLVm) with cholesterol (LI) 
(92)-Octadec-9-enoic acid (XLVm), DCC. and cholesterol (LI) in 
dichloromethane with catalytic amount of DMAP was stirred at room temperature 
(Scheme 5.6). The A'^ A -^dicyclohexylurea formed was filtered off. Filtrate on 
workup and chromatography over a column of silica gel gave ester LVni (Scheme 
5.6) 
CH3—(CH2>7—CH=CH—(CH2)7—C-OH + 
(XLVIII) 
a 
CH3~(CH2)7—CH=CH—(CH2) 
(LVIII) 
Scheme 5.6; Synthesis of (9'Z)-3p-cholesteryloctadec-9'-enoate (LVni). 
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Structural elucidation of the compound LVDI (9'Z)-3p-cholesteryloctadec-9'-
enoate 
Compound LVDI revealed characteristic IR band at 1737 cm"' (ester C=0 
stretching). Characteristic peaks were observed in H^ NMR at 6 5.36 (d, IH, 7= 4.8 
Hz, Ce-H), 5.33 (m, 2H. C9H=CioH) and 4.62 (m, IH, CsP-H). In '^ C NMR peak at 
6 170.42 (ester C=0) 139.77, 139.27. 127.67, 124.23 and 88.10 were recorded. The 
ESI-MS also in supported the structure assigned. Based on these observations 
compound LVin was characterized as (9'Z)-3p-cholesteryloctadec-9'-enoate. 
Reaction of (9Z,12/?)-12-hydroxyoctadec-9-enoic (XLK) with cholesterol (LI) 
Mixture of (9Z,12y^)-12-hydroxyoctadec-9-enoic (XLIX), DCC, and 
cholesterol (LI) in dichloromethane with catalytic amount of DMAP was stirred at 
room temperature until esterification was complete. Reaction mixture on workup 
and purification over column of silica gel afforded ester LIX (Scheme 5.7). 
o 
II 
CH3—(CH2)5—CH—CH2—CH=CH—(CHzh—C-OH + 
OH 
(XLDC) 
n 
O 
II 
CH3—(CH2)5—CH—CH2—CH=CH—(CHzh—C—O 
OH 
(LK) 
Scheme 5.7: Synthesis of (9'Z,12'i?)-3p-choIesteryl-12'-hydroxyoctadec-9'-enoate 
(LIX). 
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Structural elucidation of the compound LIX as (9'Z,12'^)-3p-cholesteryl-12'-
hydroxy octadec-9 '-enoate 
Characteristic IR band at 1737 cm~' (ester C=0 stretching) was observed. In 
H^ NMR peaks at 5 5.41 (m, 2H, C9H=CioH), 5.36 (d, IH, 7 = 4.6 Hz, Ce-H), 4.87 
(m, IH, OH, D2O exchangeable), 4.61 (m. IH, C3P-H), 3.61 (m, IH, Cu/f-OH). In 
^^ C NMR peak at 6 170.42 (ester C=0) 139.77, 139.27, 127.67, 124.23 and 77.10 
were recorded. The ESI-MS also in supported the structure. Based on these 
observations compound L K was characterized as (9'Z,12'^)-3p-cholesteryl-12'-
hydroxyoctadec-9'-enoate. 
Reaction of (9/?,12Z)-9-hydroxyoctadec-12-enoic acids (L) with cholesterol (LI) 
A mixture of (9i?,12Z)-9-hydroxyoctadec-12-enoic acids (L), DCC, and 
cholesterol (LI) in dichloromethane with catalytic amount of DMAP was stirred 
mechanically at room temperature to get ester LX which was purified by 
chromatography over a column of silica gel (Scheme 5.8). 
o 
CH3—(CH2)4—CH--CH—(CH2>2—CH—(CH2)7—C-OH + 
OH 
(L) „ HO 
o 
O 
II 
CH3—CCH2)4— CH=CH—CCH2)2—CH—(CH2)7—C—O 
OH 
(LX) 
Scheme 5.8: Synthesis of (9'/?,12'Z)-3p-cholesteryl-9'-hydroxyoctadec-12'-enoate 
(LX). 
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Structural elucidation of the compound LX as (9'/{,12'Z)-3p-cholesteryl-9'-
hydroxyoctadec-12'-enoate 
Compound LX revealed characteristic IR band at 1737 cm~^  (ester C-0 
stretching). Characteristic peaks were observed in ' H N M R at 6 5.40 (m, 2H, 
CiiH=Ci2H), 5.33 (d, IH, J = 4.6Hz, Cg-H), 4.64 (m, IH, OH, D2O exchangeable), 
4.57 (m, IH, C3P-H) and 3.60 (m, IH, CsTZ-OH,). In ^^ C NMR characteristic peak at 
6 170.42 (ester C=0) 139.72, 139.19, 127.64, 124.23 and 78.33 were recorded. The 
ESI-MS also in supported the structure assigned. Based on these observations 
compound LX was (9'y?,12'2)-3p-cholesteryl-9'-hydroxyoctadec-12'-enoate. 
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5.3.EXPERIMENTA1 
Undec-lO-enioc (XLV) (purity 98%) and {9Z)-octadec-9-enoic (XLVm) 
(97%) acids were purchased from Fluka Chemicals (Bucks, Switzerland). (9Z,12/?)-
12-Hydroxyoctadec-9-enoic (XLIX) (ricinolic, 98%) acid and (9i?, 12Z)-9-
hydroxyoctadec-12-enoic (L) (isoricinolic, 98%) acid were isolated from Ricinus 
communis and Wrightia tinctoria seed oils respectively following Gunstone's 
partition procedure.'**' Cholesterol (LI) was purchased from S d FINE-CHEM Ltd. 
(Mumbai, India). 5a,6p-dibromocholesterol'*' (LII), 10,11-dibromoundecanoic 
acid'*^  (XLVI), and 10,11-epoxyundecanoic acid**^  (XLVII) were synthesized 
following the literature methods. Thin layer chromatography was done on glass 
plates (20x5 cm) with a layer of silca gel G (Merck, Mumbai, India, 0.5mm 
thickness). Mixture of petroleum ether-ethyl acetate-acetic acid (50:50:1, v/v) were 
used as developing solvents. Column chromatography was carried out on silca gel 
(Merck, Mumbai, India, 60-120 mesh). Instruments used for recording the spectra 
are same as reported previously. 
General procedure for synthesis of 3p-choIesteryl-esters LIII-LX. 
A solution of FA (5mmol), DCC (5.5mmol), and cholesterol (5mmol) in 
dichloromethane (50mL) with catalytic amount of DMAP were stirred mechanically 
at room temperature until esterification was complete. The A^A''-dicyc]ohexylurea 
was filtered off and the filtrate was washed with water (3^50 mL), 5% acetic acid 
(3^50 mL), again with water (3>^ 50 mL) and then dried over anhydrous sodium 
sulphate. The solvent was removed under reduced pressure to give the ester which 
was chromatographed over a column of silica gel using petroleum ether-ethyl acetate 
(1:1, v/v) as eluent. All these novel compounds were characterized from their 
spectral data. 
3p-Cholesterylundec-10'-enoate (LID). White amorphous compound, yield 92%, 
m.p 86°C. 
IR(KBr, cm"^ ) : 2927, 2851, 1732, 1466. 
•HNMR(CDCl3) : 5.81 (tdd, IH, 7^ ,^^ = 6.7 Hz, ^_;,^= 10.1 Hz. J^_„^ = 
16.9 Hz, CH2=C^-), 5.36 (d, IH, J = 4.8 Hz, Ce-H), 4.98 
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(dd, IH, Jff^_ff=\0.\ Hz, ^^_„^ = 2.8H2,//zC=CH),4.93 
(dd, IH, J„^_^= 16.9 Hz, J^^_„^- 2.8 Hz, H^=CU-), 
4.61 (m, IH, CsP-H), 2.351-1.07 {brm, 44H, ring and chain 
CH2), 1.01 (s, 3H, C10-CH3), 0.90 (d, 3H, J = 6.5 Hz, C20-
CH3), 0.86 (dd, 6H, J= 6.6Hz C25-(CH3)2), 0.67 (s, 3H, Cn-
CH3). 
'^C NMR (CDCI3) : 173.41. 139.77, 139.27, 122.67, 114.23, 73.75, 56.74, 
56.17, 50.06, 42.37, 37.78, 39.59, 38.22, 37.06, 36.66, 
36.25,35.88, 34.78, 33.89, 31.97, 31.91, 29.38, 29.30, 
29.17, 29.15, 28.97, 28.32, 28.10, 27.88, 25.13, 24.36, 
23.90,22.92,22.66,21.10, 19.41, 18.79, 11.93. 
MS (ESI) m/z : 575.41 [M+Na]"". 
5o,6p-Dibromo-3p-choIesterylundec-10'-enoate (LIV): White amorphous 
compound, yield 90%, m.p 82°C. 
IR (KBr, cm"') 2932, 2850, 1738, 1466. 
'HNMR(CDCl3) : 5.73 (tdd, IH, J^^^^j = 6.7 Hz, J^^./y^^lO.l Hz, 
-^H-H =16.9 Hz, CH2=CH-l 4.95 (dd, IH, J„ „= 10.1 
Hz, J^^^^^= 2.8 Hz, HzC-Cn), 4.88 (dd, IH, ^^_^ = 
16.9 Hz, J„^_^^ = 2.8 Hz, HEC=CH-), 4.75 (m, IH, C3P-
H), 3.63 (t. IH, y = 4.8 Hz, Ce-H), 2.23-1.07 (br m, 44H, 
ring and chain CH2), 1.01 (s, 3H, C10-CH3), 0.82 (t, 3H, J 
= 6.6 Hz, C20-CH3), 0.79 (dd, 6H, J = 6.4 Hz C23-(CH3)2), 
0.63(s,3H,Ci3-CH3). 
CNMR(CDCl3) ; 173.27, 139.25, 114.23, 88.19, 71.79, 56.20, 56.10, 55.17, 
47.21, 42.72, 41.98, 41.90, 39.61, 39.54, 37.24, 36.54, 
36.16, 35.81, 34.61, 33.86, 31.03, 30.84, 29.35, 29.26, 
29.12, 28.94, 28.22, 28.07, 26.27, 25.04, 24.09, 23.84, 
22.89, 22.63, 21.32, 20.21, 18.71, 12.25. 
MS (ESI) m/z 733.75/735.79/737.76 [M+Na]"". 
13 
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'HNMR(CDCl3) 
"C NMR (CDCW 
10',ll'-Dibromo-3p-cholesterylundecanoate (LV): OfF-white solid, yield 94%, 
m.p 84°C. 
IR (KBr, cm"^) 2940, 2853, 1732, 1464. 
5.36 (d, IH, y = 4.8 Hz, Ce-H), 4.61 (m, IH, Csp-H), 4.16 
(m, IH, Cio-H), 3.85 (dd, 2H, J^ 10.0 Hz, J=2.4 Hz, 
Cn-H2), 2.31-1.07 (Arm, 44H, ring and chain CH2), 104 
(s, 3H, C10-CH3), 0.94 (d, 3H, J = 6.6 Hz, C20-CH3), 0.85 
(dd, 6H, J= 6.6 Hz Czi-iCHihX 0.61 (s, 3H, C13-CH3). 
173.37. 139.75, 122.68, 75.77, 56.73, 56.16, 53.20, 50.05, 
42.36, 39.77, 39.58, 38.22, 37.05, 36.66, 36.43, 36.24, 
36.05, 35.87, 34.76, 31.97, 31.05, 29.25, 29.21, 29.11, 
28.80, 28.31, 28.09, 27.88, 26.78, 25.09, 24.36, 23.89, 
22.92, 22.65, 21.09, 19.41, 18.78, 11.93. 
733.78/735.76/737.69 [M+Na]"". 
5a,6p,10'4r-Tetrabronio-3p-cholesteryIundecanoate (LVI): Off-white solid, 
yield 74%, m.p 88°C. 
2945, 2886, 1732, 1465. 
4.82 (m, IH, C3P-H), 4.16 (m, IH, Cio-H), 3.84 (dd, 2H, 
J= 10.0 Hz, J =2.4 Hz, Cn-H2), 3.63 (t, IH, J= 4.8 Hz, 
Ce-H), 2.58-1.07 (br w, 44H, ring and chain CH2), 1.00 (s, 
3H, C10-CH3), 0.90 (d, 3H, y = 6.6 Hz, C20-CH3), 0.85 (dd, 
6H, J = 6.6 Hz C25-(CH3)2). 0.64 (s, 3H, C13-CH3). 
MS (ESI) m/z 
IR (KBr, cm"') 
'HNMR(CDCl3) 
'^CNMR(CDCl3) 
MS (ESI) m/z 
173.18, 71.79, 56.19, 56.14, 56.09, 47.26, 44.89, 42.70, 
42.50, 39.67, 39.60, 39.53, 39.48, 37.22, 36.52, 36.40, 
36.15, 36.09. 36.01, 35.79, 35.71, 34.71, 34.56, 31.64, 
31.01, 30.83, 29.23, 29.17, 28.77, 28.05, 26.95, 26.75, 
24.99,23.83,22.63,21.41, 18.70, 11.91. 
891.31/893.67/895.81/897.73/899.91. [M+Naf. 
146 
Tatty AcufAnalogs ofCRolesteroC 
10',ir-Epoxy-3p-cholesterylundecnoate (LVII): White solid, yield 72%, m.p 
94°C. 
IR(KBr, cm"') : 2932, 2854, 1732, 1464, 1174. 
' H f^MR (CDCI3) . 5.36 (d, IH, J = 4.4 Hz, Ce-H), 4.61 (m, IH, C3P-H), 2.90 
(m, IH, Cio-H), 2.75 (dd, 2H, y = 10.1 Hz, y=2.6 Hz, 
C11-H2), 2.31-1.05 {brm, 44H, ring and chain CHj), 101 
(s, 3H, C10-CH3), 0.95 (d, 3H, y = 6.4 Hz, C20-CH3), 0.87 
(dist. t, 3H. 'CH3). 0.85 (dd. 6H, / = 6.6 Hz C25-(CH3)2), 
0.67 (s. 3H, C13-CH3). 
^^ C NMR (CDCI3) 173.18, 139.75, 122.68, 73.77, 56.73, 56.16, 53.20, 50.05, 
42.36. 39.77. 39.58, 38.22, 37.05, 36.66, 36.43, 36.24, 
36.05, 35.87, 34.76, 31.97. 31.05, 29.25, 29.21, 29.11, 
28.80, 28.31. 28.09, 27.88. 26.78. 25.09, 24.36, 23.89, 
22.92, 22.65, 21.09,19.41, 18.78, 11.91. 
MS (ESI) m/z : 591.74 [M+Na]^ 
(9'Z)-3p-CholesteryIoctadec-9'-enoate (LVHI); Viscous pale-yellow oil, yield 
78%.. 
IR(KBr, cm"') 2930, 2852, 1737, 1463. 
' H N M R (CDCI3) 5.36 (d, IH. J = 4.8 Hz. Ce-H), 5.33 (m, 2H, C9H=CioH) 
4.62 (m. IH. C3P-H), 2.31-1.07 (br w, 53H, ring and 
chain CH2), 1.01 (s, 3H, C10-CH3). 0.90 (d, 3H, J = 6.5 
Hz, CM-CH3). 0.88{dist. t. 3H, CwH^ ), 0.85 (dd, 6H,J = 
6.6 Hz C25-(CH3)2), 0.67 (s. 3H, C13-CH3). 
'^C NMR (CDCI3) 170.42, 139.77, 139.27, 127.67, 124.23, 88.10. 47.26, 
44.89, 42.70, 42.50, 42.37. 39.78, 39.59. 37.22, 37.06, 
36.40. 36.15. 36.09, 36.01, 35.88, 35.71. 34,78, 33.89, 
31.97, 31.91. 29.38, 29.30, 29.17, 29.15, 28.97, 28.32, 
28.10, 27.88, 25.13. 24.36, 24.08, 23.83, 22.89. 22.69, 
22.63, 21.31, 20.18, 19.41, 18.66, 14.21. 
MS (ESI) m/z 674.03 [M+Na]^ 
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(9'Z,12'/?)-3p-Cholesteryl-12'-hydroxyoctadec-9'-enoate 
colorless oil, yield 75%. 
IR (nujol, cm' ) 
(LK); Viscous 
'HNMR(CDCl3) 
^^CNMR(CDCl3) 
3452,2935,2863, 1737, 1463. 
5.41 (m, 2H, C9H=Cio'H), 5.36 (d, IH, J = 4.6 Hz, Ce-
H), 4.87 (m, IH, OH, D2O exchangeable), 4.61 (m, IH, 
C3P-H), 3.61 (m, IH. CizT^-OH), 2.31-1.04 {br m, 51H, 
ring and chain CH2), 1.01 (s, 3H, Cio-CHs), 0.94 (d, 3H, J 
= 6.5 Hz, C20-CH3), 0.89 (dist. t, 3H, CigHa ), 0.85 (dd, 
en, j^e.euz C25<cnz)2i o.ei (s, 3H, C,3-CH3). 
170.42, 139.77, 139.27, 127.67, 124.23, 77.10, 68.5, 
47.46, 44.39, 42.20, 42.10, 42.07, 39.75, 39.59, 37.21, 
37.06, 36.43, 36.25, 36.19, 36.11, 35.83, 35.72, 34.75, 
33.39, 31.91, 29.38, 29.33, 29.17, 29.15, 28.37, 28.22, 
28.10, 27.33, 25.13, 24.46, 24.18, 23.83, 22.89, 22.69, 
22.63, 21.31, 20.18, 19.41, 18.66, 13.67. 
690.07 [M+Na]^ 
(9'^,12'Z)-3p-ChoIesteryl-9'-hydroxyoctadec-12'-enoate (LX): Viscous oil, yield 
98%. 
3449, 2922, 2859, 1737, 1466. 
5.40 (m, 2H, Cn H=Ci2H), 5.33 (d, IH, J = 4.6 Hz, Ce-
H), 4.64 (m, IH, OH, D2O exchangeable), 4.57 (m, IH, 
C3P-H), 3.60 (m, IH, CgH-OH,), 2.31-1.07 (br m, 51H, 
ring and chain CH2), 1.01 (s, 3H, C10-CH3), 0.92 (d, 3H, 
J = 6.5 Hz, C20-CH3), 0.88 (dist. t, 3H, C18H3), 0.85 (dd, 
6H, J= 6.6 Hz C25-(CH3)2), 0.67 (s, 3H, C13-CH3). 
170.42, 139.72, 139.19, 127.64, 124.23, 78.33, 67.53, 
46.23, 44.77, 42.71, 42.39, 42.37, 39.76, 39.44, 37.22, 
37.16, 36.20, 36.15, 36.00, 35.88, 35.71, 34.34, 33.99, 
31.65, 31.11, 29.38, 29.34, 29.30, 29.06, 29.02, 28.81, 
28.32, 28.10, 27.32, 25.33, 24.36, 24.76, 23.13, 22.89, 
22.21,22.13,21.31,20.18, 19.41, 14.19. 
MS (ESI) m/z 690.09 [M+Na]^ 
MS (ESI) m/z 
IR (nujol, cm )^ 
'HNMR(CDCb) 
'^CNMR(CDCl3) 
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6.1 THEORITICAl 
Microorganisms are ubiquitously present in and around us. Almost all 
organisms are susceptible to infection by microorganisms that may cause pathogenic 
efFects. The organisms are divided into many classes based on different parameters. 
Among these, vertebrates and invertebrates are very important. In these categories, 
the invertebrates defend themselves from infection without antibodies where as the 
lymphocytes are normally involved in the adaptive immunity of vertebrates to 
combat against the microorganisms. Antimicrobial peptides are one of the major 
weapons in the iimate immunity response of invertebrates. These peptides are also 
found in vertebrates, plants and in bacteria.^  One of the major families of 
antimicrobial peptides that has been characterized is the defensins.^  Defensins are 
generally cationic antimicrobial peptides containing six disulphide paired cysteines, 
found highly effective against Gram-positive bacteria, and have potent activity 
against Gram-negative bacteria, fungi, yeast and protozoa.^  Although the vertebrates 
have the specific immune system but that may not be sufficient to combat with the 
microorganisms. Thus the usage of commercially available antibiotics like 
ampicillin, tetracycline, erythromycin, chloramphenicol etc. has increased besides 
some undesirable side efFects. So the necessity to invent the akemative medicines is 
very much in demand which may not have the side effects. 
Development of resistance to existing drugs is a constantly growing. Recent 
decline in the development of new drugs to combat infectious diseases has further 
increased the demand to synthesize new molecules with potential pharmacological 
properties. In view of the drug-resistant microorganisms, it is important that new 
drugs inhibit targets different from those of currently used drugs.'^  In addition, 
development of new agents should also shorten the lengthy therapy, thus requires the 
design of drugs that can inhibit targets involved in persistence or dormancy. This 
can be achieved by either synthesis of analogues, modifications or derivatives of 
existing compounds for shortening and improving treatment or searching for novel 
structures that can be used against drug resistant microorganism. 
Fatty acid derivatives have been found to be associated with diverse 
antimicrobial activities.^ '^  Mod et al} reported that sulphur derivatives of N,N-
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disubstituted amides of long-chain fatty acids are active against various 
microorganisms. Khan ei al^ reported various fatty acids and their derivatives as 
potential pesticidal compounds. 
Various nitrogen derivatives (232,233,234) of isoricinolic acid were found to 
be effective against a class of fungi.*** 
CH3—(CH2)4-CH=CH-(CH2)2-CH-(CH2)7—CH2OH 
OCH2CH2CN 
232 
O 
CH3—(CH2)4—CH=CH-(CH2)2-CH-(CH2)7—C-N O 
OH ^ ^ 
233 
O 
CH3—(CH2)4-CH=CH-(CH2)2-CH-(CH2)7—C-N O 
OCH2CH2CN ^ ^ 
234 
Heterocyclic compounds like oxadiazoles (235a-c) and oxothiazolidines 
(236a-c) of myrisitic, palmitic and steric acids were also reported to be active aginst 
some bacteria and fungi.*' 
N-NH 
R—«. ) = S 
^ 0 
235a-c 
O 
II 
R-C-NH-HSf 
Compound 
235a, 236a 
235b,236b 
235c, 236c 
R 
CH3-(CH2)u-CH2 
CH3-(CH2)l3-CH2 
CH3-(CH2)]5-CH2 
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El-Sayed et al '^  synthesized various nitrogen heterocyclic derivatives (237, 
238, 239, 240) of sodium sulphonate stearic acid and reported some compounds as 
promising antibacterial agents. 
NH 
239 
R = CH3-(CH2)i5-CH(S03Na)-
Antibacterial activity of fatty alkenoates 3'(2"-hydroxy-4 "• 
methoxyphenyl)-l-phenyl-propenyl-undec-10-enoate (241) and l-steryl-2-
undecenylgiycol (242) were reported by Rauf e/ alP 
O H H3CO 
i—o 
'8 
16 
o 
242 
Mujeebur-Rehman et aO^ reorted the antibacterial activity of novel alkyi 
chain substituted thiazoIidin-4-one (243) and thiazan-4-one (244) from 10-
undecenoic acid. 
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. ^ ^ 
NO2 
NO2 
Rauf et al}^ further reported antimicrobial activity of 3,5,6-trisubstituted-
1,2,4-triazines (245a,b) against a class of bacteria and fungi. 
Ri 
245a,b 
Ri 
CH3-(CH2),3-CH2 
CH3-(CH2)l5-CH2 
A number of nitrated heterocycles, particuiariy heterocycles with five 
membered rings, have been shown potential antimicrobial and antiparasitic 
activities. ^ ^ To pursue this goal, our research efforts are directed to synthesize 
derivatives of fatty acids and to report their in vitro antimicrobial properties. 
Compound 
245a 
245b 
R 
CH3 
CeHs 
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6.2 RESULTS AND DISCUSSION 
6.2.1: FATTY HYDRAZONES 
The in vitro antibacterial activity of the synthesized compounds V-XII was 
carried out against E. coli, S. aureus and S. albus. Results of antibacterial screening 
are reported in Table 6,1. It was observed that only Cll hydrazones V and IX 
showed promising results. While as hydrazones VII and Vni showed moderate 
activity against E. coli and S. albus. Hydrazones XU showed poor activity against E. 
coli and S. aureus. 
Table 6.1. Antibacterial screening data for compounds V-XII. 
Compound Diameter of zone of inhibition (mm) 
Gram-negative bacteria Gram-positive bacteria 
E. coli S. aureus S. albus 
-H-+ 
VI 
vn 
vm 
IX 
X 
XI 
xn 
Chloromycetin 
(Control) DMF 
+-H-
+ + 
++++ 
Concentration used= lOO^g/ml of DMF. 
Low activity (l-5mm) (+): moderate activity (6-lOmm) (++); high activity (11-
15mm) (+ -H-); very high activity (15-20mm) (+ + + +); no activity (-) 
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6.2.2: 2.5-DISUBS'nTUTED-l,3,4-OXADIAZOLES 
The in vitro antibacterial activity of 2,5-disubstituted-l,3,4-oxadiazoles was 
carried out against E. coli, S. typhii, E. aerogems and S. aureus. From Table 6.2 it 
may be seen that compounds, except XVTI, XVn and XXII, showed good activity 
against E. coli. Compounds XVII and XVIII showed moderate activity against E. 
coli and S. aureus. Compounds XXI and XXm showed moderate activity against S. 
typhii and S^*. aureus, while as compound XXIV was moderately active against S. 
aureus. It may be noted that compounds XIX, XX, XXI, XXIII, and XXIV, showed 
promising results against E. coli. 
Table 6.2. Response of various micro-organisms to newly synthesized compounds 
xvn-xxiv 
Compound Diameter of zone of inhibition (mm) 
E. coli S. typhii E. aerogenes S. aureus 
xvn 
xvm 
+ 
XIX 
XX ++ 
XXI 
xxn 
xxra 
XXIV 
Chloromycetin 
(Control) DMF 
++++ +-H-
+ 
I I I I 
Concentration used= 100^g/ml of DMF. 
Low activity (l-5mm) (+); moderate activity (6-lOmm) (+ +); high activity (11-
15mm) (+ + +); very high activity (16-20mm) (+ + + +); no activity (-). 
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6.2.3: 2,5-DISUBSTITUTED-l,3,4-THIADIAZOLES 
These newly synthesized compounds were evaluated in vitro against an 
assortment of two Gram-negative bacteria E. coli, S. typhii and two Gram-positive 
bacteria S. aureus and S. alhus. From Table 6.3 it may be seen that compounds XXV 
and XXVI showed moderate activity against all the bacteria while as compounds 
XXVn, XXVni, XXXI and XXXII showed good activity against these bacteria. It 
may be noticed that compounds XXVn, XXVm, XXXI and XXXII showed 
promising results against £". coli while as compounds XXVIII and XXXI showed 
promising results against S. aureus and S. albus. 
Table 6.3. Antibacterial screening data for XXV-XXXH. 
Compound Diameter of zone of inhibition (mm) 
Gram-negative bacteria Gram-positive bacteria 
E. coli S. typhii S. aureus S. albus 
XXV 
XXVI + 
XX vn •¥++ 
xxvra +++ 
XXIX 
XXX -H- + + 
XXXI 
xxxn 
Chloromycetin 
(Control) DMF 
++ '{-'rk-
I M I 
-H-++ 
Concentration used= 50^g/ml of DMF 
Low activity (I-5mm) (+): moderate activity (6-lOmm) (++); high activity (U 
15mm) (+ -H-); very high activity (15-20mm) (+ + + +); no activity (-) 
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6.2.4: 1,2,4-TRIAZOLES AND 4-OXO-l,3-THIAZOLroiNES 
The in vitro antimicrobial activity of compounds XXXVII-XLTV was 
investigated against four bacterial strains (Table 6.4). It may be seen that compounds 
XXXVn, XXXVni and XL showed moderate activity against E. coli and E. 
aerogems while as XXXVIII was moderately active against S. typhii. Compounds 
XLI and XLin showed good activity against E. coli and moderate activity against 
E. aerogenes. Compound XLIV was moderately active against all the strains of 
bacteria. It is worthy to note that compounds XXXIX, XLI and XLin shows 
potential results against E. coli. 
Table 6.4. Antibacterial activity of newly synthesized compounds XXXVII-XLIV. 
Compound Diameter of zone of inhibition 
E. coli S. typhii E. aerogenes S. aureus 
xxxvn 
xxxvni 
xxxix 
XL 
XLI 
XLH 
XLHI 
XLIV 
Chloromycetin 
-H-+ 
-H-
-H- + 
++ 
DMF used as control 
Concentration used= lOO^g/ml of DMF 
Low activity (l-5mm) (+), moderate activity (6-lOmm) (+ +), high activity (11-
15mm) (+ + +), very high activity (16-20mm) (+ + + +), no activity (-). 
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6.2.5: FATTY ACID ANALOGS OF CHOLESTEROL 
The in vitro antibacterial activities of LIII to LX were tested using the 
bacterial cultures of ^ . mutants, S. pyogenes, S. aureus, F. aeruginosa, S. 
typhimurium, E. coli and fungal cultures of Candida albicans, C. krusei, C. 
parapsilosis, and Cryptococcus neqformans, by the disk diffusion method and then 
the minimum inhibitory concentration (MIC) of all the compounds were determined. 
The zones of inhibition (mm) of every compound against Gram-positive and Gram-
negative strains of bacteria are shown in Table 6.5.1 and the minimum inhibition 
concentration (MIC) of all compounds are shown in Table 6.5.2. The compounds 
LVI and LIX were found to be the most active antibacterial agents among the eight 
compounds studied. The diameters of Zones of inhibition for different fungal strains 
are shown in Table 6.5.3 and the MIC are shown in Table 6.5.4. The in vitro 
antifungal activity assay showed that compound LX was the most active antifungal 
agent among the eight newly synthesized compounds. 
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Table 6.5.3. 
Compound 
LHI 
LIV 
LV 
LVI 
LVn 
Lvm 
Antifungal activity of fatty acid 
diameter of; 
CA 
18.3 ±0.2 
19.5 ±0.2 
15.5 ±0.5 
17.8 ±0.2 
19.6 ±1.4 
18.7 ±0.5 
1 analogs of cholesterol. 
zone of inhibition (mm) at 100 \ig/mL 
CK 
16.1 ±0.2 
17.5 ±0.4 
13.4 ±1.2 
15.5 ±0.3 
17.8 ±0.2 
16.8 ± 0.3 
CP 
15.1 ±0.2 
16.8 ±0.2 
12.8 ±0.2 
14.4 ± 0.4 
16.9 ±0.3 
15.7^0.3 
CN 
12.1 ±0.2 
15.9 ±0.4 
12.7 ±0.5 
13.8±1.2 
15.8 ±1.2 
15.1 ±0.2 
LIX 20.3 ± 1.2 18.7 ± 0.4 17.8 ± 0.4 16.9 ± 02 
LX 22.5 ± 0.5 20.7 ± 0.4 19.8 ± 0.4 19.1 ± 0.5 
Fluconazole 29 ± 0.5 29 ± 0.5 24.5 ± 0.5 19.5 ± 0.5 
DMSO - - -
CA; Candida albicans, CK; Candida krusei, CP; Candida parapsilosis. CN; 
Cryptococcus neoformans. 
Positive control (Fluconazole) and negative control (DMSO). 
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Table 6.5.4. Minimum inhibition concentration (MIC) of fatty acid analogs of 
cholesterol. 
Strains 
C albicans 
C. krusei 
C. parapsUosis 
C. neoformans 
I 
2 
256 
32 
128 
II 
1 
128 
8 
32 
Compounds 
m IV 
MIC( 
16 4 
256 512 
256 64 
128 64 
V 
;ng/mi) 
1 
128 
8 
32 
VI 
2 
256 
16 
32 
VII 
1 
64 
8 
8 
VII 
1 
64 
8 
8 
Positive 
control 
1.0 
64.0 
8.0 
8.0 
Positive control: Fluconazole. 
The varied divergence in the antimicrobial activity of these compounds 
validates the reason of this study. The importance of such work lies in the possibility 
that the new compounds might be more effective against bacteria for which a 
thorough investigation regarding the structure-activity relationship, toxicity and 
their biological effects which would be helpful in designing more potent 
antimicrobial agents for therapeutic use is required. 
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6.3 EXPEIIMENTAL 
The tested organisms used in the study included E. coli, E. aerogenes, B. 
subtilis, P. aeruginosa, S. aureus, S. albus, S. pyogenes and S. typhimurium were 
provided by Depatment of Microbiology, J. N. Medical College, A. M. U Aligarh, 
India. Nutrient broth and agar were obtained from Hi-Media Pvt. Ltd. (Mumbai, 
India). 
6.3.1. Antibacterial activity of compounds V-Xn, XVH-XXIV, XXV-XXXH 
and XXXVn-XLIV. 
The in vitro antibacterial activity of hydrazoes V-Xn was carried out against 
Gram-negative bacteria E. coli and Gram-positive bacteria S. aureus and S. albus. 
Antibacterial activity of 2,5-disubstituted oxadiazoles XVII-XXIV, 1,2,4-triazoles 
XXXVn-XL and 4-oxo-l,3-thiazolidines XLI-XLIV was carried out against E. 
coli, , E. aerogenes and S. aureus while as the antibacterial activity of 2,5-
disubstituted thiadiazoles XXV-XXXn was carried out against Gram-negative 
bacteria E. coli, S. typhii and Gram-positive bacteria S. aureus andS. albus. 
These strains were streaked on nutrient agar plates separately and grown 
overnight. Single well isolated colonies of each type of bacteria were incubated in 
separate nutrient medium for 16 hrs at 37 °C for the experiment. To determine the 
zone of inhibition cup-plate method was employed.'' In this technique bacteria 
liquid culture of each type grown in log phase was added aseptically to the 
autoclaved LB agar medium maintained at 45 °C, mixed well and poured 
immediately into sterile Petri dishes separately. After solidification wells of about 
6mm were cut into agar plates aseptically. 
Solutions of lOO^g/ml of hydrazones V-Xn, 2,5-disubstituted oxadiazoles 
XVn-XXIV, 1,2,4-triazoles XXXVH-XL and 4-oxo-l,3-thiazolidines XLI-XLIV 
and 50fig/ml 2,5-disubstituted thiadiazoles XXV-XXXn were prepared in DMF. 
Standard antibiotic Chloromycetin was screened under similar conditions. 100^1 of 
these solutions were added to each well and incubated at 37 °C. One of the wells was 
used as control by adding lOOng/ml of DMF. Zone of inhibition was measured in 
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mm after 24 hrs and compared with standard drug. Results of antibacterial screening 
are reported in Table 6.1-Table 6.4. 
6.3.2. Antimicrobial activity of compounds LIII-LX. 
Antibacterial activity of the synthesized compounds was completed by the 
disk diffusion method with slight modifications.'^  Inoculums of S. mutants, P. 
aeruginosa, S. aureus, S. pyogenes, S. typhimurium, and E. coli were prepared in 
Brain Heart Infusion medium and incubated for 18 hrs at 37 X. Subsequently a 
suspension of about lO' CFU/mL was prepared in autoclaved saline solution 
according to the McFarland protocol. Then 10 pi of this saline suspension was 
mixed with 10 mL of sterile antibiotic agar at 40 °C and plates were poured under 
aseptic conditions. Five paper disks of 6.0 mm diameter were place on these nutrient 
agar plates. One mg of each test compound was dissolved in 100 pi dimethyl 
sulphoxide (DMSO) to get ready stock solution and from this stock solution varied 
concentrations 10, 20, 25, 50, and 100 mg/ L of all trial compounds were set. 
Subsequently the compounds of varied concentrations were poured over disk plate 
on to it. The disk of Chloramphenicol (30|xg) was use as a positive control and 
DMSO poured disk as a negative control. The susceptibility was assessed on the 
basis of diameter of zone of inhibition against Gram-positive and Gram-negative 
strains of bacteria and fungi. The zones of inhibition (mm) of all compounds against 
Gram-positive and Gram-negative strains of bacteria are shown in Table 6.5.1. The 
macro dilution test with standard inoculums of IQ^ CFU/mL was used to assess the 
minimum inhibitory concentration (MIC) of test compounds (Table 6.5.2). The 
DMSO was made to dissolve the compounds. Serial dilutions of the compounds 
were prepared to the final concentrations of 512, 256, 128, 64, 32, 16, 8, 4, 2 and 1 
mg/L. These tubes were kept at 37°C for 18 hrs. For assaying antifungal activity 
Candida albicans, Candida krusei, Candida parapsilosis, Cryptococcus 
neoformans were inoculated in Sabouraud Dextrose broth medium (Hi-Media 
Mumbai) and incubated for 24 hrs at 35 °C, and subsequently a suspension of about 
10^  CFU/mL was prepared in sterile saline solution according to the McFariand 
protocol. Sabouraud Dextrose Agar (SDA) plates were streaked using sterilized 
cotton swabs of each fungal cell. Five paper disks of 6.0 mm diameter were put onto 
Sabouraud Dextrose agar plate. 1 mg of each test compound was dissolved in 100 pi 
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DMSO to get ready stock solution and from this stock solution varied concentrations 
10, 20, 25, 50, and 100 mg/L of all trial compounds were set. Subsequently the 
compounds of varied concentrations were poured over disk plate on to it. The disk of 
fluconazole (30|ig) was used as a positive control and disk of DMSO used as a 
negative control. The susceptibility of different fungal strains against test 
compounds was assessed on the basis of diameter of zone of inhibition after A% hrs 
of incubation at 35 °C. Resuhs of antifungal activity are shown in Table 6.5.3 and its 
MIC is shown in Table 6.5.4. 
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